Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADIPOQ,Adiponectin,38013,-0.267509397592134,0.00605511164385013,-0.27937741641408,-0.255641378770187,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGRP,Agouti-related protein,40516,0.278554226535196,0.00471089764402836,0.2693208671529,0.287787585917492,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN1,CCN family member 1,40280,0.376277696795498,0.00696501613376711,0.362626265173315,0.389929128417682,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES1,Liver carboxylesterase 1,40352,0.30889408803294,0.00699435904376492,0.295185144307161,0.322603031758719,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F7,Coagulation factor VII,40376,0.112466492580691,0.0027728261339443,0.10703175335816,0.117901231803222,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FURIN,Furin,40411,0.136766742167542,0.00308987388696905,0.130710589349083,0.142822894986002,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCG,Pro-glucagon,39980,0.516247567639687,0.0114006402599132,0.493902312730258,0.538592822549117,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHR,Growth hormone receptor,37671,0.109146336627775,0.00264797464214336,0.103956306329174,0.114336366926376,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.299783652267322,0.00688398725707437,0.286291037243456,0.313276267291188,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF9,Protein turtle homolog A,37990,0.31344151086301,0.00727338247523021,0.299185681211558,0.327697340514461,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INHBC,Inhibin beta C chain,40332,0.162346814191358,0.00393734707352268,0.154629613927254,0.170064014455462,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LDLR,Low-density lipoprotein receptor,40356,0.418222757091274,0.00386989700069181,0.410637758969918,0.42580775521263,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPL,Lipoprotein lipase,40359,-0.196262012273315,0.00418458195179468,-0.204463792898833,-0.188060231647797,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFGE8,Lactadherin,40332,0.233096741822002,0.00366330389883407,0.225916666180288,0.240276817463717,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPY,Pro-neuropeptide Y,40489,0.356310214349363,0.00584154673862722,0.344860782741653,0.367759645957072,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRAP1,Proline-rich acidic protein 1,37998,0.171872529077066,0.00385530560217232,0.164316130096808,0.179428928057324,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,40424,0.180611869021864,0.00425009125044792,0.172281690170986,0.188942047872742,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.127755593294495,0.00304525147298712,0.12178690040744,0.13372428618155,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS15,Enteropeptidase,40305,0.332123349168361,0.00854830858795936,0.315368664335961,0.348878034000762,1.11253701323807e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPM,Carboxypeptidase M,40415,0.123012387809259,0.00318701800612763,0.116765832517249,0.129258943101269,1.1130928985743e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0795190265372833,0.00205474096876205,0.0754917342385097,0.083546318836057,1.11633468152081e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRP1,Neuropilin-1,40424,-0.100765539907012,0.00262138942211005,-0.105903463174348,-0.0956276166396763,1.2573598892816e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTH,Parathyroid hormone,37572,0.277380468038508,0.00729991163088444,0.263072641241974,0.291688294835041,7.98443200884444e-300
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG2,Desmoglein-2,40332,-0.0945362950987011,0.00251136035149269,-0.0994585613876268,-0.0896140288097755,4.012427263773e-297
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC39A5,Zinc transporter ZIP5,40341,0.187257348702046,0.00499373523046111,0.177469627650343,0.19704506975375,5.90215571178987e-295
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.146186117187122,0.00392816790990754,0.138486908083703,0.153885326290541,9.08395079938042e-291
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR37,Prosaposin receptor GPR37,40042,0.231394314920442,0.00626845539013284,0.219108142355782,0.243680487485103,4.79784684922562e-286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL27,C-C motif chemokine 27,40359,0.202656333584041,0.00556167646995547,0.191755447702928,0.213557219465154,2.80097913847115e-279
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD4,T-cell surface glycoprotein CD4,40309,0.102436260267916,0.00285697203946868,0.0968365950705579,0.108035925465275,8.82114463477392e-271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASGR1,Asialoglycoprotein receptor 1,40228,0.097924833630256,0.00274297716832169,0.0925485983803455,0.103301068880167,1.66749768641626e-268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL23,C-C motif chemokine 23,40422,0.136644955582799,0.00383750817800221,0.129123439553914,0.144166471611683,2.67116484000279e-267
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.26747683544238,0.00752228920400777,0.252733148602525,0.282220522282235,2.63112060588691e-266
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.291140564878055,0.00821236057855731,0.275044338144083,0.307236791612027,5.42190372510814e-265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.25828810999545,0.00740833695413447,0.243767769565347,0.272808450425554,1.13558891274351e-256
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300LG,CMRF35-like molecule 9,40332,-0.121625678346527,0.0035377031792413,-0.12855957657784,-0.114691780115214,6.62892164202184e-250
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON3,Serum paraoxonase/lactonase 3,40422,-0.0884259963965661,0.0025724980082216,-0.0934680924926804,-0.0833839003004517,7.23449426164654e-250
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.336779985297303,0.00982982535764685,0.317513527596316,0.356046442998291,3.06212321375406e-248
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLTP,Phospholipid transfer protein,40461,-0.1100372835293,0.00321468761725012,-0.11633807125911,-0.103736495799489,6.90307664883641e-248
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.3696770919427,0.011038918158924,-0.391313371534191,-0.348040812351209,9.93495520691987e-238
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.171301337407651,0.00512118280597902,0.161263819107932,0.18133885570737,5.68192095244373e-237
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APCS,Serum amyloid P-component,37882,0.112402836663294,0.00336174629138204,0.105813813932185,0.118991859394402,1.62125433673666e-235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINF1,Pigment epithelium-derived factor,37790,0.0805879671969106,0.00242661692270381,0.0758317980284111,0.0853441363654101,1.96081152514189e-232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROC,Vitamin K-dependent protein C,40372,0.0785958928812533,0.00237476918924152,0.0739413452703399,0.0832504404921666,2.33074292114822e-232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.262037591977638,0.00791464621159394,0.246524885402914,0.277550298552362,2.33701678607493e-232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTR,Transthyretin,37871,0.0794110703067651,0.00239362572186615,0.0747195638919075,0.0841025767216228,4.91172110357363e-232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUSB,Beta-glucuronidase,40419,0.181752522087198,0.00550344406386199,0.170965771722028,0.192539272452367,1.99653137686459e-231
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.457478993949901,0.0139153975329193,0.43020481478538,0.484753173114423,2.71819631188803e-229
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F9,Coagulation factor IX,40372,0.0554297016935733,0.00169183938249917,0.0521136965038749,0.0587457068832716,6.81457869690863e-228
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.107007279481605,0.00326819271017615,0.10060162176966,0.11341293719355,1.14896536279964e-227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.20782163764877,0.00635017719736363,0.195375290341938,0.220267984955603,2.21272339155366e-227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0938108510402041,0.00286087090311588,-0.0994181580103112,-0.088203544070097,8.42815426356118e-227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFI,Complement factor I,38013,0.0611843200391328,0.0018863711098134,0.0574870326638986,0.0648816074143671,2.45644242208257e-222
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.313510869066146,0.00971878543661517,0.29446204961038,0.332559688521911,3.47231129791192e-221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.193143910721787,0.00599237894674187,-0.204888973457401,-0.181398847986173,6.61298686037773e-221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL6,C-X-C motif chemokine 6,40516,0.235994293475265,0.00732966064214871,0.221628158616654,0.250360428333877,1.84200851156144e-220
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGR3,Anterior gradient protein 3,39963,0.179142072123484,0.00561153155647735,0.168143470272788,0.190140673974179,1.18912521336576e-216
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTA1,Glutathione S-transferase A1,40333,0.248712453617126,0.00780363799101365,0.233417323154739,0.264007584079513,4.02050418639429e-216
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0923720107544624,0.00291153471533985,0.0866654027123963,0.0980786187965285,2.79445355817068e-214
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPIND1,Heparin cofactor 2,37981,0.0816768117133467,0.00257188346759552,0.0766359201168594,0.0867177033098339,1.55366677109287e-213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRIP2,Cysteine-rich protein 2,40228,0.10782844423814,0.00340661630174974,0.101151476286711,0.11450541218957,3.06011318707174e-213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.155530952642454,0.00492495366208084,0.145878043464776,0.165183861820133,2.12076856709163e-212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACY1,Aminoacylase-1,40359,0.177021451447568,0.00561644958195901,0.166013210266929,0.188029692628208,1.47229173552563e-211
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.163874123538026,0.005199818711325,0.153682478863829,0.174065768212223,1.67960472516774e-211
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN3,Contactin-3,40332,0.102909347019565,0.00330165951561224,0.0964380943689646,0.109380599670165,4.59589786680002e-207
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFH,Complement factor H,37301,0.0678318655586294,0.00217299632578452,0.0635727927600918,0.0720909383571671,2.93880892107567e-206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.170896385560546,0.00553576591952609,0.160046284358275,0.181746486762817,3.78092694303342e-203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHBG,Sex hormone-binding globulin,37987,-0.156983340966332,0.0050799741813128,-0.166940090361705,-0.147026591570959,1.11776814032742e-202
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF21,Fibroblast growth factor 21,40453,0.340970435132345,0.0110671502180646,0.319278820704938,0.362662049559752,1.54647100455532e-202
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA5,Plasma serine protease inhibitor,37835,0.0953870688515505,0.00310092140239493,0.0893092629028565,0.101464874800245,7.85849809423751e-201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPB1,Beta-ureidopropionase,37990,0.26429040334676,0.00860710471473922,0.247420478105871,0.281160328587649,3.18961995253512e-200
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTA3,Glutathione S-transferase A3,39980,0.218938221572715,0.00715189009214918,0.204920516992103,0.232955926153327,6.86341837092412e-200
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS3,"Nitric oxide synthase, endothelial",39961,0.157923870538427,0.00516944861372994,0.147791751255516,0.168055989821337,4.32211722700709e-199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP5,Retinol-binding protein 5,40305,0.159503542979186,0.0052261552332348,0.149260278722046,0.169746807236326,7.57279188636077e-199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0995621471917697,0.00327467045194213,-0.105980501277576,-0.0931437931059631,1.8158668062577e-197
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.0898710497057568,0.0029709510324735,0.0840479856821087,0.0956941137294049,1.75660668653638e-195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS8,Prostasin,40293,0.115389552320101,0.00381977067027615,0.10790280180636,0.122876302833842,5.92252581669194e-195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA1,Ephrin type-A receptor 1,40400,0.0972961141121351,0.00323065643429353,0.0909640275009198,0.10362820072335,7.55240466676116e-194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.207040653953527,0.00693788479642128,0.193442399752542,0.220638908154513,2.14413407958549e-190
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLA,Alpha-galactosidase A,37642,0.101924907740425,0.00341676402131891,0.0952280502586394,0.10862176522221,2.78999676516902e-189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.129072697324769,0.00435183631966758,0.120543098138221,0.137602296511318,3.78926960758967e-188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMBP,Protein AMBP,40470,0.0560313787022945,0.00189648206224679,0.0523142738602908,0.0597484835442982,7.56480637811812e-187
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF8,Immunoglobulin superfamily member 8,40359,0.0832261414600861,0.00283271472159651,0.077674020605757,0.0887782623144153,8.15359316629701e-185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFM,Afamin,38013,0.0518560598415987,0.00176157918798608,0.048403364633146,0.0553087550500515,1.1071076327942e-184
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAT,Tissue-type plasminogen activator,40490,0.136395435788067,0.00464700284880742,0.127287310204405,0.14550356137173,1.67823267471895e-184
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C9,Complement component C9,37987,-0.134808237348244,0.00460209820751389,-0.143828349834971,-0.125788124861516,6.15255445376569e-183
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.204497954034103,0.00700530093859236,0.190767564194462,0.218228343873744,1.68583354365841e-182
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0708067566604225,0.00242581794847855,0.0660521534814045,0.0755613598394405,1.77192198689552e-182
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAMR1,Inactive serine protease PAMR1,40332,0.0768280268843314,0.00264777997236411,0.0716383781384977,0.082017675630165,2.037481462329e-180
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL16,C-C motif chemokine 16,40536,0.145541006502402,0.00501871622348237,0.135704322704377,0.155377690300428,2.80377001188444e-180
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFB1,BPI fold-containing family B member 1,40261,-0.168763054490654,0.00584681387717846,-0.180222809689924,-0.157303299291384,1.39585496674098e-178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA4,Kallistatin,37781,0.0654395681966323,0.00226753751267083,0.0609951946717975,0.0698839417214671,1.06293502002782e-177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM20A,Pseudokinase FAM20A,37990,0.0768962810414055,0.00267668340811732,0.0716499815614956,0.0821425805213155,3.10928436822515e-176
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCHE,Cholinesterase,37748,0.0767996905603727,0.00267494726834317,0.0715567939144201,0.0820425872063253,6.16639060849463e-176
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,39980,0.295209580051417,0.0103087148536716,0.275004498938221,0.315414661164614,8.36365814224028e-176
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHMP6,Charged multivesicular body protein 6,37990,0.151169546555049,0.00527505808016699,0.140830432717921,0.161508660392176,2.11376344798872e-175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFP,Properdin,38013,0.0589119759637683,0.00206991613493709,0.0548549403392916,0.062969011588245,4.13833959369528e-173
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0497548901215434,0.00175420206701611,0.0463166540701918,0.0531931261728949,1.48053253545827e-172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.149639788108824,0.00529194110140149,0.139267583550077,0.160011992667571,1.37628455204331e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KYNU,Kynureninase,40516,0.11953640699955,0.00423590157621914,0.11123403991016,0.127838774088939,4.83089338077995e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.222917023123159,0.00789012901873264,0.207452370246443,0.238381675999875,1.18946247139263e-170
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFR2,Fibroblast growth factor receptor 2,40411,0.057191434231736,0.00202958795826427,0.053213441833538,0.061169426629934,1.54615909635648e-170
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAPIN,SNARE-associated protein Snapin,37959,0.152661989321108,0.00543976704752697,0.142000045907956,0.163323932734261,1.74817027727768e-168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLUL1,Clusterin-like protein 1,40338,-0.120716376634899,0.00432570079332119,-0.129194750189809,-0.11223800307999,2.33815014418082e-167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.158151700540342,0.00568365584584359,-0.169291665998196,-0.147011735082489,2.15008029842461e-166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,37598,0.222462459436645,0.00799344306471854,0.206795311029797,0.238129607843493,1.11607188361077e-165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F10,Coagulation factor X,37987,0.0683471892947133,0.00245929233985525,0.063526976308597,0.0731674022808295,2.31146672806014e-165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F11R,Junctional adhesion molecule A,40332,0.14877853033965,0.00536881766551902,0.138255647715232,0.159301412964067,4.17852247030354e-165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,P4HB,Protein disulfide-isomerase,40266,0.101586484675767,0.00367262632624272,0.0943881370763317,0.108784832275203,1.67593715649243e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKB,Creatine kinase B-type,37998,-0.158650419987134,0.0057479580163185,-0.169916417699118,-0.147384422275149,3.37720109374061e-163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0495166550916369,0.00180241408476112,0.0459839234855051,0.0530493866977686,2.31522269677638e-162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOMO1,Nodal modulator 1,40332,0.0616653556863961,0.00225023981883034,0.0572548856414886,0.0660758257313035,1.38079128567297e-161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREG1,Protein CREG1,40145,0.0938106260068551,0.00342381661376275,0.0870999454438802,0.10052130656983,1.71512356082938e-161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.176175327790217,0.00644566491806208,0.163541824550815,0.188808831029619,3.98390307654603e-160
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.174393509101317,0.00640535145824435,0.161839020243158,0.186947997959476,1.72322812520861e-159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTN4R,Reticulon-4 receptor,40489,0.0875097726617411,0.00322105842752657,0.081196498143789,0.0938230471796931,6.01696523126418e-159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL16,Pro-interleukin-16,40516,0.104301748067992,0.00384120205524462,0.0967729920397127,0.111830504096272,8.67860698156302e-159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRP,Gastrin-releasing peptide,37628,0.140613056800094,0.00517561493471209,0.130468851528059,0.15075726207213,3.36352632856818e-158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUMB,Protein numb homolog,37598,0.215042212369227,0.00791830544938049,0.199522333688441,0.230562091050013,4.53760546997607e-158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.106606837967071,0.00394521281065277,0.0988742208581918,0.114339455075951,2.92544469915488e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNCA,Alpha-synuclein,37671,0.291550303178122,0.0108128710723568,0.270357075876303,0.312743530479941,6.31961329273737e-156
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAB2,Stabilin-2,37998,0.0715445015173146,0.00265575911649794,0.0663392136489787,0.0767497893856506,9.30001511186623e-156
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTSS1,Protein MTSS 1,37901,0.282934215780698,0.0105210772085125,0.262312904452013,0.303555527109382,3.32439357991193e-155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPY30,Protein dpy-30 homolog,40414,0.151712656358058,0.0056555732381819,0.140627732811222,0.162797579904895,4.39863167442389e-155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAT2,Linker for activation of T-cells family member 2,40305,0.311498437140542,0.0116221251254858,0.28871907189459,0.334277802386495,8.40210467052838e-155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO3,Beta-enolase,37628,0.144793579987529,0.00540213334156362,0.134205398638065,0.155381761336994,3.88846679735362e-154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.183947158323903,0.00689966653540868,0.170423811914502,0.197470504733304,1.14733768600518e-152
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18R1,Interleukin-18 receptor 1,40516,0.0821178549671943,0.00310174791972249,0.0760384290445382,0.0881972808898504,3.26596670565286e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.351983449376532,0.0132679453558211,0.325978276479123,0.377988622273942,3.38124975175296e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.171693286926418,0.00647009228876155,0.159011906040446,0.184374667812391,3.48910374374379e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.144412790917053,0.00544639360002018,0.133737859461014,0.155087722373093,5.68915053054048e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PYY,Peptide YY,37562,0.23832380709284,0.00903888825239219,0.220607586118151,0.256040028067529,2.50516075624798e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP29,Synaptosomal-associated protein 29,40411,0.227819497476325,0.00867950232148203,0.21080767292622,0.24483132202643,1.06047171024114e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCLY,Selenocysteine lyase,40434,0.119101591862849,0.0045414028984022,0.110200442181981,0.128002741543717,1.8393239705757e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR5,Cadherin-related family member 5,40359,0.0971598183720696,0.00371081771698396,0.0898866156467811,0.104433021097358,5.58934731405224e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL17,C-X-C motif chemokine 17,40516,0.103197814011708,0.00394633170943321,0.0954630038612191,0.110932624162197,1.18269670265083e-147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTYMK,Thymidylate kinase,37990,0.171965264754349,0.0065859323696107,0.159056837309912,0.184873692198786,1.13465865211391e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSD,Cathepsin D,39243,0.0990565857180061,0.00379866777048386,0.0916111968878578,0.106501974548154,1.34876012522402e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0687002664993663,0.00263673213812205,0.0635322715086471,0.0738682614900855,1.38870539086581e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.152997798114588,0.00587122504203417,0.141490197032201,0.164505399196975,1.48007297295428e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NHLRC3,NHL repeat-containing protein 3,37370,0.0789520966847853,0.00303863382389984,0.0729963743899416,0.084907818979629,4.0078776128376e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0850547816488006,0.00328993727585422,0.0786065045881263,0.0915030587094748,2.08048929265632e-144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABL1,Tyrosine-protein kinase ABL1,40305,0.1668027040413,0.00646951054473392,0.154122463373622,0.179482944708979,1.23893468829454e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.218190000993792,0.0084643477641532,0.201599879376052,0.234780122611532,1.47684884929012e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MVK,Mevalonate kinase,40044,0.188348273163875,0.0073105892284729,0.174019518276068,0.202677028051682,2.22252496190016e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCS1,Neuronal calcium sensor 1,40489,0.0700472420097567,0.00272386994870359,0.0647084569102977,0.0753860271092158,6.00777001601236e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAA80,N-alpha-acetyltransferase 80,37572,0.291555860600413,0.0113122605583108,0.269383829906124,0.313727891294702,6.1548256910746e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0514154117211295,0.00200032736160758,0.0474947700923786,0.0553360533498803,8.19592129085929e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFPI,Tissue factor pathway inhibitor,40309,0.0762463932619645,0.00296744425074668,0.070430202530501,0.0820625839934279,1.1076140165128e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EEF1D,Elongation factor 1-delta,37990,0.224317128680738,0.00871844990287154,0.20722896687111,0.241405290490366,1.43739922509743e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0913757809086513,0.00358147768790855,-0.098395477176952,-0.0843560846403505,9.17047206317333e-141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH9,Myosin-9,37998,0.273033190730033,0.0106960851469097,0.25206886384209,0.293997517617976,2.03735857310908e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FYB1,FYN-binding protein 1,40311,0.221478730774039,0.00871283245764698,0.204401579157051,0.238555882391027,9.42675823857578e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR2,Cadherin-related family member 2,40305,0.186020181648979,0.00732245500404225,0.171668169841056,0.200372193456902,1.38916632030292e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0736279320246156,0.00293292374944753,0.0678794014756984,0.0793764625735328,2.0520453032359e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YES1,Tyrosine-protein kinase Yes,40305,0.271341593698853,0.010817389202694,0.250139510861573,0.292543676536133,3.33605747567024e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTBS,Di-N-acetylchitobiase,37819,0.0648241258885059,0.00258088222518451,0.0597655967271443,0.0698826550498676,4.51833396123568e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAMDC4,Apical endosomal glycoprotein,37900,0.130692792395002,0.00520734844475099,0.12048638944329,0.140899195346714,6.88232599651725e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0485304577615898,0.00194172106830518,0.0447246844677116,0.0523362310554679,2.93944814244678e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYAP1,Synapse-associated protein 1,37671,0.134789145578868,0.00538547029416786,0.124233623802299,0.145344667355437,4.102431416118e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.201489489574169,0.00805808362328042,0.18569564567254,0.217283333475799,7.39089674449822e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0931894315868225,0.00373537957138968,0.0858680876268987,0.100510775546746,8.14988056609887e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HJV,Hemojuvelin,37959,0.1098584174783,0.00439834967083757,0.101237652123459,0.118479182833142,1.20067010631676e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGF,Hepatocyte growth factor,40516,0.0814352402620385,0.0032709258618628,0.0750242255727874,0.0878462549512895,2.80202064931344e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.189216816643297,0.00760103182240157,0.17431879427139,0.204114839015204,9.10558509010569e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL22,C-C motif chemokine 22,40204,0.12194102897362,0.00491191009390505,0.112313685189566,0.131568372757674,1.72386451608459e-133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MLN,Promotilin,40341,0.210167029476065,0.00847463448894326,0.193556745877737,0.226777313074394,3.0590907843456e-133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL13,C-X-C motif chemokine 13,40471,0.150076230754501,0.00605311530695045,0.138212124752878,0.161940336756124,3.39786510656034e-133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEG1,Protein HEG homolog 1,37671,0.0624321303607239,0.00251930311523143,0.0574942962548703,0.0673699644665776,1.46817773409962e-132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0959448935723809,0.00388105742007854,-0.103551766115735,-0.088338021029027,1.98642341401782e-132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.120401087739676,0.00487699058121038,0.110842186200504,0.129959989278849,1.21229921119012e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORD,Sorbitol dehydrogenase,40417,0.15694495963295,0.00638459973429854,0.144431144153724,0.169458775112175,5.32680690905901e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPPC,C-type natriuretic peptide,40341,0.101087254766251,0.00411920477062256,0.0930136134158309,0.109160896116671,1.45601244323173e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.113580249644503,0.00463262006204445,0.104500314322896,0.12266018496611,7.46934160152628e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL2,Angiopoietin-related protein 2,40377,0.0931181092389134,0.00380681561232551,0.0856567506387554,0.100579467839071,9.44575935725475e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA3F,Semaphorin-3F,40359,0.060336710434544,0.00247174220223702,0.0554920957181594,0.0651813251509285,3.11277189116345e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KHK,Ketohexokinase,37628,0.15042341492172,0.00615854449412905,0.138352667713227,0.162494162130213,6.64828032194753e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0921576493441215,0.00378800655359483,-0.0995821421891674,-0.0847331564990756,2.13374507082217e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXLNA,Alpha-taxilin,40228,0.206414530300158,0.00850742513335633,0.18973997703878,0.223089083561537,1.04671950609528e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YTHDF3,YTH domain-containing family protein 3,40044,0.196305730824635,0.0081022669737562,0.180425287556073,0.212186174093197,2.48942590783716e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD2AP,CD2-associated protein,40359,0.147386965669646,0.00611240069292012,0.135406660311523,0.15936727102777,3.34462359809745e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCN2,Ficolin-2,40291,0.0943726413798794,0.00391934256283834,0.0866907299567162,0.102054552803043,7.55975158049134e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KDR,Vascular endothelial growth factor receptor 2,40411,0.0579759862256765,0.00241370984542996,0.0532451149286338,0.0627068575227193,2.88437581884591e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCAM,Cell surface glycoprotein MUC18,40403,-0.0777816493428911,0.00325256330981314,-0.0841566734301249,-0.0714066252556573,3.3334189505588e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TJAP1,Tight junction-associated protein 1,40411,0.188468520167138,0.00788413161436509,0.173015622202983,0.203921418131294,4.109934897558e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES3,Carboxylesterase 3,40305,0.156208181472798,0.00655465978191394,0.143361048300246,0.169055314645349,2.2986576575794e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSP1,Lymphocyte-specific protein 1,40341,0.0910535598211726,0.00382186168874403,0.0835627109112343,0.0985444087311109,2.68522918885606e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.216832202930427,0.00910801149467978,0.198980500400855,0.23468390546,4.03174115169099e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SARG,Specifically androgen-regulated gene protein,37931,0.247280765942919,0.0103708963226358,0.226953809150553,0.267607722735286,4.09370600014094e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.103456989732362,0.00434425718642639,0.0949422456469663,0.111971733817758,8.93628579345039e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.186111929090779,0.00785090967169266,0.170724146134262,0.201499712047297,3.94957081382884e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BECN1,Beclin-1,37628,0.138471705444667,0.00583450874918228,0.127036068296269,0.149907342593064,5.82677159340865e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.219612619097393,0.0092843859464052,0.201415222642438,0.237810015552347,1.35990663472941e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPY,Pancreatic prohormone,40337,0.227983616222951,0.00964106014456308,0.209087138339607,0.246880094106294,1.57460555780034e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.163741717460717,0.0069221112672518,0.150174379376903,0.17730905554453,3.46756462270745e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSO,Cathepsin O,40516,0.0679010921670281,0.00287869191648856,0.0622588560107106,0.0735433283233457,5.84651529407204e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.102233399268361,0.0043439130555598,0.0937193296794635,0.110747468857258,2.06408809890368e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.108916090689391,0.0046319884138162,0.0998373933983108,0.11799478798047,3.32924991872775e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROS1,Vitamin K-dependent protein S,38013,0.0564434411967917,0.00239810624359022,0.0517431529593549,0.0611437294342286,4.32596659059622e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.121864518115381,0.00518741093217194,0.111697192688324,0.132031843542438,5.55477215462573e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK1,Dickkopf-related protein 1,40471,0.133889446087938,0.00570539045349102,0.122706880799096,0.145072011376781,9.17894406711164e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDUA,Alpha-L-iduronidase,40489,0.101483196679407,0.00432515637127815,0.0930058901917021,0.109960503167112,9.93550369190369e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOST,Sclerostin,40330,0.0866904550278943,0.00369822400188085,0.0794419359842078,0.0939389740715808,1.72788805699521e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN1,Dynactin subunit 1,40489,0.147288340427766,0.00628811076096795,0.134963643336268,0.159613037519263,2.4735964644637e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.187941670226584,0.0080167625372298,0.172228815653614,0.203654524799554,3.67937145486304e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUCB2,Nucleobindin-2,40447,0.0830901854751971,0.00355121229248722,0.0761298093819221,0.090050561568472,4.47373934950903e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLKB1,Plasma kallikrein,37721,0.0563890210097287,0.00240648777404466,0.0516723049726011,0.0611057370468562,5.17011809878492e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.185492855635031,0.00793983634016198,0.169930776408313,0.201054934861748,2.53790106049614e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORT1,Sortilin,40330,0.0810534537088491,0.00347535800033483,0.0742417520281929,0.0878651553895054,2.54433334574015e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OXT,Oxytocin-neurophysin 1,40471,0.294490919359411,0.0126554308743894,0.269686274845608,0.319295563873214,7.98507782001446e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC1B,C-type lectin domain family 1 member B,40471,0.214355992767786,0.00921380405515052,0.196296936819691,0.232415048715882,8.9920370908331e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADH1B,All-trans-retinol dehydrogenase,37671,0.164459693416317,0.00706481734921661,0.150612651411853,0.178306735420782,1.65699857237887e-117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FETUB,Fetuin-B,40372,0.0750057175982946,0.00323302372419382,0.0686689910988748,0.0813424440977145,3.97339012438032e-117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LBR,Delta(14)-sterol reductase LBR,40471,0.145572276861934,0.0062756282644569,0.133272045463598,0.157872508260269,4.17664387840232e-117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATRN,"Attractin, Isoform 2",38013,0.0363161690401968,0.00156367550542544,0.033251365049563,0.0393809730308307,4.84142321875216e-117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0602395817536907,0.00260369204641218,0.0551363453427228,0.0653428181646585,1.64515247007308e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0890906626410315,0.00384617819892721,0.0815521533711342,0.0966291719109288,1.96339610830762e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EZR,Ezrin,40471,0.0522755567994654,0.00226521615398228,0.0478357331376601,0.0567153804612707,6.01734168938522e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EHBP1,EH domain-binding protein 1,37990,0.164914321451547,0.00713542373231763,0.150928890936204,0.178899751966889,6.0624521862908e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES2,Cocaine esterase,40305,0.118027396827763,0.00511909897902927,0.107993962828865,0.12806083082666,1.01135416024928e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,39961,0.173692409389078,0.00754540341741639,0.158903418690942,0.188481400087214,2.51974937257634e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP3S2,AP-3 complex subunit sigma-2,37942,0.102727799907418,0.00446152769091492,0.0939832056332243,0.111472394181611,4.25240487475318e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.107879064416014,0.00469966211303355,0.0986677266744687,0.11709040215756,9.18759015803244e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAXX,Protein PAXX,37671,0.0993436206888974,0.00433561844396392,0.0908458085387281,0.107841432839067,5.59905515222466e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGRN,Agrin,40422,0.0725696088288151,0.00317755820226822,0.0663415947523694,0.0787976229052608,1.25770567914384e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD63,CD63 antigen,40203,0.113750488444379,0.0049879178093424,0.103974169538068,0.12352680735069,2.76159201556767e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",40305,0.167726580383544,0.00736698608465264,0.153287287657624,0.182165873109463,6.21263333303836e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THOP1,Thimet oligopeptidase,40288,0.0651798926645162,0.00286825613386125,0.0595581106421481,0.0708016746868842,1.60307390101405e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.22646800601029,0.00997143708953918,0.206923989314793,0.246012022705787,2.1363436132084e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AXIN1,Axin-1,40341,0.204282815199802,0.00900083185122854,0.186641184771394,0.221924445628209,2.9691095140961e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GH1,Somatotropin,40330,-0.380669688337401,0.0167726449085228,-0.413544072358105,-0.347795304316696,2.98576248318591e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP20,Centrosomal protein 20,39980,0.159974004961023,0.00704866373308304,0.14615862404418,0.173789385877865,3.28424829825449e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.107694618740743,0.00474931734177092,0.0983859567508717,0.117003280730614,5.08157884827341e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPK9,Mitogen-activated protein kinase 9,40341,0.0932064557669813,0.00411276892832456,0.0851454286674651,0.101267482866497,6.17817284960243e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.151520348148274,0.00670147588023199,0.13838545542302,0.164655240873529,2.15634734516902e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.118655191198806,0.00525126933936756,0.108362703293646,0.128947679103966,3.03519257776948e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACE2,Angiotensin-converting enzyme 2,40042,0.105808695529036,0.00468423210054097,0.0966276006119759,0.114989790446096,3.41679687248898e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.156567102818607,0.00693343499568908,0.142977570227057,0.170156635410158,3.5946278867802e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MME,Neprilysin,40305,0.175459048273859,0.00778320069722026,0.160203974907307,0.190714121640411,8.56020962258946e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.144407256684399,0.00641347570239159,0.131836844307711,0.156977669061086,1.67946359098637e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL7,Angiopoietin-related protein 7,40489,0.0797647852815506,0.0035459212110684,0.0728147797078565,0.0867147908552446,2.36410778357085e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.23327069380199,0.0103725155059734,0.212940563410282,0.253600824193698,5.64351477273277e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINF2,Alpha-2-antiplasmin,37755,0.0291342939349863,0.00129875988518608,0.0265887245600216,0.031679863309951,2.00960244504751e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0601944657354591,0.00268853993861578,0.0549249274557722,0.0654640040151461,2.43439568947551e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGLN1,Egl nine homolog 1,40341,0.113850750293243,0.00508625808882954,0.103881684439137,0.123819816147349,2.74148316798643e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.23973593687392,0.0106954233381654,0.218772907131116,0.260698966616724,2.98182346731765e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTD,Biotinidase,38013,0.0442521807286183,0.00197747714011035,0.040376325534002,0.0481280359232346,5.97020550479021e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A4,Protein S100-A4,40411,0.123520829568686,0.0055286646173097,0.112684646918759,0.134357012218613,6.72915686078783e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0811166550707571,0.00363181786350131,0.0739982920582945,0.0882350180832196,7.65013929738432e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP5,Fatty acid-binding protein 5,40432,0.147664542619248,0.00662491352623572,0.134679712107826,0.16064937313067,2.09556741929803e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.080582256022378,0.00361798953880038,0.0734909965263292,0.0876735155184267,3.06756777436719e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.225984292189322,0.0101584132627441,0.206073802194344,0.2458947821843,5.45792834635274e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0638857238232157,0.0028679146776446,0.0582646110550323,0.0695068365913991,5.60185056237987e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARF6,ADP-ribosylation factor 6,37901,0.223649889371837,0.0100669746649445,0.203918619028546,0.243381159715129,2.02727042352809e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP85,Centrosomal protein of 85 kDa,39980,0.133819149882312,0.0060353655059771,0.121989833490597,0.145648466274027,2.90538545073266e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0573220370944057,0.00258336152367136,0.0522586485080099,0.0623854256808016,3.63925929953314e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.049138758357917,0.00222177154971947,0.0447840861204668,0.0534934305953671,8.72549208075623e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STC1,Stanniocalcin-1,40471,0.0875376241568309,0.0039685981916,0.0797591717012949,0.0953160766123669,3.0664062664289e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS9,Galectin-9,40350,0.0679980921624267,0.00308277047019164,0.0619558620408511,0.0740403222840023,3.15789232149598e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELP,P-selectin,40403,0.12180322512232,0.00552454571259888,0.110975115525626,0.132631334719014,3.85155695427977e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.137824208877381,0.0062500787063071,0.125574054613019,0.150074363141743,6.67776683363364e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNA4,Plexin-A4,40341,0.17358331376089,0.00791442199832919,0.158071046644165,0.189095580877616,4.57900489288512e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,40341,0.130246096912467,0.00594670625189778,0.118590552658748,0.141901641166187,8.73711847432873e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPL,N-acetylneuraminate lyase,37990,0.0905218539386222,0.00413170625838724,0.0824237096721832,0.0986199982050612,1.38347549696125e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.22514486574869,0.0102885255803991,0.204979355611108,0.245310375886272,2.43360451983485e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.156520276636848,0.00718397502467702,0.142439685588481,0.170600867685215,2.02250950844894e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLB1,Beta-galactosidase,40228,0.0850524527595542,0.00391011565467679,0.0773886260763877,0.0927162794427207,2.17932097882751e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YOD1,Ubiquitin thioesterase OTU1,37562,0.1324930228462,0.00609754295194522,0.120541838660387,0.144444207032013,7.07110001437302e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0604308481649744,0.00278225214583942,0.0549776339591292,0.0658840623708197,7.48067298754921e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD6,T-cell differentiation antigen CD6,40502,0.11035340842969,0.00509718979912424,0.100362916423406,0.120343900435973,1.77521745111865e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BACH1,Transcription regulator protein BACH1,40341,0.150691432542463,0.00696449253543636,0.137041027173008,0.164341837911919,2.40145018185506e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAB2,Disabled homolog 2,40489,0.228386060221864,0.0105672724214459,0.20767420627583,0.249097914167898,3.9023891410778e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNIP1,TNFAIP3-interacting protein 1,37942,0.183774888261076,0.00850146032041999,0.167112026033053,0.200437750489099,6.62293416918168e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.198610466361548,0.009189401195557,0.180599240018256,0.21662169270484,7.14657672077952e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBIN,Erbin,40305,0.211807389457576,0.00981351300708041,0.192572903963699,0.231041874951454,7.51376541122009e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTSS2,Protein MTSS 2,37900,0.203622411976871,0.00942977043466574,0.185140061924926,0.222104762028816,1.09137862564747e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL17,C-C motif chemokine 17,40333,0.187129443605858,0.00868385435910852,0.170109089062005,0.20414979814971,1.52906832756318e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0777283962006333,0.00360823174635923,0.0706562619777692,0.0848005304234974,3.42850074440122e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.142485596864281,0.00662328410159878,0.129503960025147,0.155467233703414,3.47603355030917e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.213812182256808,0.00994417687787516,0.194321595576173,0.233302768937444,4.16425618854384e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R9B,Neurabin-2,40516,0.193519341660335,0.0090047620051055,0.175870008130328,0.211168675190342,5.00428355129488e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.175549451713632,0.00817422092933489,0.159527978692135,0.191570924735128,7.11694614146566e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH2D1A,SH2 domain-containing protein 1A,40341,0.112960613594394,0.005260059696307,0.102650896589632,0.123270330599156,7.18819607013876e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEP,Leptin,40359,0.131620163706132,0.00612952346235898,0.119606297719909,0.143634029692356,7.46945195840624e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0437872066194224,0.00203720695370179,0.0397942809901669,0.047780132248678,9.36261038540247e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATG16L1,Autophagy-related protein 16-1,37901,0.174308113607084,0.00811858114248264,0.158395694567818,0.19022053264635,1.42838127722193e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLIN1,Perilipin-1,39961,0.0728737283242665,0.00339936952895365,0.0662109640475173,0.0795364926010157,1.71097824781328e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP23,Synaptosomal-associated protein 23,40359,0.178489394686691,0.00834170884887463,0.162139645342897,0.194839144030485,3.64538869854457e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.152424728655997,0.00711469484570221,0.138479926758421,0.166369530553574,4.12371936908589e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.204947611512618,0.00959421188286374,0.186142956222205,0.223752266803031,7.42360063158553e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCR,Breakpoint cluster region protein,40341,0.186239247482729,0.00873514578363369,0.169118361746807,0.203360133218651,1.79890771108347e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KAZN,Kazrin,37901,0.212582897526092,0.00995876549002336,0.193063717165646,0.232102077886538,1.86974667618592e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.121052520336358,0.00567822475042048,0.109923199825534,0.132181840847182,1.91606381799014e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0895930756921158,0.00420295435440581,0.0813552851574804,0.0978308662267511,1.96833658064703e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0495365993069645,0.00232572640226244,0.0449781755585301,0.0540950230553989,2.75958536957239e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IKBKG,NF-kappa-B essential modulator,40341,0.18776162692211,0.00882377952290171,0.170467019057223,0.205056234786997,4.26828329082383e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTUD7B,OTU domain-containing protein 7B,37959,0.129031513002591,0.00606645928956251,0.117141252795049,0.140921773210134,8.96685713730136e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC13,Mucin-13,39961,0.101833786851857,0.00481597964184022,0.0923944667538504,0.111273106949864,7.35126655567313e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGFR,Opioid growth factor receptor,40305,0.0669369924946552,0.0031679390882672,0.0607278318816515,0.0731461531076589,9.44971262916014e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD5,Programmed cell death protein 5,40471,0.118192722209576,0.00559739846797479,0.107221821212345,0.129163623206806,1.21800740263562e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSME1,Proteasome activator complex subunit 1,40216,0.0761273440056115,0.00361526411411415,0.0690414263419478,0.0832132616692753,4.25122814711844e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRPK2,SRSF protein kinase 2,40341,0.167025217822374,0.0079376612377701,0.151467401796345,0.182583033848404,5.65761202042684e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP2B,DNA topoisomerase 2-beta,37598,0.159584374519797,0.00758567323980574,0.144716454969778,0.174452294069817,1.15430741639371e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELE,E-selectin,40536,0.100507594599796,0.00479958567548208,0.0911004066758509,0.109914782523741,4.33694655070092e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.100797926091673,0.00482116707576251,0.0913484386231787,0.110247413560168,9.56545827942728e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17RB,Interleukin-17 receptor B,40126,-0.107274447938764,0.0051318509818606,-0.117332875863211,-0.0972160200143175,9.99897623170735e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFC,Vascular endothelial growth factor C,40411,0.111865131726384,0.00535807660872481,0.101363301573284,0.122366961879485,1.60499668477859e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSZ,Cathepsin Z,40345,0.0622708628779786,0.00298286643564363,0.0564244446641171,0.0681172810918401,1.68053741816328e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFA,Vascular endothelial growth factor A,40456,0.117721690256218,0.00564132575112945,0.106664691784004,0.128778688728431,1.95631224588934e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,40396,0.103719640033505,0.00497107140333263,0.0939763400829735,0.113462939984037,2.10595576498066e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDLIM7,PDZ and LIM domain protein 7,40422,0.250011612663288,0.0119960401555473,0.226499373958416,0.273523851368161,3.37888945557404e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.139521913644101,0.00669525149855653,0.126399220706931,0.152644606581272,3.79050581057705e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL5,C-X-C motif chemokine 5,40309,0.229302312643366,0.0110205219949905,0.207702089533185,0.250902535753548,6.92704298413616e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCXR,L-xylulose reductase,40411,0.10414520412121,0.00501575370759592,0.0943143268543218,0.113976081388098,1.6345280241852e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.205357387474718,0.00988525558580703,0.185982286526536,0.2247324884229,2.39644008157428e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0873731514912669,0.00421666581924041,0.0791084864855557,0.0956378164969781,4.14494656849684e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0834553670130346,0.00402961181600419,0.0755573278536664,0.0913534061724029,4.75259674136806e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.163620548949805,0.00790702455597951,0.148122780820086,0.179118317079525,7.36060707899383e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEXIM1,Protein HEXIM1,40341,0.162301031824636,0.00784580739954709,0.146923249321524,0.177678814327749,7.90024157176696e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAT,Linker for activation of T-cells family member 1,40516,0.150068906852858,0.00725584185947389,0.135847456808289,0.164290356897426,8.28210226811407e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AAMDC,Mth938 domain-containing protein,37628,0.106738304705807,0.00516109602909002,0.0966225564887905,0.116854052922823,1.54991942859971e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BID,BH3-interacting domain death agonist,40341,0.132517292428767,0.00643325505600665,0.119908112518994,0.14512647233854,4.61071895627544e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.186777981454971,0.0090832072161434,0.16897489531133,0.204581067598612,9.65203315949034e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINH1,Serpin H1,37714,0.254734488203341,0.0123739573711985,0.230481531755792,0.27898744465089,1.01748568033754e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.110433791640487,0.00537351681411868,0.0999016986848142,0.120965884596159,1.15756548107765e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK11,Serine/threonine-protein kinase STK11,40042,0.143993696053126,0.00700634776023238,0.130261254443071,0.157726137663182,1.24633986210268e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,40536,0.133226635063861,0.00648645716567537,0.120513179019138,0.145940091108585,1.47648817214704e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.225199534166099,0.0109726945902696,0.203693052769171,0.246706015563028,3.40369312233783e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FN1,Fibronectin,38013,0.0516145933335741,0.00251635099600182,0.0466825453814105,0.0565466412857377,4.20672419167207e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLSCR3,Phospholipid scramblase 3,37919,0.117811008995362,0.00575291192411896,0.106535301624089,0.129086716366635,8.32881471036054e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.113636662507797,0.00555041023242301,0.102757858452248,0.124515466563346,9.2280649525388e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.189539990798343,0.00926897288484155,0.171372803944054,0.207707177652633,9.79311413663024e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLA2,Src-like-adapter 2,37959,0.202802747164942,0.00991006229292534,0.183379025070808,0.222226469259076,1.09407835151496e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCK2,Cytoplasmic protein NCK2,40422,0.204940821083681,0.0100330200654288,0.185276101755441,0.224605540411921,1.43079289634351e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0777843500125722,0.00380658433009592,0.0703234447255842,0.0852452552995602,2.02006555213755e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.186502418836011,0.0091506014713161,0.168567239952232,0.204437597719791,3.52865119087761e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOK2,Docking protein 2,40359,0.236147433162807,0.0115941836872248,0.213422833135846,0.258872033189768,4.67369093888771e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHACTR2,Phosphatase and actin regulator 2,37959,0.223415518828733,0.0109583633025548,0.201937126755725,0.24489391090174,5.01459954607637e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.15069292243037,0.0073989266464547,0.136191026203319,0.165194818657421,7.52098067386304e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,40305,0.268828317654171,0.0132139863053361,0.242928904495712,0.29472773081263,7.52836244636224e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD5,T-cell surface glycoprotein CD5,40470,0.0653148875855773,0.00321108445603834,0.0590211620517422,0.0716086131194125,7.89949814305304e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOD,Apolipoprotein D,37345,-0.0871706553563566,0.00427896249177972,-0.0955574218402448,-0.0787838888724683,7.93312718075168e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRP14,Signal recognition particle 14 kDa protein,40305,0.115605543225548,0.00569574079039498,0.104441891276374,0.126769195174723,1.92860393802791e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0446827777152951,0.00220270639551133,0.0403654731800929,0.0490000822504973,2.40903105596345e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFC,Platelet-derived growth factor C,39980,0.057796441656145,0.00285384688906683,0.052202901753574,0.063389981558716,4.93657122080341e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL5,C-C motif chemokine 5,40403,0.194200753365655,0.0096229720883968,0.175339728072397,0.213061778658913,1.87855246588621e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL7,C-C motif chemokine 7,40341,0.117854364657094,0.00584774103174276,0.106392792234878,0.12931593707931,3.23836794570029e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXO1,Forkhead box protein O1,40341,0.163431459512983,0.00813077955836071,0.147495131578596,0.17936778744737,9.27543917468278e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0516299503541403,0.00256851903268349,0.0465956530500806,0.0566642476581999,9.72270768835124e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.206834752846997,0.0102826471784587,0.186680764377218,0.226988741316776,1.07408153910268e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIAE,Sialate O-acetylesterase,40374,0.0903207105128591,0.00449904077825724,0.0815025905874749,0.0991388304382433,1.50166708244591e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP43,Centrosomal protein 43,39934,0.133154266391187,0.00663225805425163,0.120155040604854,0.14615349217752,1.57332590045869e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.133028861117235,0.00663036713676389,0.120033341529178,0.146024380705293,2.96273284749709e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.112152976693616,0.00559695583840615,0.101182943250339,0.123123010136892,3.10386894578859e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUOM,Fucose mutarotase,37671,0.120004903008434,0.00599609232912282,0.108252562043354,0.131757243973515,8.28933581044478e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGF,Placenta growth factor,40516,0.0504274909986709,0.00252534327751303,0.0454778181747453,0.0553771638225964,1.19370058775811e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC27,Cell division cycle protein 27 homolog,39980,0.116830485240716,0.00585073101969519,0.105363052442113,0.128297918039319,1.29808738648131e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.176150522805837,0.00882229675844389,0.158858821159287,0.193442224452387,1.33680461512697e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFX1,Transcriptional repressor NF-X1,37562,0.130495726102311,0.00652885543320403,0.117699169453231,0.143292282751391,1.41734484286882e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCTN3,Tectonic-3,37990,0.0559336543812495,0.00280490804038765,0.0504360346220897,0.0614312741404093,3.17000308755232e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.122817013075892,0.00616663531583217,0.110730407856861,0.134903618294923,3.58779583851165e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN2,CCN family member 2,40358,0.110161844752137,0.00553502661952603,0.0993131925778656,0.121010496926408,4.41828343080452e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPB2,Carboxypeptidase B2,37981,0.0427667103001046,0.00214706250011761,0.038558467799874,0.0469749528003351,4.92887168260921e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.161034703055563,0.00808776215082153,0.145182689239953,0.176886716871174,5.75997211912183e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0843862478500167,0.00424709032173631,0.0760619508194135,0.0927105448806199,8.54285185212514e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.138225055029904,0.00695283894209422,0.1245974907034,0.151852619356409,1.05367560380367e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.119095334696304,0.00599619251996529,0.107342797357172,0.130847872035436,1.49566417163685e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNMBP,Dynamin-binding protein,40228,0.117408572051692,0.0059176392194935,0.105809999181485,0.129007144921899,1.51056974609627e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARSB,Arylsulfatase B,40305,0.104509380193337,0.0052751959256287,0.0941699961791047,0.114848764207569,2.61903767094283e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELN,Elastin,37990,0.0669873776032082,0.00337835447837915,0.0603658028255851,0.0736089523808313,2.82590361411901e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0395143033799781,0.00199521054999058,0.0356036907019966,0.0434249160579596,3.08292741669235e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTDH,Protein LYRIC,37598,0.174360684936386,0.00879682847837298,0.157118901118775,0.191602468753997,3.54933316288209e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAO1,Hydroxyacid oxidase 1,40489,0.247931692127824,0.0125321659548905,0.223368646856239,0.272494737399409,4.3715173051567e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USO1,General vesicular transport factor p115,40305,0.172164905879688,0.00870302580715439,0.155106975297665,0.18922283646171,4.61770762304057e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.207048889318201,0.01046862126833,0.186530391632274,0.227567387004128,7.60286534810894e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.144407611014952,0.00731019715922933,0.130079624582862,0.158735597447041,7.92406611368721e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.146224641746911,0.00739946491577367,0.131721690511995,0.160727592981828,1.03310888912973e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,37671,0.149958882446037,0.00758895095477211,0.135084538574684,0.164833226317391,1.12541131548729e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPD52L2,Tumor protein D54,37671,0.204609213486485,0.0103765346610453,0.184271205550837,0.224947221422134,2.50897564821425e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0375816899861206,0.00190791778502691,0.0338421711274679,0.0413212088447734,3.52649114523908e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MINK1,Misshapen-like kinase 1,37942,0.175431999884463,0.00890968304743497,0.157969021111491,0.192894978657436,4.09569768585811e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CMIP,C-Maf-inducing protein,37900,0.155363142968895,0.00789802560265029,0.139883012787701,0.17084327315009,5.93496292677874e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL13,C-C motif chemokine 13,40483,0.131677365191232,0.00670417699653524,0.118537178278023,0.144817552104441,6.84552516920326e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL10,C-X-C motif chemokine 10,40422,0.127369972091968,0.00649108043050827,0.114647454448172,0.140092489735764,9.90731849954943e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PXN,Paxillin,39961,0.0975853848917237,0.00497285931941547,0.0878385806256694,0.107332189157778,1.03362769832942e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QDPR,Dihydropteridine reductase,40290,0.0825063954179889,0.00421318707439123,0.0742485487521821,0.0907642420837957,2.15064931372427e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EREG,Proepiregulin,40192,0.15099369331,0.00771319500748823,0.135875831095323,0.166111555524677,2.48801597746027e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISM1,Isthmin-1,40341,0.0733443772341636,0.00375254592348263,0.0659893872241377,0.0806993672441896,4.39246104534643e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.170948834634644,0.00874690096362748,0.153804908745935,0.188092760523354,6.74777299934333e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.121062544046295,0.00620691988541397,0.108896981070884,0.133228107021707,1.40648999246141e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.209006512830586,0.010730707300405,0.187974326521792,0.23003869913938,1.63828481339685e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.126319165196193,0.00649438572632645,0.113590169172593,0.139048161219793,2.8272786500251e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP2,Methionine aminopeptidase 2,40453,0.110004160593076,0.00565935744818697,0.0989118199946294,0.121096501191522,3.3763646887994e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.191996653425005,0.0098722490044803,0.172647045376224,0.211346261473787,4.17053397299279e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELOA,Elongin-A,40305,0.0952098882319816,0.00490215457000367,0.0856016652747744,0.104818111189189,4.62938848849472e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.114095705410275,0.00587991678671499,0.102571068508314,0.125620342312237,6.80779568994662e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBPL,FK506-binding protein-like,37901,0.11008644024952,0.00567336776539144,0.0989666394293523,0.121206241069687,9.6070207258187e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,A1BG,Alpha-1B-glycoprotein,38013,0.0326182431596197,0.00168482663156607,0.0293159829617502,0.0359205033574892,2.16455374986645e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VNN1,Pantetheinase,37987,0.134742604969111,0.00696023504121396,0.121100544288331,0.14838466564989,2.22000182045836e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,37959,0.141191068450287,0.00729591402677346,0.126891076957811,0.155491059942763,2.53937279544288e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON2,Serum paraoxonase/arylesterase 2,40042,0.0638768522653325,0.00330794374950099,0.0573932825163106,0.0703604220143544,4.00957487697097e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.207450186386462,0.0107506927729853,0.186378828551411,0.228521544221513,4.98634058306881e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP3B1,AP-3 complex subunit beta-1,37901,0.141933819610563,0.00734804539234114,0.127531650641574,0.156335988579551,5.08247653795057e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNCG,Gamma-synuclein,40228,0.124074881606355,0.00643423808992622,0.111463774950099,0.13668598826261,6.46150179664558e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.191857750476021,0.00997089389993755,0.172314798432143,0.211400702519899,1.38479812140429e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAMBP,STAM-binding protein,40192,0.119460935626439,0.00621724480214168,0.107275135814241,0.131646735438637,2.38922502845517e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASHC3,WASH complex subunit 3,37942,0.138683818949946,0.00721876104633164,0.124535047299136,0.152832590600756,3.58171916913199e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNST,Consortin,40359,0.198929849107448,0.0103756570978638,0.178593561195635,0.219266137019261,5.12034301025786e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0940982478595335,0.00490377795540955,0.0844868430669308,0.103709652652136,5.51671603722495e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MASP1,Mannan-binding lectin serine protease 1,40192,0.0437795058930327,0.00228717457066991,0.0392966437345196,0.0482623680515457,9.44420791015461e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NSFL1C,NSFL1 cofactor p47,40471,0.122684447010828,0.00641484416292569,0.110111352451494,0.135257541570163,1.23467223054675e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH2,Cadherin-2,40359,0.0648623548309479,0.00339297033807843,0.0582121329683142,0.0715125766935816,1.46601601014358e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.167374077355114,0.00876366579592253,0.150197292395105,0.184550862315122,2.95985126351951e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0511605058618986,0.00268322676417117,0.0459013814041231,0.0564196303196741,3.73031744875664e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD36,Platelet glycoprotein 4,37598,0.0814759703159366,0.0042712610836226,0.0731042985920363,0.0898476420398369,4.85817032281751e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAX1BP1,Tax1-binding protein 1,37942,0.117726822909179,0.0061755930048168,0.105622660619738,0.12983098519862,5.72344767099878e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.128615975195186,0.00675495354363272,0.115376266249666,0.141855684140706,9.28770412827468e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAG1,Dystroglycan,40422,0.0863259190561225,0.00455402558567312,0.0774000289082032,0.0952518092040418,2.92094187652001e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSG,Alpha-2-HS-glycoprotein,37987,0.0493707214117295,0.00260338381421691,0.0442680891358643,0.0544733536875946,3.58202664056426e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF3,Immunoglobulin superfamily member 3,40305,0.0627664795618486,0.00332088789320964,0.0562575392911577,0.0692754198325395,8.29482237083526e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST3,Cystatin-C,40372,0.0510434873001713,0.00270112570250202,0.0457492809232673,0.0563376936770752,8.76081383941139e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYTL4,Synaptotagmin-like protein 4,37990,0.133286332404909,0.00704661084486242,0.119474975148979,0.147097689660839,8.88080222137714e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.129568158844225,0.00685663330905491,0.116129157558478,0.143007160129973,1.31331352440193e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.153567255887151,0.00813337677021602,0.137625837417528,0.169508674356775,1.78841926784837e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG4,BAG family molecular chaperone regulator 4,37598,0.0884264855359962,0.00468432667321492,0.0792452052564949,0.0976077658154974,1.91199111175113e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0982353725682181,0.00521257588228691,0.0880187238389357,0.1084520212975,2.27187732407984e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMN,Protein amnionless,40044,0.0864916637846724,0.00458924964189375,0.0774967344865606,0.0954865930827841,2.32525442515505e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFB,Platelet-derived growth factor subunit B,40422,0.155334795467331,0.00824593140870077,0.139172769906278,0.171496821028385,2.61251211727611e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0957510211447765,0.00508013533308027,0.0857939558919391,0.105708086397614,3.19422727301702e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NIT2,Omega-amidase NIT2,37936,0.137075167402987,0.00727795318166178,0.122810379166929,0.151339955639044,3.96603360877484e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMMD1,COMM domain-containing protein 1,37628,0.111814928374246,0.00593652791190848,0.100179333666905,0.123450523081586,4.12293830139601e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMA,Granzyme A,40516,0.063750637930887,0.00338988595171987,0.0571064614655161,0.070394814396258,4.63195739022121e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.110765061000652,0.00589104541723698,0.0992186119828671,0.122311510018436,5.08347373275074e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCBP2,Poly(rC)-binding protein 2,37959,0.13000336071406,0.00691500993108155,0.11644994124914,0.143556780178979,7.40036703034401e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA5,Integrin alpha-5,40332,0.0449986773622226,0.00239595424170736,0.0403026070484762,0.0496947476759691,7.51065649333061e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT5,ADP-sugar pyrophosphatase,40332,0.0942951043070358,0.00502101523458625,0.0844539144472468,0.104136294166825,7.65335670372952e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA1,GDNF family receptor alpha-1,40453,0.0503044656229713,0.0026797856804323,0.045052085689324,0.0555568455566186,8.78381606760561e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0894366772839785,0.00475921184804736,0.0801086220618057,0.0987647325061514,9.14542948840398e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOF,Apolipoprotein F,37987,-0.0436459097950739,0.00232435408571973,-0.0482016438030846,-0.0390901757870633,1.1138324068311e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM5,Tripartite motif-containing protein 5,40341,0.153751550551481,0.00819713834140631,0.137685159402325,0.169817941700637,1.17523459606538e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDRKH,Tudor and KH domain-containing protein,39961,0.153327824799901,0.00818201303430039,0.137291079252672,0.169364570347129,1.68655168764879e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEP1A,Meprin A subunit alpha,37901,0.123576339761973,0.0065939557801607,0.110652186432858,0.136500493091088,2.21825606336476e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0536043989687672,0.00286373197751284,0.0479914842928421,0.0592173136446924,2.36849021351506e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.188071178090507,0.0100482676489975,0.168376573498472,0.207765782682543,2.42657999567598e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYDGF,Myeloid-derived growth factor,37990,0.180703843190906,0.0096640510313064,0.161762303169545,0.199645383212266,4.73955249929301e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.165634341492906,0.00887083015200855,0.148247514394969,0.183021168590842,5.79488353740132e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.135741147118679,0.00728255044732847,0.121467348241915,0.150014945995443,1.02215404754973e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0885527906088929,0.00475599716124528,0.0792310361728521,0.0978745450449336,1.46263464728851e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AZI2,5-azacytidine-induced protein 2,37959,0.0989416745802679,0.00530889251117256,0.0885362452583697,0.109347103902166,1.46582318089472e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAMP8,Vesicle-associated membrane protein 8,37598,0.158802460204593,0.00854223464406007,0.142059680302235,0.175545240106951,3.63774259911265e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH1A1,Retinal dehydrogenase 1,40332,0.0943028431149761,0.00508380363248265,0.0843385879953101,0.104267098234642,5.20957589525801e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TALDO1,Transaldolase,37966,0.0797599788111023,0.00429941001232351,0.0713331351869483,0.0881868224352564,6.9419703695093e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEC31A,Protein transport protein Sec31A,37628,0.136922076254201,0.00738094194882628,0.122455430034501,0.1513887224739,7.41457055178648e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THPO,Thrombopoietin,40042,0.0681342949621459,0.00367728717654081,0.0609268120961259,0.0753417778281658,7.93237141095418e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOLM2,Protein GOLM2,40471,0.0400070330923199,0.0021606598299127,0.035772139825691,0.0442419263589488,9.44112056795054e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX15,Sorting nexin-15,37671,0.0967702787800273,0.00522058956961787,0.0865379232235762,0.107002634336478,9.5725075872279e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD99L2,CD99 antigen-like protein 2,40332,0.0423567341970101,0.00228902549890425,0.0378702442191578,0.0468432241748625,1.18956472780937e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.104440228992736,0.00564254552514426,0.0933808397634536,0.115499618222019,1.55674229318417e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MITD1,MIT domain-containing protein 1,40228,0.171386334504556,0.00929618293575774,0.153165815950471,0.189606853058641,4.1352224533244e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYN,Tyrosine-protein kinase Lyn,40305,0.148754280249493,0.00807216484113816,0.132932837160862,0.164575723338124,4.75114823215802e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNB3,Plexin-B3,40310,0.0826354948981228,0.00449547352530497,0.0738243667885251,0.0914466230077206,1.09281273222535e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.157683716332913,0.00861487812108742,0.140798555215581,0.174568877450244,6.10019670282014e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CMC1,COX assembly mitochondrial protein homolog,37990,0.15853951963717,0.00866944418617848,0.14154740903226,0.17553163024208,8.08688929704855e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUS,RNA-binding protein FUS,39960,0.0693286519800208,0.00379840017038469,0.0618837876460668,0.0767735163139748,1.17490288772241e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FMNL1,Formin-like protein 1,39961,0.105207421229779,0.00576977775549199,0.0938986568290148,0.116516185630543,1.61717882336915e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGCC,Regulator of cell cycle RGCC,37959,0.13161679030188,0.00722009909386771,0.117465396077899,0.14576818452586,2.28811296282609e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCC,Tubulin-specific chaperone C,40228,0.142324875910184,0.00781905159067489,0.126999534792461,0.157650217027907,2.77918184261125e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLK1,Protein delta homolog 1,40536,0.0928908294288119,0.00510745944034959,0.0828802089257267,0.102901449931897,3.51963751967908e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL11,Eotaxin,40516,0.0659443792984624,0.00362681725663257,0.0588358174754626,0.0730529411214622,3.84621363561101e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.115115235256778,0.00633077054260647,0.102706924993269,0.127523545520287,5.17370402411961e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OCLN,Occludin,37959,0.0764305142033077,0.00420591457300884,0.0681869216402104,0.084674106766405,6.3258219855389e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIT1,ARF GTPase-activating protein GIT1,37598,0.171182077169891,0.00942024929690051,0.152718388547966,0.189645765791816,6.72867052579208e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MENT,Protein MENT,37671,-0.0379573968249322,0.00209028358758865,-0.042054352656606,-0.0338604409932585,8.3459410678567e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH2B3,SH2B adapter protein 3,39980,0.170583122949215,0.00940696811853053,0.152145465436895,0.189020780461534,9.71600184854786e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0990938775514309,0.00546491999752659,0.0883826343562788,0.109805120746583,1.3429011648637e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAS6,Growth arrest-specific protein 6,40429,-0.0448631895119176,0.00247721553064009,-0.0497185319519722,-0.040007847071863,1.40427761954463e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HYOU1,Hypoxia up-regulated protein 1,40536,0.0377666857669458,0.00208593408058832,0.0336782549689927,0.0418551165648989,1.51615049857358e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGKA,Diacylglycerol kinase alpha,37598,0.0948825177162095,0.00523584625398747,0.0846202590583941,0.105144776374025,1.63492522537219e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.175288261819632,0.00968384266958232,0.156307930187251,0.194268593452014,1.66991225252264e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPB1,Carboxypeptidase B,40536,0.0982610070582587,0.00542895517009312,0.0876202549248761,0.108901759191641,1.68622714298772e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.124936485390243,0.00694629162978964,0.111321753795855,0.138551216984631,1.28451785424847e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRKL,Crk-like protein,40374,0.184246618591529,0.0102581648110806,0.164140615561811,0.204352621621247,1.99473459174945e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS8,Galectin-8,40471,0.104522684774567,0.00581976252378188,0.0931159502279548,0.11592941932118,2.01124689857184e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESM1,Endothelial cell-specific molecule 1,40357,-0.0586244326471236,0.00326451834455316,-0.0650228886024478,-0.0522259766917994,2.10341727641067e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0542843040283796,0.00302091971400353,0.0483633013889326,0.0602053066678265,2.39618576750671e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0811387380625835,0.00451793378729193,0.0722835878394913,0.0899938882856757,2.75748730574744e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.138451868536436,0.00772186375899759,0.123317015568801,0.153586721504071,3.46571293347408e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.150566920669616,0.00840756182492101,0.134088099492771,0.167045741846462,5.0199402845548e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,40042,0.128812437659897,0.00720298029096057,0.114694596289614,0.14293027903018,8.11961965406978e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE4,Ribonuclease 4,37575,0.047164918982731,0.00263632065862359,0.0419977304918288,0.0523321074736333,9.67016951817458e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRAP,BRCA1-associated protein,37778,0.188785987952904,0.0105594901625836,0.16808938723424,0.209482588671568,1.16140479055708e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASAH2,Neutral ceramidase,40228,0.0903118138872242,0.00505893989442459,0.080396291694152,0.100227336080296,1.38048771568491e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGA,Protein O-GlcNAcase,37901,0.120959100913672,0.00677015344549628,0.1076896001605,0.134228601666845,1.40382945787689e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTNB,Dystrobrevin beta,37878,0.0719225167478654,0.00402684154049482,0.0640299073284956,0.0798151261672353,1.55729047772858e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.133850550469162,0.00750853878839578,0.119133814443906,0.148567286494417,2.15843730631889e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAT2,Signal transducer and activator of transcription 2,37598,0.132170803838713,0.0074070140857025,0.117653056230737,0.14668855144669,2.17170981810358e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDHD2,Phospholipase DDHD2,37959,0.113681064444676,0.00638440758245882,0.101167625583057,0.126194503306296,4.00841736080172e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0353854403868698,0.00198915504762912,0.0314866964935167,0.0392841842802229,4.11386951842797e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0819034130316847,0.00460044461705019,0.0728865415822663,0.090920284481103,4.23378937640122e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.136031830236274,0.00764402743464004,0.121049536464379,0.151014124008168,4.7904540104342e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0546711932396325,0.00307262492801506,0.048648848380723,0.060693538098542,5.04516671568956e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0551978492253964,0.00310559934475311,0.0491108745096803,0.0612848239411125,5.40895901653e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIRBP,Cold-inducible RNA-binding protein,37901,0.163363422457633,0.00918944994412758,0.145352100567143,0.181374744348123,6.67153606786468e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STIP1,Stress-induced-phosphoprotein 1,40307,0.111950073639541,0.00630649499606662,0.0995893434472509,0.124310803831832,7.93962459979456e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL3,C-C motif chemokine 3,40341,0.105306014026278,0.00593333531578191,0.0936766768073457,0.116935351245211,8.39073954561665e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C3,Complement C3,37360,0.080443399099463,0.00453540696104511,0.0715540014558145,0.0893327967431114,1.45615437889946e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB27B,Ras-related protein Rab-27B,37990,0.140054312137107,0.00790561880954907,0.12455929927039,0.155549325003823,1.9214438748994e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTRK3,NT-3 growth factor receptor,40471,-0.037225553694315,0.00210438955892624,-0.0413501572298104,-0.0331009501588196,2.30667165219437e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOLGA3,Golgin subfamily A member 3,37959,0.133732521492074,0.00756063205634194,0.118913682661644,0.148551360322504,3.124834044192e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.107970583190661,0.00610928776590413,0.0959963791694892,0.119944787211833,3.21057443222595e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM13A,Protein FAM13A,37901,0.114890260051388,0.00649635034069356,0.102157413383629,0.127623106719148,3.29701413767106e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0778995104538034,0.0044102235278643,0.0692554723391894,0.0865435485684174,3.67871860707268e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.183745612239936,0.0103939486121907,0.163373472960042,0.20411775151983,3.70834251581732e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0597405143345616,0.00337955376321012,0.0531165889586698,0.0663644397104535,4.08326762162955e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GASK1A,Golgi-associated kinase 1A,37562,0.0739356493149658,0.00418425407413325,0.0657345113296646,0.0821367873002669,4.50573061425293e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NIT1,Deaminated glutathione amidase,37628,0.084629379216288,0.00479181088750926,0.0752374298767699,0.0940213285558062,5.19249996572745e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COCH,Cochlin,37990,0.0792373865030927,0.00449578607788048,0.0704256457904469,0.0880491272157384,9.2952202568446e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.180733418719487,0.0102543275003465,0.160634936818808,0.200831900620166,9.59219180321255e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS2,Trypsin-2,40403,0.0849957181467361,0.00483699652910288,0.0755152049496944,0.0944762313437777,1.781915353902e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.132598661985711,0.00755241313265759,0.117795932245702,0.14740139172572,2.3980889599706e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,37671,0.139395030161159,0.00793333581936659,0.123845691955201,0.154944368367118,2.46125032703208e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0752842279355421,0.00428965267495864,0.0668765086926231,0.083691947178461,2.70307561892862e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.105105503094661,0.00598511481814359,0.0933746780510997,0.116836328138223,2.94872319875736e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.144637455138273,0.00824486341802607,0.128477522838942,0.160797387437604,4.00485597210327e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0482840654064278,0.00275814424648748,0.0428781026833123,0.0536900281295433,5.50240870273088e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMPR2,GMP reductase 2,37671,0.114378595996105,0.00654082573125591,0.101558577562843,0.127198614429366,1.04120657570792e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.115162056397495,0.00659309502634222,0.102239590145864,0.128084522649126,1.40931800037696e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5E,5'-nucleotidase,40411,0.0971660657941937,0.00557603313881255,0.0862370408421211,0.108095090746266,2.21470286174509e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.151151534458551,0.00866702749640998,0.134164160565587,0.168138908351515,2.35233384166075e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4A,C-type lectin domain family 4 member A,40341,-0.057818250564782,0.00331949024826538,-0.0643244514513822,-0.0513120496781818,2.5498262600027e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASC3,Protein CASC3,37572,0.068962543750134,0.00395593555706857,0.0612089100582796,0.0767161774419884,2.66769633488466e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.194088421820095,0.0111651253660706,0.172204776102596,0.215972067537593,4.60813482368768e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.088559549762862,0.00509417858126875,0.0785749597435753,0.0985441397821488,4.66522992108311e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIP,Gastric inhibitory polypeptide,37628,0.0868949031352897,0.00499637766139501,0.0771020029189554,0.0966878033516239,5.34241326583023e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP3,Metalloproteinase inhibitor 3,40422,0.220517049893189,0.0127171758192393,0.19559138528748,0.245442714498899,9.57058573510688e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.121443001068253,0.00701164013159283,0.107700186410331,0.135185815726175,1.34532941673786e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBNL,Drebrin-like protein,40422,0.154068589963124,0.0088970403119018,0.136630390951797,0.171506788974452,1.42338256280508e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1S,Complement C1s subcomponent,38013,0.0346619518006888,0.00200066515516776,0.03074064809656,0.0385832555048176,1.5771684691278e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0887919736285053,0.00512723975573253,0.0787425837072696,0.098841363549741,1.81661329145738e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RWDD1,RWD domain-containing protein 1,40471,0.107431651783743,0.00621018959385705,0.0952596801797837,0.119603623387703,1.9126941352056e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.147914261363312,0.00854899145965786,0.131158238102382,0.164670284624241,1.9301572973784e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,40359,0.13217967863856,0.00764547309899258,0.117194551364535,0.147164805912586,2.31474724856333e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.246038955003733,0.0142261575480223,0.218155686209609,0.273922223797856,2.67879831595493e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNLR1,Interferon lambda receptor 1,40341,0.0623373714885609,0.00360975523834187,0.0552622512214109,0.069412491755711,3.22951319594667e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS1BP3,HCLS1-binding protein 3,37628,0.149317604253211,0.00864163749405209,0.132379994764869,0.166255213741553,3.63258204686984e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D23,TBC1 domain family member 23,40305,0.148853232849985,0.00863376922067251,0.131931045177467,0.165775420522503,5.24237225717981e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.111381989985622,0.00646241353465827,0.098715659457692,0.124048320513552,5.67085378996483e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18,Interleukin-18,40292,0.0787121053656989,0.00456690562045419,0.0697609703496087,0.0876632403817891,5.7610585502552e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0954486395513263,0.00554496897358039,0.0845805003631087,0.106316778739544,8.38071012486818e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.133887896235824,0.00777726368005664,0.118644459422913,0.149131333048735,1.06761313268928e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0939467664544646,0.00546385448817601,0.0832376116576397,0.10465592125129,1.15170367572279e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMPR,GMP reductase 1,40516,0.0845418056549128,0.00492348373511132,0.0748917775340946,0.094191833775731,1.67766348611176e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICA1,Islet cell autoantigen 1,40044,0.131101061552061,0.00765175087996833,0.116103629827323,0.146098493276799,3.29966088280794e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.1618703199598,0.0094689318855269,-0.180429426455432,-0.143311213464167,6.15680081528164e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0950340768974606,0.00556355914139168,0.0841295009803329,0.105938652814588,9.8005758409367e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.117310283915745,0.00687415842793438,0.103836933396994,0.130783634434496,1.00783847818623e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.078074611917619,0.00457369160426927,0.0691101763732512,0.0870390474619868,1.17371722754498e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0581200700436496,0.00340765661322013,0.0514410630817381,0.064799077005561,1.18981272921684e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.147027791668705,0.00862084178100593,0.130130941777933,0.163924641559477,1.21143646989388e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMOX2,Heme oxygenase 2,39961,0.0749668718806785,0.00439748547272915,0.0663478003541293,0.0835859434072276,1.40878598803296e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.198194989561108,0.0116335751508623,0.175393182265418,0.220996796856799,1.71880003950008e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0802516362127806,0.00471148319284719,0.0710171291548001,0.0894861432707611,1.79599914891709e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS1,Galectin-1,40359,0.0552684807353384,0.00324652742945103,0.0489052869736144,0.0616316744970624,2.03128352023568e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DFFA,DNA fragmentation factor subunit alpha,40516,0.111502365365674,0.00655044541581578,0.0986634923506748,0.124341238380673,2.06620327356068e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0987061057701787,0.00580839652665112,0.0873216485779425,0.110090562962415,3.45781322743219e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPHN1,Oligophrenin-1,37942,0.175477212066001,0.0103187111396738,0.15525253823224,0.195701885899762,3.46932906134481e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TWF2,Twinfilin-2,37998,0.135879280716214,0.00799754996604539,0.120204082782765,0.151554478649663,4.47489486520559e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST13,Hsc70-interacting protein,37671,0.0934445053201065,0.00549987417480068,0.0826647519374972,0.104224258702716,4.63029874435666e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUB1,NEDD8 ultimate buster 1,40341,0.136629096744786,0.00805545195711835,0.120840410908834,0.152417782580738,5.8234928776342e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPART,Spartin,37671,0.126280796844712,0.007448266726257,0.111682194061248,0.140879399628176,8.42484325962086e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0543095267751959,0.00320662413434837,0.0480245434718731,0.0605945100785187,8.70585713524211e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF2,TNF receptor-associated factor 2,40341,0.116150998085111,0.00686933428104109,0.102687102894271,0.129614893275952,1.39760640976905e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA1,Carboxypeptidase A1,40536,0.0933326842315391,0.00552069614492112,0.0825121197874937,0.104153248675584,1.43879258897334e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UMOD,Uromodulin,40502,-0.0883192080159055,0.00523193172465013,-0.0985737941962198,-0.0780646218355913,2.19353778469359e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.134406391149969,0.00796124801126439,0.118802345047891,0.150010437252047,2.7081376085993e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.0439304087825278,0.00260696600894827,0.0388207554049892,0.0490400621600664,3.65579670067387e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESYT2,Extended synaptotagmin-2,37942,0.132661284320744,0.00787773790637099,0.117220918024256,0.148101650617231,5.45668553186097e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD1,Sushi domain-containing protein 1,40042,0.0799626680202659,0.00475254574685397,0.0706476783564321,0.0892776576840997,5.72743771742065e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0524015819840735,0.00311538117838464,0.0462954348744396,0.0585077290937074,6.0884020913372e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IST1,IST1 homolog,37812,0.162778859108796,0.00967130581683505,0.143823099707799,0.181734618509792,6.41353384212996e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,39980,0.150237991670014,0.00894870363789518,0.132698532539739,0.167777450800288,1.05249544887366e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHMP1A,Charged multivesicular body protein 1a,40228,0.128313605151054,0.00765853355515058,0.113302879382959,0.143324330919149,1.82460156165851e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBXN1,UBX domain-containing protein 1,37671,0.111861173218058,0.00667150389010174,0.0987850255934587,0.124937320842658,1.8768757547801e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GTPBP2,GTP-binding protein 2,37572,0.129275882412205,0.00771544812438454,0.114153604088411,0.144398160735999,2.29528703049056e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.138300096069112,0.00826196059953294,0.122106653294028,0.154493538844197,2.38163920739922e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.135441884540194,0.00810131831580355,0.119563300641219,0.151320468439169,3.26300424000164e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0623432220182278,0.00372837044000965,0.0550356159558089,0.0696508280806467,3.88446218053341e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.108529810927147,0.00649390451324998,0.0958017580811766,0.121257863773117,4.59618604647669e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0724814641349583,0.00434127024929447,0.0639725744463412,0.0809903538235755,4.78179607665038e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0445533522978849,0.00266969005377139,0.039320759792493,0.0497859448032769,5.36301214718404e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDLIM5,PDZ and LIM domain protein 5,37959,0.190852500807229,0.0114340247115724,0.168441812372547,0.21326318924191,6.28548993211819e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBKS,Ribokinase,39991,0.0797093396078051,0.00479160782799949,0.0703177882649261,0.0891008909506841,1.32092987511859e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX4,Syntaxin-4,40305,0.0957695861173517,0.00575875153446288,0.0844824331098045,0.107056739124899,1.39818167548717e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0725329533265337,0.00436726844695504,-0.0810927994825656,-0.0639731071705019,1.97959578258688e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0557023971764413,0.00335507317939834,0.0491264537448205,0.0622783406080621,2.17951063961358e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASSF2,Ras association domain-containing protein 2,39980,0.0881156884501351,0.00530786052077353,0.077712281829419,0.0985190950708512,2.31608825137301e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD69,Early activation antigen CD69,40288,0.140821104634481,0.00848564989029661,0.124189230849499,0.157452978419462,2.48687019933983e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53,Cellular tumor antigen p53,39980,0.0688895998819612,0.0041581676755752,0.0607395912378338,0.0770396085260886,4.01784214281416e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRY2,Protein sprouty homolog 2,40044,0.147320394391224,0.008892859036306,0.129890390680064,0.164750398102384,4.07417498594126e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RFC4,Replication factor C subunit 4,37900,0.0328597827137487,0.00198449862926338,0.0289701654003925,0.0367494000271049,5.59989656259415e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3GLB2,Endophilin-B2,37942,0.107074909670859,0.00647004976625773,0.094393612128994,0.119756207212724,6.44679072055515e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.123630555075861,0.00750059579457914,0.108929387318486,0.138331722833236,1.96264607462302e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFB2,BPI fold-containing family B member 2,37951,0.108051898775954,0.00655859087861968,0.0951970606538594,0.120906736898049,2.15870647227506e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAX,Protein max,39961,0.165706098322585,0.0100753382712739,0.145958435310889,0.185453761334282,2.86630574599753e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0585224649540831,0.00355623132113506,0.0515522515646583,0.0654926783435078,2.91802342224269e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGBP1,Immunoglobulin-binding protein 1,37959,0.0970591635396767,0.00591885232968186,0.0854582129735002,0.108660114105853,7.44027665921255e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL3,C-X-C motif chemokine 3,40350,0.147057309874327,0.00898222197588933,0.129452154801584,0.16466246494707,9.33523288392522e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0867331617471138,0.00529971657710837,0.0763457172559814,0.0971206062382462,1.04447378914878e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0922013798864633,0.00564340052236149,0.0811403148626348,0.103262444910292,1.62166208469374e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0572999758120117,0.00350807005912786,0.0504241584961211,0.0641757931279023,1.7344205081279e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.12278492975161,0.00752013065422105,0.108045473669336,0.137524385833883,1.96717990014264e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.050199778396484,0.00307510045462648,0.0441725815054161,0.0562269752875519,1.99787675977698e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOK1,Docking protein 1,37942,0.214931738916339,0.0131726903037452,0.189113265920998,0.24075021191168,2.78305757664458e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.113297100088593,0.00695230023062698,0.0996705916365639,0.126923608540622,3.98535127115688e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNPY4,Protein canopy homolog 4,40305,0.117379329720052,0.00720989347481567,0.103247938509414,0.131510720930691,4.10681964458102e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YWHAQ,14-3-3 protein theta,37671,0.116118959580241,0.00712707613388028,0.102149890357835,0.130088028802646,4.18718109607012e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.107376419509511,0.00659033069155439,0.0944593713540645,0.120293467664958,4.20340907427459e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM2,Paralemmin-2,37942,0.0581958218097266,0.00357272442186524,0.0511932819428707,0.0651983616765825,4.33003858772136e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53I3,Quinone oxidoreductase PIG3,37419,0.084359583506801,0.00518272379670931,0.0742014448652507,0.0945177221483512,5.5119754188704e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.121370016225093,0.0074728181900375,0.10672329257262,0.136016739877567,7.64018872293904e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.163935585647375,0.0100954635162588,0.144148477155508,0.183722694139242,8.01081314809409e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADD1,Alpha-adducin,37671,0.109933215128586,0.00678192576726661,0.0966406406247434,0.123225789632428,1.57695665033449e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRADD,Death domain-containing protein CRADD,40192,0.119611872461069,0.00738742676503847,0.105132516001594,0.134091228920544,1.72466245004121e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.150594691287881,0.00930394009196955,0.132358968707621,0.168830413868142,1.8540633531283e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPI,Glucose-6-phosphate isomerase,37987,0.0731758909263604,0.00452094780727876,0.0643148332240941,0.0820369486286268,2.23609021390488e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN3,Ataxin-3,37942,0.0973592891483884,0.00602560305417101,0.0855491071622132,0.109169471134564,3.52726387922773e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPACT,Protein IMPACT,37942,0.0887426385621513,0.00549953394457825,0.0779635520307779,0.0995217250935246,4.9419434467457e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.130977175076969,0.00811670209665694,0.115068438967521,0.146885911186417,5.0400288568321e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JAM3,Junctional adhesion molecule C,37671,0.0789434723272383,0.00489292477045807,0.0693533397771405,0.0885336048773361,5.24740905467075e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMOT,Angiomotin,37671,0.0650574656455171,0.00403273054804112,0.0571533137713565,0.0729616175196777,5.40371550664455e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0660717650765284,0.00409923252428041,0.0580372693289388,0.074106260824118,5.59204832276071e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPARC,SPARC,40411,0.110049276403676,0.00683058697873228,0.096661325925361,0.123437226881992,6.09148451450931e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEFTY2,Left-right determination factor 2,40453,0.0806012574166827,0.00501244769391734,0.0707768599366047,0.0904256548967606,9.94933851045234e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPBP,Platelet basic protein,37934,0.130388582528425,0.0081034084571277,0.114505901952454,0.146271263104395,1.02310946385869e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0441833039012222,0.00274988792726705,0.0387935235637788,0.0495730842386656,1.22371149384091e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.131368720712814,0.00818911766590927,-0.147419391337996,-0.115318050087632,1.83516668069721e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.160050684191578,0.00997050763631622,0.140508489224399,0.179592879158758,1.87782013169243e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YJU2,Splicing factor YJU2,37900,0.0496566980043758,0.0030947125119756,0.0435910614809036,0.055722334527848,2.08955914315054e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0842895937900525,0.00525784952149545,0.0739842087279214,0.0945949788521836,2.18604950378998e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",40042,0.144034586634793,0.00898736123872374,0.126419358606895,0.161649814662692,2.4014843092381e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDC,Nuclear migration protein nudC,40516,0.0977530962488754,0.00610733355411194,0.085782722482816,0.109723470014935,3.22076009911219e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.152605538844869,0.00954230968939894,0.133902611853647,0.171308465836091,4.11717470795475e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTUD6B,Deubiquitinase OTUD6B,37901,0.0910498306326967,0.00569068809662882,0.0798960819633043,0.102203579302089,4.30926199055316e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0889645004354536,0.00556132276615144,0.0780643078137968,0.0998646930571104,4.62878187469926e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0653504377433309,0.00408823101650431,0.0573375049509825,0.0733633705356794,5.53012223527748e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,37901,0.128598619897294,0.00804690398080211,0.112826688094922,0.144370551699666,5.7820597635734e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP2B1,AP-2 complex subunit beta,37572,0.0756144888725548,0.0047310443898606,0.066341641868428,0.0848873358766816,5.81926835225069e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CETN3,Centrin-3,37901,0.118534423997299,0.00742019743953998,0.103990837015801,0.133078010978797,6.41159453218842e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX8,Syntaxin-8,40341,0.0752974235291508,0.00471894192449269,0.0660482973571451,0.0845465497011565,7.10824775073294e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM17,Splicing factor 45,37959,0.117717461423068,0.00737939073289394,0.103253855586596,0.13218106725954,9.06921827967093e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFA,Platelet-derived growth factor subunit A,40536,0.110635427401025,0.00694104295301676,0.0970309832131122,0.124239871588938,9.19585441140983e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0863158497814998,0.00541502911799972,0.0757023927102204,0.0969293068527793,9.22082394619234e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,37572,0.124928207478693,0.00783666555122971,0.109568342998283,0.140288071959103,1.11066587531514e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.101377935301614,0.00636805363242941,0.0888965501820519,0.113859320421175,1.25584612672324e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRAS,Ras-related protein R-Ras,37572,0.200650667462405,0.0126113020372486,0.175932515469398,0.225368819455412,1.80942710793169e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PENK,Proenkephalin-A,37671,0.0474172858432307,0.00298189218169523,0.0415727771671081,0.0532617945193534,2.05322876835889e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLG4,Disks large homolog 4,37942,0.107749390107136,0.00677821008436914,0.0944640983417725,0.1210346818725,2.1785946962146e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP10,Caspase-10,39961,0.109995424755716,0.00692689405482951,0.0964187124082498,0.123572137103181,2.44296113064462e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0771372988846199,0.00485885940131545,0.0676139344580416,0.0866606633111981,2.53153874777486e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PF4,Platelet factor 4,37934,0.149222831694703,0.00939424028066344,0.130810120744603,0.167635542644803,2.6281072053136e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLG,Plasminogen,37705,0.0344040931538053,0.00216623442649886,0.0301582736778676,0.0386499126297431,2.78926413889254e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIFBP,KIF-binding protein,40305,0.126059932431528,0.00794641987194947,0.110484949482507,0.141634915380549,3.05886133629801e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATOX1,Copper transport protein ATOX1,40411,0.109781183373212,0.00692242127086275,0.0962132376823205,0.123349129064103,3.28437582674441e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0620665780085226,0.00391590354681472,0.0543914070567658,0.0697417489602795,3.86423023011657e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0885146555585073,0.00558773129023807,0.0775627022296407,0.099466608887374,4.4658917189786e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UROD,Uroporphyrinogen decarboxylase,37671,0.1077764245861,0.00680093333869099,0.0944465952422659,0.121106253929935,4.81083201138823e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA11,Annexin A11,40312,0.10299755646558,0.00650462338687381,0.0902484946273072,0.115746618303853,4.83250622033449e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0882143422005298,0.00557832047253669,0.0772808340743579,0.0991478503267017,6.84189279532252e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.168550851746235,0.0106711671703223,0.147635364092403,0.189466339400067,8.9057155767593e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDCP1,CUB domain-containing protein 1,40228,0.0739879173891792,0.00468648148435483,0.0648024136798438,0.0831734210985147,1.01242456611335e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0981975520972054,0.00622316621233661,0.0860001463210257,0.110394957873385,1.38477938144575e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MIF,Macrophage migration inhibitory factor,40307,0.104731484196528,0.00665183221553681,0.0916938930540758,0.11776907533898,1.96195249499101e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDC4,Syndecan-4,40359,0.0687589099575943,0.00437081620881901,0.060192110188309,0.0773257097268796,2.40888583219297e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RILP,Rab-interacting lysosomal protein,40434,0.091516189332867,0.00581793215119393,0.0801130423165269,0.102919336349207,2.44889918147351e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA2,Apolipoprotein A-II,37987,-0.0723648790922466,0.00459734863677226,-0.0813756824203203,-0.063354075764173,2.4662088975624e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0830246955631644,0.00528576477806796,0.0726645965981512,0.0933847945281776,3.57308066579574e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARB2,Lysosome membrane protein 2,40011,0.0468165333639404,0.00298083799351328,0.0409740908966543,0.0526589758312264,3.65878521033917e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPP,Lipoma-preferred partner,37562,0.102056548062035,0.00649408506757015,0.089328141329598,0.114784954794473,3.78229075043659e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACYBP,Calcyclin-binding protein,37642,0.155669254324497,0.00990697899237549,0.136251575499441,0.175086933149553,3.88740931706921e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.146817409326126,0.00934764470817151,0.12849602569811,0.165138792954142,4.20728497692979e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0937098609585027,0.00596861360594806,0.0820113782908445,0.105408343626161,4.60423654320734e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.10097856030937,0.00643229922856731,0.0883712538213783,0.113585866797362,4.82963778198497e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK24,Serine/threonine-protein kinase 24,39961,0.0935295875456513,0.00596276543407212,0.0818425672948699,0.105216607796433,5.02268521109606e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.1280328237266,0.00816871492288174,0.112022142477752,0.144043504975448,6.04663269882487e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKD2,Polycystin-2,37562,0.0903198781050912,0.00576485229782232,0.0790207676013595,0.101618988608823,7.94208556442569e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SULT2A1,Bile salt sulfotransferase,40341,0.0804198203482089,0.0051462981764804,0.0703330759223074,0.0905065647741105,1.22109499378341e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCB,Tubulin-folding cofactor B,40228,0.152446826625333,0.00975868494959253,0.133319804124131,0.171573849126534,1.32947769324155e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RILPL2,RILP-like protein 2,37990,0.14686260245028,0.00940109963291583,0.128436447169765,0.165288757730795,1.5458906837404e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POSTN,Periostin,37998,-0.0572401490472406,0.00366419222577576,-0.0644219658097611,-0.0500583322847201,1.5535377616005e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRAP2,GRB2-related adapter protein 2,40359,0.191218314253976,0.0122537306081984,0.167201002261908,0.215235626246045,1.70871767939361e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2,Microtubule-associated protein 2,37942,0.0690837954371768,0.00443501792286843,0.0603911603083547,0.0777764305659989,3.09939046027921e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0967879996293906,0.006215975968101,0.0846046867319127,0.108971312526869,3.41221942259223e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.102063955464217,0.00656178528355309,0.0892028563084528,0.114925054619981,3.72675591393669e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMSB10,Thymosin beta-10,40332,0.113976015505716,0.00732947892865605,0.0996102368055503,0.128341794205882,3.96569403116244e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1R2,Interleukin-1 receptor type 2,40330,0.0293073009281421,0.00188613716141674,0.0256104720917653,0.0330041297645189,4.77640226451832e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTBDN,Retbindin,40305,0.043861365749247,0.00282506838595515,0.0383242317127749,0.0493984997857191,5.79538702104367e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0707575788163242,0.00455828418582815,0.061823341812101,0.0796918158205474,6.00434412279946e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA4D,Semaphorin-4D,40471,0.044719256701877,0.00288233416509573,0.0390698817382894,0.0503686316654646,6.77944328064077e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.155725236649881,0.0100398603268148,0.136047110409324,0.175403362890438,8.73917931522925e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED8,Protein TMED8,37901,0.153978424249011,0.00992945529975968,0.134516691861482,0.17344015663654,9.04594786275296e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGF,Pro-epidermal growth factor,40324,0.153745037706962,0.00992710083130413,0.134287920077606,0.173202155336318,1.0427405764474e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARK7,Parkinson disease protein 7,40332,0.0800350447139511,0.00516906091873136,0.0699036853132376,0.0901664041146645,1.10689074545925e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0307715394082036,0.0019916741657567,-0.0346752207730867,-0.0268678580433205,1.83576660225449e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNM3,Dynamin-3,37959,0.0820202410467961,0.00530677730663547,0.0716189575257906,0.0924215245678016,1.97700970240008e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPP1,Tripeptidyl-peptidase 1,40255,0.0667065615981858,0.00431891673173796,0.0582414848039794,0.0751716383923922,1.99642651282478e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0922325423739595,0.00597292870902568,0.0805256021042692,0.10393948264365,2.44120731684088e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF19,Fibroblast growth factor 19,40422,0.114220295058584,0.00740237463991602,0.0997116407643486,0.128728949352819,2.48657414052994e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEXN,Nexilin,37987,0.101912581242942,0.00660052233130445,0.0889755574735851,0.114849605012299,2.50521338657672e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINE2,Glia-derived nexin,37990,0.095770500631693,0.00620724929610762,0.0836042920113221,0.107936709252064,2.97336020447697e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXJ3,Forkhead box protein J3,37598,0.0651949039195983,0.00422539877706573,0.0569131223165494,0.0734766855226471,3.04406354538483e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,40305,0.048201347445886,0.00312721402578535,0.0420720079553468,0.0543306869364253,3.22963628868548e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.129324088118894,0.0083847287705465,0.112890019728623,0.145758156509165,3.2331429036361e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0567403098803458,0.00368763696438549,0.0495125414301502,0.0639680783305413,4.8087749299705e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.113789070726842,0.00739557039727504,0.0992937527481833,0.128284388705501,4.99341148931646e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSTB,Cystatin-B,40097,0.0622138510497717,0.00404660907855964,0.0542824972557948,0.0701452048437486,5.93518372310243e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCA,Calcitonin,40192,0.0815646376377001,0.00531349062078944,0.0711501960209528,0.0919790792544474,8.48122151068461e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APPL2,DCC-interacting protein 13-beta,37671,0.165727850027696,0.0107932101067652,0.144573158218436,0.186882541836956,9.37494718102235e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CETN2,Centrin-2,39961,0.0995498257076885,0.00648804078525364,0.0868332657685913,0.112266385646786,9.53990314863758e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.047371357989613,0.00309054330386751,0.0413138931140326,0.0534288228651933,1.19350123970157e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LACTB2,Endoribonuclease LACTB2,40359,0.0977628413986282,0.00638050620113159,0.0852570492444103,0.110268633552846,1.29257255707208e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.144955468595769,0.00945474717220835,0.12642416413824,0.163486773053297,1.33895622226882e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB1,Leukocyte elastase inhibitor,40287,0.131384333761961,0.00858868635346284,0.114550508509174,0.148218159014749,1.88771312834885e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDT,D-dopachrome decarboxylase,37998,0.0605722110587633,0.00395832168044502,0.052813900565091,0.0683305215524355,2.0181804554092e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD226,CD226 antigen,37598,0.0620238163726423,0.00405399898119276,0.0540779783695045,0.0699696543757801,2.17945804261131e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKG1,cGMP-dependent protein kinase 1,37671,0.1851195644453,0.0121077935167512,0.161388289152468,0.208850839738132,2.52497419520119e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0805899096580667,0.00527225439982784,0.0702562910344041,0.0909235282817293,2.66692966130866e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0694122772249029,0.00454407541769812,0.0605058894062146,0.0783186650435912,3.04273626325019e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F13B,Coagulation factor XIII B chain,37934,0.0381043646594015,0.00249601705689965,0.0332121712278782,0.0429965580909248,3.51342634039804e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BIN2,Bridging integrator 2,40332,0.133606191539168,0.0087629684654495,0.116430773346887,0.150781609731449,4.05167223514774e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMG3,Proteasome assembly chaperone 3,40341,0.0755410392808465,0.00495522486310507,0.0658287985491606,0.0852532800125325,4.17111700509642e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.092882128862258,0.00609344569497855,0.0809389753001,0.104825282424416,4.25079276306553e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARSA,Arylsulfatase A,40332,0.0655282268077072,0.00430558803602979,0.0570892742570888,0.0739671793583256,6.11850415296197e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0548220857945983,0.00360885937668311,0.0477487214162994,0.0618954501728972,9.28905128642051e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS3BP,Galectin-3-binding protein,38013,0.0435152218970596,0.00286411683338376,0.0379015529036275,0.0491288908904918,1.04428180120015e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.0994154928926379,0.00654871667708134,0.0865800082055585,0.112250977579717,1.29882540378795e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN2L,Ataxin-2-like protein,37959,0.0708482680533227,0.00467192713385043,0.0616912908709758,0.0800052452356695,1.60858346804249e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APP,Amyloid-beta precursor protein,40309,0.0980679712897009,0.00647334063239977,0.0853802236501973,0.110755718929204,1.74990162621562e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0553912767116324,0.00365690421303486,0.0482237444540841,0.0625588089691807,1.84177655585424e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.046210381833245,0.00305506107920557,-0.0521983015484879,-0.0402224621180021,2.46639376740393e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.125176985594621,0.00827124110149815,0.108965353035684,0.141388618153557,2.54534219984696e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0722837789671674,0.00477630791149297,0.0629222154606412,0.0816453424736936,2.59789445066383e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIAPIN1,Anamorsin,40411,0.0931389472152387,0.00616327391498107,0.0810589303418758,0.105218964088602,3.05696103219019e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAM2,Neural cell adhesion molecule 2,40332,-0.0394534108720341,0.00261076544097204,-0.0445705111363393,-0.0343363106077289,3.07432930747777e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATG4A,Cysteine protease ATG4A,39980,0.0869228134890579,0.00575484111026764,0.0756433249129333,0.0982023020651825,3.50435029245753e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD72,B-cell differentiation antigen CD72,37671,0.0619355833063408,0.004099345111005,0.053900866888771,0.0699702997239106,3.79453476124211e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPT1,Angiopoietin-1,40263,0.123640596770679,0.00819782346387251,0.107572862781489,0.139708330759869,4.80883182105242e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REEP4,Receptor expression-enhancing protein 4,37959,0.0907851334890964,0.00601591545923381,0.0789939391889982,0.102576327789195,4.84867474958823e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12A_IL12B,Interleukin-12,40305,0.114034545250663,0.00757147298942183,0.0991944581913962,0.12887463230993,6.56926425550536e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.135336220958207,0.00898541442794936,0.117724808679426,0.152947633236988,7.47401433925684e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,37671,0.172532897262139,0.0114598770472453,0.150071538249538,0.194994256274739,8.38761943598682e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCG2,Secretogranin-2,40392,0.0468585628355856,0.00311753694602281,0.0407481904213809,0.0529689352497903,1.02944845545922e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCT5,T-complex protein 1 subunit epsilon,39980,0.0660601800753357,0.00439490312560122,0.0574461699491573,0.074674190201514,1.04425672885736e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD22,B-cell receptor CD22,40516,0.0595138164892883,0.00396234347146146,0.0517476232852239,0.0672800096933528,1.20126713234251e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSS,Cathepsin S,37057,0.0357922100640562,0.0023817559366269,0.0311239684282675,0.0404604516998449,1.32629697655576e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0888858028358081,0.00593042342761289,0.0772621729176868,0.100509432753929,1.9354527063187e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0590271170016797,0.00393624061176211,0.0513120854026259,0.0667421486007334,1.99411963979168e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.109074963910273,0.00727984430332793,0.0948064690757506,0.123343458744796,2.13106823786887e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD274,Programmed cell death 1 ligand 1,40228,0.0502577423046706,0.00335716048604075,0.0436777077520308,0.0568377768573105,2.54299773406155e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NBN,Nibrin,40044,0.0737815104124454,0.00492899548250098,0.0641206792667434,0.0834423415581473,2.62209582103845e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3B,Protein FAM3B,40305,0.0520173748393658,0.00348822100958817,0.045180461660573,0.0588542880181586,5.97843175721057e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G15,Phospholipase A2 group XV,40411,0.0370678346861702,0.0024864526807287,0.032194387431942,0.0419412819403985,6.3448457885287e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0447472050358372,0.00300119825047439,0.0388648564649074,0.050629553606767,7.16253754947915e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.131538740109225,0.00882536401640161,0.114241026637078,0.148836453581372,7.84463729555687e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG6,Large proline-rich protein BAG6,40042,0.0517259758167803,0.00347276670561715,0.0449193530737707,0.0585325985597899,7.84745397369515e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F2R,Proteinase-activated receptor 1,40396,0.0826867828254352,0.00555359989656491,0.071801727028168,0.0935718386227024,8.4117601454847e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0854323619024621,0.00573993095855921,0.0741820972236861,0.0966826265812382,9.24176684651304e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.134468838862123,0.00903874976603468,0.116752889320695,0.152184788403551,1.17649115301565e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL2,ADAMTS-like protein 2,37998,0.0445002194174277,0.00299199925444393,0.0386359008787176,0.0503645379561378,1.2143198385514e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP1,Metalloproteinase inhibitor 1,40167,0.0404209431868501,0.0027200366074051,0.0350896714363362,0.0457522149373641,1.29294199912162e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP7,Caspase-7,37942,0.120491781392978,0.00810542472979473,0.104605148922581,0.136378413863376,1.36081415245662e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP2,Caspase-2,40341,0.0970811287034154,0.00653547610772995,0.0842715955322647,0.109890661874566,1.39959103837791e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEPR,Leptin receptor,40359,-0.0440374421393726,0.00296639180408231,-0.0498515700753739,-0.0382233142033712,1.59702106549203e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD207,C-type lectin domain family 4 member K,40029,0.0551091582070666,0.00371313592938749,0.0478314117854671,0.0623869046286661,1.71559192179303e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBI,Acyl-CoA-binding protein,40270,0.113112303550725,0.00762340776424445,0.0981704243328057,0.128054182768644,1.80292314775256e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TADA3,Transcriptional adapter 3,37900,0.0558887534823611,0.00376780924937124,0.0485038473535935,0.0632736596111287,2.19378590757617e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRB1,Chymotrypsinogen B,40332,0.0762706645677721,0.00514519653688537,0.0661860793554767,0.0863552497800674,2.20280967615215e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0907031574670897,0.0061162595269992,0.0787152887941712,0.102691026140008,2.34099279411849e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB33A,Ras-related protein Rab-33A,37562,0.0957767646847093,0.00645924648712687,0.0831166415699406,0.108436887799478,2.42830211395998e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPSE,Heparanase,37848,0.133336969996327,0.0089956000103946,0.115705593975954,0.150968346016701,2.57723383108118e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0555123435700793,0.00374531340309187,0.0481715293000192,0.0628531578401394,2.64699681901325e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALB2,Calretinin,39961,0.0450948999131845,0.00304470263912788,0.0391272827404939,0.0510625170858751,2.70344982672655e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSNL1,Visinin-like protein 1,37942,0.0536973416923272,0.00362764067118068,0.0465871659768131,0.0608075174078414,3.44216500758812e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARF1,Scavenger receptor class F member 1,40536,0.0605131632206368,0.00409459833169903,0.0524877504905067,0.0685385759507669,4.21467217512752e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH9,Protocadherin-9,37901,0.0483911293247229,0.0032746679878272,0.0419727800685816,0.0548094785808642,4.96409388273969e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0369915014301368,0.00250496420589213,0.0320817715865883,0.0419012312736854,4.99222157978947e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3C,Protein FAM3C,40330,0.0423038999896766,0.0028703674066114,0.0366779798727183,0.0479298201066349,7.70854508273296e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL32,Interleukin-32,40341,-0.0608556853268426,0.00413186913133793,-0.068954148824265,-0.0527572218294203,8.88738560603092e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D5,TBC1 domain family member 5,40341,0.11158424664199,0.0075783057066023,0.0967307674570493,0.12643772582693,9.44906148633859e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0544642973384708,0.00370382511213975,0.0472048001186769,0.0617237945582648,1.24724495413005e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0511644505196686,0.00347934168271214,0.0443449408215528,0.0579839602177844,1.26712509384131e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0909754622552777,0.00619266812528316,0.0788378327297227,0.103113091780833,1.53478887212273e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB6,Serpin B6,40433,0.0847693989327783,0.00577534155732394,0.0734497294804234,0.0960890683851333,1.84877969145294e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0644238017838033,0.0043874570580132,-0.0730232176175092,-0.0558243859500974,1.93816440985116e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.11386091349841,0.00775539159598347,0.098660345970282,0.129061481026537,1.99858128334699e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA4,Protein disulfide-isomerase A4,37998,0.0858779081970435,0.00585155272496659,0.0744088648561089,0.097346951537978,2.15713590483686e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGR,Tyrosine-protein kinase Fgr,39961,0.0783742657594971,0.00534373698198048,0.0679005412748153,0.0888479902441788,2.22551804011596e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL2,C-C motif chemokine 2,40203,0.0749561640091045,0.00511223723505823,0.0649361790283904,0.0849761489898186,2.34770321501647e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNA4,Ephrin-A4,40203,0.0417178553387149,0.00284662153421978,0.0361384771316442,0.0472972335457857,2.5948417975252e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.108512821887929,0.00740611685078818,0.0939968328603842,0.123028810915474,2.7036574012936e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.134325581352913,0.00916785408426551,0.116356587347752,0.152294575358073,2.72364323116288e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THTPA,Thiamine-triphosphatase,37884,0.125550469207044,0.00857434493503427,0.108744753134377,0.142356185279711,3.53170350179326e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP3R1,Calcineurin subunit B type 1,40228,0.0582965160809061,0.00399234601541826,0.0504715178906863,0.0661215142711258,5.60122275310358e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA2,Carboxypeptidase A2,40398,0.0904217861917599,0.00619904694684796,0.0782716541759379,0.102571918207582,6.97322698968285e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0546569388487273,0.00374728203389407,0.0473122660622949,0.0620016116351596,7.99914075341406e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4G,C-type lectin domain family 4 member G,40341,0.046409992607274,0.00318537351808766,0.0401666605118222,0.0526533247027258,8.8971145695728e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0917277018762351,0.00629378247183837,0.0793918882314319,0.104063515521038,9.45483178743893e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.154859220322935,0.0106473630803903,0.13399038868537,0.1757280519605,1.27951081461742e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0564270579088108,0.00387743811324197,0.0488272792068566,0.0640268366107651,1.28490133154403e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6AP2,Renin receptor,39980,0.0586278621315634,0.00403372483910895,0.0507217614469099,0.0665339628162169,1.50464726805807e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.0610892771435642,0.00420104928876666,0.0528552205375815,0.0693233337495468,1.52202607116283e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0404931683196232,0.00278535390233318,0.0350338746710501,0.0459524619681962,1.62085370172286e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA14,Carbonic anhydrase 14,40489,-0.0484611297326061,0.00333905898480491,-0.0550056853428237,-0.0419165741223884,1.99091253307219e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPB1,Heat shock protein beta-1,40116,0.0951273220901678,0.0065549370555733,0.0822796454612441,0.107974998719091,2.05577039093543e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.140240783434248,0.00966160491748924,0.121304037795969,0.159177529072526,2.26181921955361e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTF1,Cardiotrophin-1,40042,0.118634124342072,0.00817834701271277,0.102604564197155,0.134663684486989,2.26269140980364e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPI,Mannose-6-phosphate isomerase,40305,0.120287505358595,0.00829312091706837,0.104032988361141,0.136542022356049,2.28152446698031e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.103323393910143,0.00711950409804844,0.0893691658779679,0.117277621942318,2.3330029630574e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP10,Stromelysin-2,40341,-0.0840403379554646,0.00579687627793558,-0.0954022154602184,-0.0726784604507109,2.51809917859206e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAP3,Cytosol aminopeptidase,40044,0.0689414876294958,0.00475599599388583,0.0596197354814795,0.078263239777512,2.61907755147118e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMT,Catechol O-methyltransferase,39877,0.119296385220672,0.00823051992684072,0.103164566164064,0.13542820427728,2.68908017796498e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL11,C-X-C motif chemokine 11,40471,0.111376553536387,0.00768651498967049,0.0963109841566326,0.126442122916141,2.79541009760515e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JPT2,Jupiter microtubule associated homolog 2,37901,0.123089526653256,0.00848986541880577,0.106449390432397,0.139729662874115,2.81705798682465e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0941785230653125,0.00649908998743208,0.0814403066899456,0.106916739440679,3.19759124832559e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA1,Apolipoprotein A-I,38013,-0.0386637308681912,0.00267014180451843,-0.0438972088050474,-0.0334302529313351,3.64169287322376e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MGLL,Monoglyceride lipase,40396,0.120658523979765,0.00834093919423762,0.104310283159059,0.137006764800471,3.9606059142875e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,37628,0.086627602132377,0.00599142334310653,0.0748844123798882,0.0983707918848658,5.06575045254372e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANG,Angiogenin,40309,0.048125156532349,0.00333225907169751,0.0415939287518218,0.0546563843128761,5.57713306389027e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.129108479713865,0.0089467297172484,0.111572889468058,0.146644069959672,7.54993358892497e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MICALL2,MICAL-like protein 2,37572,0.0956569236854874,0.00663110488783396,0.0826599581053328,0.108653889265642,8.15783973351096e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.085286888638101,0.0059176924016157,0.0736882115309342,0.0968855657452678,8.55712537668193e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.125234733190241,0.00869014176019875,0.108202055340252,0.142267411040231,9.76387489657442e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0741485282375193,0.00514709343638753,0.0640602251021997,0.0842368313728388,1.05483770161465e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.13096297289532,0.00909886984901218,0.113129187991256,0.148796757799384,1.1205011647659e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MESD,LRP chaperone MESD,40332,0.168232088317845,0.011695632689514,0.145308648246398,0.191155528389293,1.27699685648736e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYO9B,Unconventional myosin-IXb,40044,0.0923493811045341,0.00641981904758197,0.0797665357712734,0.104932226437795,1.27703158368721e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DXO,Decapping and exoribonuclease protein,37942,0.0637729964938313,0.00443818831751075,0.0550741473915103,0.0724718455961524,1.78008559028027e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGCT,Gamma-glutamylcyclotransferase,37978,0.0672236162937875,0.00468051203438676,0.0580498127063895,0.0763974198811856,1.95396507633308e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD244,Natural killer cell receptor 2B4,40516,0.0369327163133991,0.00257644407385247,0.0318828859286483,0.04198254669815,2.56208291770772e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA3,Annexin A3,40442,0.0969305499017099,0.00676683202667437,0.0836675591294282,0.110193540673992,2.97936780472199e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0907870281540366,0.00634560687940722,0.0783496386703984,0.103224417637675,3.88327666948262e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPC5,Glypican-5,40228,0.0772996951544086,0.00541294913104143,0.0666903148575674,0.0879090754512498,5.59949075795152e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APLP1,Amyloid-like protein 1,40359,-0.0718931562985726,0.00503525691734931,-0.0817622598565772,-0.0620240527405679,5.77525457275801e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.138949779035365,0.00973199824483259,0.119875062475493,0.158024495595237,5.80668583568459e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF6,SLAM family member 6,39980,0.0525053105877014,0.00367833354416657,0.0452957768411349,0.0597148443342679,6.1865104286813e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCN1,Ficolin-1,37967,0.0779556888190661,0.00546044935358137,0.0672532080860466,0.0886581695520856,6.61791707290647e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0377235499560539,0.00264426551935575,0.0325407895381166,0.0429063103739911,6.83098880331984e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSC22D1,TSC22 domain family protein 1,37959,0.0929907073101638,0.00652084395507658,0.0802098531582137,0.105771561462114,8.28705224959327e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL4,C-C motif chemokine 4,40376,0.0930797266864791,0.00654319349732833,0.0802550674317155,0.105904385941243,1.21292980845167e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,37987,0.099266541433082,0.00698077883335528,0.0855842149197056,0.112948867946458,1.46559580813776e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMMT,MICOS complex subunit MIC60,37900,0.061232077739652,0.00430637864054093,0.0527915756041918,0.0696725798751122,1.49474227211952e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM106A,Transmembrane protein 106A,37900,0.0964733002031646,0.00678727557396084,0.0831702400782014,0.109776360328128,1.60548497277309e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.14859544509262,0.0104570303017783,0.128099665701135,0.169091224484106,1.69241505911132e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WDR46,WD repeat-containing protein 46,37900,0.0489897228552599,0.00344829665674016,0.0422310614080492,0.0557483843024706,1.76949075859568e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.13465043472279,0.00947841359778051,0.11607274407114,0.15322812537444,1.78373413395759e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0839679249368449,0.00591673360123277,0.0723711270784286,0.0955647227952611,2.22369908992848e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP3,Caspase-3,40536,0.120711784049714,0.00851564572714831,0.104021118424504,0.137402449674925,2.44303017663707e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.101459402232414,0.00716764148008374,0.0874108249314496,0.115507979533378,3.64065389914971e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK13,Kallikrein-13,40032,0.059290027730348,0.00419568895261062,0.0510664773832311,0.0675135780774648,4.63163245229897e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0499740288031726,0.00353679414405246,0.0430419122808298,0.0569061453255155,5.29178531459872e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.101524815801794,0.00719374582326773,0.0874250739881889,0.115624557615398,6.57896319864076e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMPER,BMP-binding endothelial regulator protein,37671,0.030727204517505,0.00217707110472525,0.0264601451522435,0.0349942638827665,6.59463572275174e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0789612356436707,0.0056040965819418,0.0679772063430648,0.0899452649442766,8.27129425716979e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.047980469040863,0.00340378583750815,0.041309048799347,0.054651889282379,8.35028193825657e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0402542828771835,0.0028584042778591,0.0346518104925797,0.0458567552617873,9.04631809681126e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.0999831718854147,0.00710109427860987,0.0860650270993393,0.11390131667149,1.05806989065421e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.128712136533975,0.00914225274831196,0.110793321147284,0.146630951920667,1.06426054170101e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F12,Coagulation factor XII,38013,0.0569027292340455,0.00404364249844016,0.0489771899371028,0.0648282685309882,1.16102573911362e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSAP,Prosaposin,37901,0.0387733544147957,0.00275622569355597,0.033371152055426,0.0441755567741654,1.24515560931328e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP170,Centrosomal protein of 170 kDa,37628,0.105425971470601,0.00749905352115855,0.0907278265691303,0.120124116372072,1.43231995946066e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERMAP,Erythroid membrane-associated protein,37598,0.061119111476331,0.00435090905835796,0.0525913297219494,0.0696468932307126,1.67516985297719e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINC1,Antithrombin-III,37981,0.0200074730304546,0.0014255968338505,0.0172133032361076,0.0228016428248016,1.96540404112798e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0647434292643797,0.00461597471094464,0.0556961188309283,0.0737907396978312,2.21454602959817e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1RL,Complement C1r subcomponent-like protein,37993,0.0263145192248826,0.00187801579511762,0.0226336082664521,0.0299954301833131,2.68789730075313e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCA,Tubulin-specific chaperone A,37671,0.118248150900341,0.00843948371073363,0.101706762827303,0.134789538973379,2.7562401348833e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRGN,Neurogranin,37987,0.122817190338671,0.00876665407848063,0.105634548344849,0.139999832332493,2.77548308362506e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0536641374803667,0.00383070969624855,0.0461559464757196,0.0611723284850139,2.8075106413082e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.117033496242379,0.00835942970325939,0.10064901402399,0.133417978460767,3.16992647036106e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EHD3,EH domain-containing protein 3,37628,0.158788409685209,0.0113633923904828,0.136516160599863,0.181060658770556,4.65320459765393e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMFG,Glia maturation factor gamma,37990,0.0970135379245017,0.00694406688408529,0.0834031668316945,0.110623909017309,4.75652452652867e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CERT,Ceramide transfer protein,39961,0.0830696838919886,0.00594900779012714,0.0714096286233394,0.0947297391606378,4.80221024698865e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0483133867296333,0.00345909154932538,0.0415335672929555,0.055093206166311,5.11333578536072e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12B,Interleukin-12 subunit beta,40516,0.0732598585400533,0.00525290217050983,0.062964170285854,0.0835555467942526,5.95719596668946e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0718128298895754,0.00514675540567683,0.0617251892944488,0.0819004704847019,6.20137671405527e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2,Complement C2,40372,0.0323340709340051,0.00231920918128397,0.0277884209386885,0.0368797209293217,6.39127260674135e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0563269962833259,0.00405897062893947,0.0483714138506045,0.0642825787160472,1.55904387435659e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFB,Complement factor B,37770,0.044100933589182,0.00317884205649148,0.0378704031584587,0.0503314640199053,1.84478909160986e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LARP1,La-related protein 1,37900,0.0853166149779653,0.00615205344765161,0.0732585902205682,0.0973746397353625,1.97047702793733e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FIS1,Mitochondrial fission 1 protein,40354,0.103474652998049,0.00746750445490283,0.0888383442664396,0.118110961729659,2.07286725115608e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.034919258123825,0.00251851409987704,0.029982970488066,0.039855545759584,2.08150575845526e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0680117835252397,0.00491377669319898,0.0583807812065697,0.0776427858439097,2.85275859747873e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL8,C-C motif chemokine 8,40470,0.0807385524087038,0.00584052554517485,0.0692911223401611,0.0921859824772465,3.24063764964989e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L1,Bcl-2-like protein 1,37942,0.133710150409434,0.00966909109679778,0.11475873185971,0.152661568959157,3.37549688218942e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMTN,Smoothelin,37905,0.128741674839253,0.00933282816354863,0.110449331638698,0.147034018039809,5.39485687341447e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.101990725723976,0.00739660882653066,0.0874933724239764,0.116488079023977,5.8172522332916e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.125827388737387,0.00913320229074646,0.107926312247524,0.14372846522725,6.20267077092371e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB9,Serpin B9,40228,0.0446892751092219,0.00324534899679313,0.0383283910755074,0.0510501591429364,6.81375017310686e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP5,Microfibrillar-associated protein 5,40536,0.0546455510950372,0.00396954984788509,0.0468652333931824,0.0624258687968919,7.12600007005702e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSL,Cathepsin L1,40359,0.0323037546139419,0.00234669368123542,0.0277042349987205,0.0369032742291634,7.22304718099928e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.149468774342933,0.010860867195373,0.128181474640002,0.170756074045864,7.68756653142632e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.107862639020412,0.00783955035327185,0.0924971203279997,0.123228157712825,7.93907269629284e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD83,CD83 antigen,40341,0.0447088921378607,0.00325615008104433,0.0383268379790138,0.0510909462967076,1.16647106504723e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0795955480203915,0.00579975881473902,0.068228020743503,0.0909630752972799,1.27896003359693e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIF1,Allograft inflammatory factor 1,39980,0.0700480806066163,0.00510696745562517,0.060038424393591,0.0800577368196417,1.43830403306636e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0760001899237317,0.00554353148273054,0.0651348682175799,0.0868655116298836,1.54385060550197e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSR1,Macrophage scavenger receptor types I and II,40471,0.0592810040696987,0.00432735602370219,0.0507993862632424,0.067762621876155,1.78305398198598e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.136027494592651,0.00994098305493707,0.116543167804975,0.155511821380328,2.47973836007182e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.115696826589114,0.00845949583308937,0.0991162147562584,0.132277438421969,2.71868756183409e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C19orf12,Protein C19orf12,39961,0.0821446538098262,0.00601116132286032,0.0703627776170199,0.0939265300026324,2.87283744014655e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0393809346445313,0.00288484785143172,0.0337266328557252,0.0450352364333375,3.46536211929996e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FEN1,Flap endonuclease 1,39980,0.0818725504413594,0.00600125855775114,0.0701100836681672,0.0936350172145517,3.91084037414226e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTD,Deoxycytidylate deaminase,37671,0.124610445779884,0.00915221661536465,0.106672101213769,0.142548790345998,6.22458002066019e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPB6,Heat shock protein beta-6,40489,0.0480202051254591,0.00353031999206679,0.0411007779410082,0.05493963230991,6.63435298779429e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN2,Nectin-2,40330,0.038048542352381,0.00279868681831201,0.0325631161884895,0.0435339685162726,7.33975289558667e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,40411,0.109989657171281,0.00809435903540962,0.0941247134618784,0.125854600880684,8.01408080723723e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUGT1,Protein SGT1 homolog,39980,0.107020996515194,0.00787922121227884,0.0915777229391275,0.122464270091261,8.78911678278958e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGH,Gamma-glutamyl hydrolase,40077,0.0450134027997652,0.00331517491176208,0.0385156599727116,0.0515111456268189,9.33292293936623e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0479333453517479,0.00352877656646333,-0.054849747422016,-0.0410169432814797,9.57321268271112e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LONP1,"Lon protease homolog, mitochondrial",37628,0.114305011766971,0.00841605402456205,0.0978095458788298,0.130800477655113,9.80508387376815e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.130379550322451,0.00960073616926177,0.111562107430698,0.149196993214204,9.86529669267281e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRD1,Natural killer cells antigen CD94,40516,0.0598718363656509,0.00441604584564128,0.051216386508194,0.0685272862231078,1.20745222883566e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.101092940639749,0.00746049831367887,0.0864703639449386,0.11571551733456,1.47577545038733e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFA,Protransforming growth factor alpha,40341,0.0628247858908193,0.00464092401542971,0.0537285748205771,0.0719209969610616,1.60403817862073e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP6,Platelet glycoprotein VI,40311,0.115058313729603,0.00851064323764387,0.0983774529838211,0.131739174475385,2.03940125002977e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL16,C-X-C motif chemokine 16,40517,0.0310512573530339,0.00229976167515797,0.0265437244697243,0.0355587902363435,2.55899129606646e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYBB1,Beta-crystallin B1,37990,0.0848122907705872,0.00627855546987256,0.072506322049637,0.0971182594915374,2.58873303122956e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F2,Prothrombin,38013,0.0192540660379786,0.00142547029847454,0.0164601442529685,0.0220479878229887,2.62380737125121e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFASC,Neurofascin,40516,0.0355711422637058,0.00263675683504001,0.0304030988670274,0.0407391856603843,2.98424974709656e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXO3,Forkhead box protein O3,39980,0.126616702004534,0.00938743484897394,0.108217329700545,0.145016074308523,3.14527698963921e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NADK,NAD kinase,40359,0.0698985901948991,0.00518487753361859,0.0597362302290067,0.0800609501607916,3.39529977932014e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.104152948396366,0.0077253326463642,0.0890112964094921,0.11929460038324,3.74581490381449e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.040444281538443,0.00300205003685356,0.0345602634662101,0.046328299610676,3.8314817113398e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ING1,Inhibitor of growth protein 1,39925,0.0581354417816019,0.00432025038793136,0.0496677510212565,0.0666031325419474,4.79750936984574e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHRL,Appetite-regulating hormone,40359,0.102610755546119,0.00763532237121831,0.0876455236985311,0.117575987393707,5.97893521382243e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0416513261082157,0.00310219889442134,0.0355710162751498,0.0477316359412815,7.04219475579754e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL18,C-C motif chemokine 18,40172,0.0912564886355691,0.00680354861378959,0.0779215333525415,0.104591443918597,8.49746093171732e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACYP1,Acylphosphatase-1,37622,0.085887487658343,0.00641130480268451,0.0733213302450814,0.0984536450716047,1.17337805499204e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL7,Interleukin-7,40341,0.0835068128106504,0.00623832683179552,0.0712796922203312,0.0957339334009697,1.21069026395969e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK10,Kallikrein-10,40354,0.0508690348397829,0.00380028017186483,0.0434204857029278,0.0583175839766379,1.21811297690967e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XCL1,Lymphotactin,40489,0.0729168461208811,0.00545692691910152,0.0622212693594422,0.0836124228823201,1.65461974901667e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100P,Protein S100-P,40042,0.0693165314611447,0.00519400186265171,0.0591362878103474,0.0794967751119421,2.09646360204514e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.142772074152851,0.0107034943678663,0.121793225191833,0.163750923113869,2.29033485618248e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0726338593805465,0.00544339142591153,0.0619648121857599,0.0833029065753332,2.36188174817615e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0783653478208748,0.00588553385200888,0.0668297014709374,0.0899009941708123,3.11485492484322e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.06311007699077,0.00473763404370693,0.0538243142651044,0.0723958397164356,3.18422570492709e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGXT,Serine--pyruvate aminotransferase,40359,0.0990415787638337,0.00744118269107852,0.0844568606893198,0.113626296838348,3.32549321956308e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0631801840883228,0.00474883122125899,0.0538724748946552,0.0724878932819904,3.62273661871341e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMVK,Phosphomevalonate kinase,39951,0.142420144191734,0.0107171317519714,0.12141456595787,0.163425722425598,4.44159005598107e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0556923185064,0.00419401254004107,0.0474720539279195,0.0639125830848805,5.54303654919249e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0468662995459161,0.00353179315485014,0.0399439849624098,0.0537886141294224,6.23489054372526e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NACC1,Nucleus accumbens-associated protein 1,37900,0.0706939253311028,0.00532906075805779,0.0602489662453096,0.0811388844168961,6.51522850320795e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPXM1,Probable carboxypeptidase X1,40411,0.0880957313241572,0.00665172885073623,0.0750583427767142,0.1011331198716,7.92578451304187e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLO1,Lactoylglutathione lyase,40042,0.0759621130982005,0.00573746936747585,0.0647166731379479,0.0872075530584532,8.49243147208564e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADM,Pro-adrenomedullin,40489,0.0344957719589045,0.00260722796982348,0.0293856051380505,0.0396059387797585,9.40993243539012e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BDNF,Brain-derived neurotrophic factor,37998,0.106119531175428,0.00801712798338825,0.0904059603279875,0.121833102022869,9.51908980194571e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RP2,Protein XRP2,40305,0.0528649809282463,0.00399636934945519,0.0450320970033142,0.0606978648531785,9.78768575236621e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0372568301498036,0.00281755663182256,0.0317344191514313,0.0427792411481758,1.04082872039202e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PQBP1,Polyglutamine-binding protein 1,39980,0.0706444850928479,0.00534416933082514,0.0601699132044306,0.0811190569812652,1.11683484667216e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNMT,Histamine N-methyltransferase,40147,0.0592457679612785,0.00448894503501084,0.0504474356926572,0.0680441002298997,1.46080341755474e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.0399359222081292,0.003026269230653,-0.0458674099002091,-0.0340044345160493,1.58200340202686e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.0848378705525549,0.0064356966443792,0.0722239051295716,0.0974518359755381,1.80666608087223e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,37572,0.05514472733812,0.00418510167915518,0.0469419280469758,0.0633475266292641,2.13313335395563e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0616347717553953,0.00468194714358732,0.0524581553539642,0.0708113881568265,2.25363263828688e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0865123393434039,0.00657244527031718,0.0736303466135822,0.0993943320732256,2.33135423285817e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0377823595293769,0.00287116994468755,-0.0434098526209645,-0.0321548664377893,2.41707654362303e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0590021834174582,0.00448437318219937,0.0502128119803474,0.0677915548545689,2.73315335943466e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLNK,B-cell linker protein,37598,0.0489104647075261,0.00371885872069139,0.041621501614971,0.0561994278000813,2.9319168051544e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0339083381813195,0.00258152622854139,0.0288485467733784,0.0389681295892606,3.3175116918678e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0758880200601947,0.00577939992558475,0.0645603962060486,0.0872156439143408,3.80509231279043e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN2,Dynactin subunit 2,40305,0.119303998108941,0.00909888973517824,0.101470174227992,0.137137821989891,4.49326241355703e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEMIP2,Cell surface hyaluronidase,37598,0.0429625978981886,0.00327728759917164,0.0365391142038121,0.049386081592565,5.12308033664999e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.067105836618975,0.00512599405633207,0.0570588882685642,0.0771527849693859,6.45878779500453e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP5,Platelet glycoprotein V,37671,0.0455203167790914,0.00348113664979644,0.0386972889454903,0.0523433446126924,7.83453578591811e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0860980599213722,0.00659276841319454,0.0731762338315109,0.0990198860112336,9.78856405738328e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0973723164086129,0.00746772671925225,0.0827355720388785,0.112009060778347,1.25726760054963e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.0624039243573931,0.00479255549118834,0.0530105155946639,0.0717973331201222,1.62596111157027e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0889393890769306,0.00683363378132938,0.0755454668655251,0.102333311288336,1.7196489906948e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIABLO,"Diablo homolog, mitochondrial",40314,0.137854473458036,0.0106002340501667,0.117078014719709,0.158630932196362,1.80603766537376e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.149308117614992,0.0114977119742635,0.126772602145435,0.171843633084548,2.30078903836467e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS3,Galectin-3,40374,0.037190545599298,0.00286535680458412,0.0315744462623131,0.0428066449362829,2.50643425219117e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0521158350980722,0.00401349840034286,0.0442493782334002,0.0599822919627442,2.54809903031744e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREML2,Trem-like transcript 2 protein,40332,0.0420445719989692,0.00324582616708332,0.0356827527114859,0.0484063912864526,3.50764830562789e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0392613857653406,0.00303214038444578,0.0333183906118268,0.0452043809188543,3.7212695834671e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP7,Matrilysin,40015,0.0605431867774921,0.00467584325713117,0.0513785339935151,0.0697078395614692,3.79195160862929e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB10,Ras-related protein Rab-10,37990,0.0672558286266202,0.00520225207810394,0.0570594145535365,0.0774522426997039,5.23597993620849e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FADD,FAS-associated death domain protein,40359,0.0955384830252243,0.00739497350670938,0.0810443349520739,0.110032631098375,5.4336455842299e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0797982372618154,0.00617638225761443,-0.0919039464867397,-0.0676925280368911,5.90856740889572e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0766281150757684,0.00593604687761613,0.0649934631956408,0.088262766955896,6.81511826538219e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABHD14B,Protein ABHD14B,40171,0.0729963144442587,0.00566329656031257,0.0618962531860461,0.0840963757024714,8.03134481215344e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.110590710265365,0.00858396340153714,0.0937661419983527,0.127415278532378,9.30138135553922e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.156563305104132,0.0121839044822828,0.132682852318858,0.180443757889407,1.42731266360722e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0765989623740088,0.00596752800188617,0.0649026074903119,0.0882953172577057,1.59986408010069e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTX3,Pentraxin-related protein PTX3,40341,-0.0610822663057127,0.00476287222741789,-0.0704174958714518,-0.0517470367399737,1.82989160299048e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0375004692687784,0.00292627781898413,0.0317649647435695,0.0432359737939873,2.2299868370192e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDK,Midkine,40352,0.0627883345339265,0.00490794416893859,0.0531687639628068,0.0724079051050461,2.73269995071609e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP1,Interstitial collagenase,39757,0.115344043315127,0.0090158714080072,0.0976729353554333,0.133015151274822,2.76929133122103e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSME2,Proteasome activator complex subunit 2,40152,0.0458940587726534,0.00358782670884481,0.0388619184233176,0.0529261991219893,2.80396371157812e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MET,Hepatocyte growth factor receptor,40375,-0.0249094688471345,0.00194756524135744,-0.028726696720195,-0.0210922409740739,2.84279798805908e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF23,Fibroblast growth factor 23,40469,0.0762145692113769,0.00597153059519263,0.0645103692447994,0.0879187691779545,4.00184463858801e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNRD2,Protein ZNRD2,37901,0.084226670850775,0.00660182793358518,0.0712870881009481,0.097166253600602,4.60820291167631e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.087621187765301,0.00686855024958119,0.0741588292761219,0.10108354625448,4.66472008754822e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.113369789693873,0.00890107665980965,0.0959236794406457,0.130815899947099,5.61059698353489e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0554400662741779,0.00435408479989691,0.04690606006638,0.0639740724819758,6.41284090821703e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0461573120424888,0.00362973619253677,0.0390430291051167,0.0532715949798609,7.26918130235157e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTF2,Transcription termination factor 2,37572,0.0600600182590916,0.00472330086367905,0.0508023485662806,0.0693176879519025,7.97873642237115e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSNAX,Translin-associated protein X,37562,0.0487060855162782,0.00383230726490652,0.0411947632770615,0.056217407755495,8.64855098687536e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0813960047205645,0.00642153707027203,0.0688097920628314,0.0939822173782977,1.22615504492899e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0608751207628831,0.00480339845034882,0.0514604598001994,0.0702897817255668,1.34235631744053e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0684404562346687,0.00540278991117368,0.0578509880087683,0.0790299244605691,1.45386920823185e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MZT1,Mitotic-spindle organizing protein 1,39980,0.0646782297961814,0.0051092251769231,0.0546641484494122,0.0746923111429507,1.5098481953415e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0366364891019286,0.00289893709498204,0.0309545723957638,0.0423184058080934,1.95425186513935e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,37598,0.10731642184437,0.00850014077079862,0.0906561459336044,0.123976697755135,2.48982367613681e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0854287109487614,0.00677068208652916,0.0721581740591643,0.0986992478383586,2.53450624646531e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASET2,Ribonuclease T2,40465,0.0322792088831716,0.00255941226296127,0.0272627608477675,0.0372956569185757,2.69926790249187e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G4A,Cytosolic phospholipase A2,40422,0.105999155735685,0.00843077066839912,0.0894748452256228,0.122523466245747,4.41161169638183e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,37901,0.119371321083574,0.00949152962642195,0.100767923015787,0.137974719151361,4.53055931845321e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0544924075503516,0.00433408986420872,0.0459975914165026,0.0629872236842007,4.78726995959919e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0778712573732026,0.00619654551486027,0.0657260281640765,0.0900164865823287,4.81187840565368e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0691269460078384,0.00549936635970966,0.0583481879428075,0.0799057040728694,4.97507158913451e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STXBP1,Syntaxin-binding protein 1,37959,0.0943266786267354,0.00750710101401588,0.0796127606392642,0.109040596614206,5.22870270972223e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB8,Serpin B8,40516,0.066302125654433,0.00528516530664897,0.055943201653401,0.076661049655465,6.24410964934529e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPPK1,Epiplakin,37628,0.0896154387655437,0.00714987074818013,0.0756016920991107,0.103629185431977,7.80142406128854e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNMA1,Paraneoplastic antigen Ma1,37628,0.0680330495112669,0.00543491127237162,0.0573806234174185,0.0786854756051153,9.53028568354585e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0370685039713445,0.00296387701731157,-0.0428777029252752,-0.0312593050174138,1.00892023574257e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0843367063029848,0.00675407042547827,0.0710987282690474,0.0975746843369222,1.40424482983331e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFL7,Epidermal growth factor-like protein 7,39980,0.048788047080099,0.00391168297952096,0.0411211484402379,0.0564549457199601,1.56289347690868e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSE,Cathepsin E,37671,0.0623932009002254,0.0050031215373396,0.0525870826870398,0.0721993191134111,1.70499464811903e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.13043576265531,0.0104638873646202,0.109926543420655,0.150944981889966,1.85525933830068e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLF4,Krueppel-like factor 4,37541,0.0472883174054701,0.00380132251182122,0.0398377252823005,0.0547389095286397,2.51117879664936e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.064747893863967,0.00520925284010878,0.0545377582973538,0.0749580294305802,2.64330960986968e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0688308979803603,0.00555138170282173,0.0579501898428297,0.0797116061178909,3.89450500102613e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLRX,Glutaredoxin-1,40260,0.0680549389397141,0.00548916222144391,0.0572961809856841,0.0788136968937442,3.89982202400923e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.105525881998771,0.00851392310552514,0.0888385927119419,0.1222131712856,4.09592717169795e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF2,Fibroblast growth factor 2,40341,0.0795187901845758,0.00641731080255052,0.0669408610115768,0.0920967193575749,4.2314957038475e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0625900356930568,0.00505088317043957,0.0526903046789952,0.0724897667071183,4.48372027659385e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.104539818607051,0.00847264838039881,0.0879334277814692,0.121146209432633,8.66550210959814e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASAH1,Acid ceramidase,37882,0.0552328352784415,0.00447849955924798,0.0464549761423155,0.0640106944145675,9.2898004968503e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,37880,0.104682086729885,0.00849429996907459,0.0880332587904985,0.121330914669271,1.03858497138547e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK4,Dickkopf-related protein 4,40203,0.0543852556602686,0.00441494852461572,0.0457319565520218,0.0630385547685154,1.04135426790014e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0544747283152052,0.00442054067689435,0.0458104685884922,0.0631389880419181,1.04699485900903e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0566828449115693,0.00460159054507253,0.0476637274432271,0.0657019623799114,1.12300059434205e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSB,Cathepsin B,40353,-0.0644564783365649,0.00523542433084667,-0.0747179100250244,-0.0541950466481055,1.12854096712056e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0727472001020359,0.00592349055581865,0.0611371586126313,0.0843572415914404,1.63534467145231e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD164,Sialomucin core protein 24,40332,0.0315517879620648,0.00257080902270257,0.0265130022775678,0.0365905736465619,1.81007076119002e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAP18,Chromatin complexes subunit BAP18,37942,0.0771946337926519,0.00629060634493532,0.0648650453565787,0.0895242222287251,1.9683129520668e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CORO1A,Coronin-1A,39990,0.106888646192427,0.00872088913417091,0.0897957034894516,0.123981588895402,2.23147284637276e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL3,Angiopoietin-related protein 3,40355,0.0430198814879009,0.00351497279976695,0.0361305348003577,0.0499092281754441,2.7431353428302e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP1,Guanylate-binding protein 1,37931,0.0765105293107437,0.00625171427735174,0.0642571693271343,0.0887638892943531,2.94806932803219e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX9,Sorting nexin-9,40359,0.0814194032284083,0.00665627724161499,0.0683730998348429,0.0944657066219736,2.98978421570083e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBN1,Drebrin,37598,0.0614661797742815,0.00502283705959352,0.0516214191374782,0.0713109404110848,3.01520818986376e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFA2,BPI fold-containing family A member 2,37150,-0.131949186251067,0.0107966435754603,-0.153110607658969,-0.110787764843165,3.71986416076838e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3BP1,SH3 domain-binding protein 1,37901,0.0553661022357469,0.00453746085954062,0.0464726789510473,0.0642595255204465,4.59065977313274e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0353623293366246,0.00289891330160461,0.0296804592654796,0.0410441994077696,4.77845963246796e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA6,Integrin alpha-6,40341,0.0627813362480297,0.0051525135656149,0.0526824096594245,0.0728802628366349,5.32448625957966e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPLAH,5-oxoprolinase,37628,0.0806874608581125,0.00661943330346835,0.0677133715833146,0.0936615501329105,5.38991606809726e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN9,Septin-9,40305,0.0332113669560984,0.00272618242953689,0.0278680493942061,0.0385546845179908,5.47520150176997e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.060042247471199,0.00493158153877589,0.0503763476551983,0.0697081472871998,5.9590380438683e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.137623847852474,0.0113179200463653,-0.159806971143349,-0.115440724561598,7.21155089895083e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0534423742746484,0.00439930247821555,0.0448197414173459,0.0620650071319509,8.91730873216379e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAL,Integrin alpha-L,37598,0.0513291239817479,0.00423484548072894,0.0430288268395192,0.0596294211239766,1.24067295829695e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRG1,Scrapie-responsive protein 1,37990,0.0322678240178258,0.00266389161781055,0.0270465964469171,0.0374890515887345,1.34413227035482e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",37942,0.123977795511257,0.0102433943502918,0.103900742584685,0.144054848437829,1.51569671194487e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0387126392803899,0.00320875590294982,0.0324234777106083,0.0450018008501716,2.26870624541421e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0865834288054016,0.00717903794071826,0.0725125144415938,0.100654343169209,2.39285554887336e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0433742568394375,0.00359728060562978,0.0363235868524031,0.0504249268264718,2.6560959089113e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0812237293176161,0.00674179429436374,0.0680098125006632,0.094437646134569,2.7843052376533e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCF2,Neutrophil cytosol factor 2,40324,0.0970318609640929,0.0080619064014335,0.0812305244172833,0.112833197510903,3.21270331146223e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARD3,Partitioning defective 3 homolog,37714,0.0868741146169721,0.00721591151414682,0.0727309280492443,0.1010173011847,3.29186958933514e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.139480743253192,0.0115914018703355,0.116761595587334,0.162199890919049,3.31533513024185e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM1,Intercellular adhesion molecule 1,40291,0.0332096943372663,0.00276373433507411,0.027792775040521,0.0386266136340115,4.06756337071763e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BGN,Biglycan,39956,-0.14142947473718,0.0117896966721141,-0.164537280214524,-0.118321669259836,5.21895681930899e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACRBP,Acrosin-binding protein,37900,0.0440328475727389,0.00367665179966414,0.0368266100453972,0.0512390851000807,6.94735973513725e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRMD4B,FERM domain-containing protein 4B,37562,0.0819264980917237,0.00684387705715609,0.0685124990596978,0.0953404971237497,7.49816416499848e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPCAL1,Hippocalcin-like protein 1,40516,0.0849768350346767,0.00710876614429587,0.0710436533918568,0.0989100166774965,8.54305397141125e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TST,Thiosulfate sulfurtransferase,39923,0.0877564012654762,0.00734384330071831,0.0733624683960683,0.102150334134884,9.08701057417486e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGES2,Prostaglandin E synthase 2,37484,0.0634581173419991,0.0053096752205372,0.0530511539097462,0.0738650807742521,9.46536980309386e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0802410183925129,0.00672181332636525,0.067066264272837,0.0934157725121888,1.03882665322443e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0783729014329629,0.00656558918009299,0.0655043466399807,0.0912414562259452,1.12205979280458e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRN1,Secernin-1,40341,0.0649873749814834,0.00545292752505027,0.0542996370323849,0.0756751129305819,1.31512752057803e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD40LG,CD40 ligand,40516,0.0883953409376232,0.00741957929949947,0.0738529655106043,0.102937716364642,1.37595440160002e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDHB,Succinate dehydrogenase,37901,0.0823059645234031,0.00690956518008151,0.0687632167704433,0.0958487122763628,1.49602299142127e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL26,C-C motif chemokine 26,40341,0.102448362073967,0.00861572813803059,0.085561534923427,0.119335189224507,1.81325940115385e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.140883838605802,0.0118798692438218,0.117599294887912,0.164168382323693,2.64378697137952e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0793789894603814,0.00669357405077234,0.0662595843208676,0.0924983945998952,2.82531161056937e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGMN,Legumain,40422,0.0407722907457365,0.00344062104896059,0.0340286734897738,0.0475159080016993,2.92822884851845e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0501117581471246,0.00422727020021193,0.0418263085547092,0.05839720773954,2.95523390934498e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GET3,ATPase GET3,37990,0.0645201992436446,0.00545182699642099,0.0538346183306595,0.0752057801566298,3.72432305323418e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0597566547851265,0.00505196188088239,0.049854809498597,0.0696585000716559,3.79331857713299e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.109127126781144,0.00922987398698133,0.091036573766661,0.127217679795628,4.04767056667946e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA2,Annexin A2,37441,0.0821039316915064,0.00695511117504351,0.0684719137884211,0.0957359495945917,5.36960876249821e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN4,CCN family member 4,40489,0.0467366993012174,0.00396661001617125,0.0389621436695217,0.054511254932913,6.50295897744992e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL1,Growth-regulated alpha protein,40329,0.110985029513741,0.00942227340051356,0.0925173736487341,0.129452685378747,6.79859958928995e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.133149151691417,0.01130507537221,0.110991203961886,0.155307099420949,7.28242394903709e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREH,Trehalase,37998,0.0849795031522044,0.00722700938516142,0.070814564757288,0.0991444415471208,9.10127940578711e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA13,Carbonic anhydrase 13,40173,0.118019289010549,0.010044628172741,0.0983318177919764,0.137706760229121,9.6443300497762e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD84,SLAM family member 5,40341,0.035083810197975,0.00298685522030034,0.0292295739661863,0.0409380464297636,1.00072508369005e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKN3,Serine/threonine-protein kinase N3,37714,0.0880892302557947,0.00750313183525162,0.0733830918587015,0.102795368652888,1.13583116802199e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0651058942849325,0.00554897819165103,0.0542298970292964,0.0759818915405685,1.1752052913467e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWC2,Brorin,40167,0.0441860694293705,0.00376768915279898,0.0368013986898845,0.0515707401688565,1.24622083735373e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.042828379129556,0.00365453283336565,0.0356654947761594,0.0499912634829527,1.44458587983061e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DMD,Dystrophin,37628,0.05925630856801,0.00505945064923242,0.0493397852955145,0.0691728318405056,1.58527639205498e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADA,Adenosine deaminase,40516,0.0385690225269442,0.00329790182008277,0.032105134959582,0.0450329100943065,1.81300871236626e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.103048847993023,0.0088231909837493,0.0857553936648741,0.120342302321171,2.30065528175584e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN6,Dynactin subunit 6,39961,0.0799234884287255,0.00685826483140649,0.0664812893591687,0.0933656874982822,2.96892696852945e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0867038812340758,0.00744637218496875,0.0721089917515371,0.101298770716615,3.32723338562688e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1F,Protein phosphatase 1F,37990,0.0590464443641797,0.00507786096678134,0.0490938368692883,0.0689990518590711,4.16342351666648e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0758531344270315,0.00653353945857455,0.0630473970882254,0.0886588717658376,5.18935158616358e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.0273863224082634,0.00236032540083705,-0.032012560193904,-0.0227600846226228,5.31287673683506e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.035203065263038,0.00303559266139771,0.0292533036466985,0.0411528268793775,6.01126343845362e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0459725012647014,0.00396967194998366,0.0381919442427334,0.0537530582866694,6.87001973602856e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE6,Ribonuclease K6,37917,0.0330579632538156,0.0028641500725078,0.0274442291117003,0.0386716973959309,1.12974792617965e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAST,Gastrin,37942,0.145890128136421,0.0126494753733735,0.121097156404608,0.170683099868233,1.24775611303344e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD302,CD302 antigen,40305,0.0335891208518987,0.00291529888591775,0.0278751350354999,0.0393031066682975,1.35821829595675e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNC79,Protein unc-79 homolog,37482,0.0633593431099818,0.00549666629886958,0.0525858771641974,0.0741328090557662,1.3591310695115e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0430130823917085,0.00373595868806967,0.0356906033630919,0.050335561420325,1.49619316405231e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB2B,Ras-related protein Rab-2B,37900,0.0686544156268239,0.0059637883216766,0.0569653905163377,0.08034344073731,1.59763922533394e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDZD2,PDZ domain-containing protein 2,37562,0.0687014783881226,0.00597128792130321,0.0569977540623683,0.0804052027138769,1.73750247113972e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNAS,Neuroendocrine secretory protein 55,37959,0.100692625682618,0.00877081991553615,0.0835018186481674,0.117883432717069,2.28879440928839e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SWAP70,Switch-associated protein 70,37901,0.0392196361551715,0.00341706764483736,0.0325221835712903,0.0459170887390527,2.36777821259655e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTC,Probetacellulin,39980,0.0837876562127687,0.00730889920365032,0.0694622137736141,0.0981130986519233,2.65541995684574e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCS,Copper chaperone for superoxide dismutase,40228,0.0535991661807395,0.00467892343785579,0.0444284762425421,0.0627698561189368,2.90862833150655e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0914428432644011,0.0079885071406371,0.0757853692687524,0.10710031726005,3.20494496428136e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA4,Carbonic anhydrase 4,40536,-0.0259124108911426,0.00226613832016174,-0.0303540419986597,-0.0214707797836256,3.67211596400077e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNF,Tumor necrosis factor,40014,0.0440862654789339,0.00386100341241702,0.0365186987905966,0.0516538321672713,4.46129991383058e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.107280987018095,0.00940869186071938,0.0888399509710847,0.125722023065105,5.32584071841302e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPON2,Spondin-2,40267,-0.0381951306312336,0.0033503800613775,-0.0447618755515335,-0.0316283857109337,5.4602424564114e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0526452150552303,0.00462148908935523,0.043587096440094,0.0617033336703665,6.06860288369804e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0596126526853048,0.00523602917285424,0.0493500355065104,0.0698752698640991,6.46430488245377e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.05075350825253,0.0044577365824483,0.0420163445509314,0.0594906719541287,6.76236539609305e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MIA,Melanoma-derived growth regulatory protein,40411,0.0407982193666671,0.00358520844040795,0.0337712108234676,0.0478252279098667,6.89002241021314e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NID2,Nidogen-2,40332,0.0813782818832971,0.00715251260414377,0.0673593571791753,0.0953972065874189,7.05900638385246e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN1,Contactin-1,40536,-0.0304652006168375,0.00267906512129633,-0.0357161682545783,-0.0252142329790967,7.53206320527677e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0334041904383998,0.00294453340699546,0.0276329049606887,0.0391754759161109,1.02601853099099e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0792890043905093,0.00699081509286106,0.0655870068085016,0.092991001972517,1.06381661814236e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0644188574688341,0.00568061684359921,0.0532848484553796,0.0755528664822885,1.13083883422926e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPR,Nucleoprotein TPR,37562,0.0517208198720059,0.00456601187645659,0.042771436594151,0.0606702031498609,1.31867574113999e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0307593382952368,0.00272224408867002,0.0254237398814436,0.0360949367090301,1.81086256794552e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0472692143562212,0.00418602014238453,0.0390646148771475,0.0554738138352948,1.85926947694431e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX16,Syntaxin-16,39980,0.0646095560775498,0.00573273721320562,0.0533733911396668,0.0758457210154328,2.39187594868294e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL25,C-C motif chemokine 25,40516,0.053415235752112,0.00474038497996884,0.044124081191373,0.0627063903128509,2.42950999960122e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.10281969611237,0.00913297550628479,0.084919064120052,0.120720328104688,2.73372471588064e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BGLAP,Osteocalcin,37998,0.0997540526473708,0.00886425157518576,0.0823801195600067,0.117127985734735,3.00015658884924e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFRP4,Secreted frizzled-related protein 4,37671,0.0457229073903194,0.0040641896890931,0.0377570955996969,0.0536887191809419,3.13752247813203e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0429508291707014,0.00381904430232427,0.0354655023381458,0.0504361560032569,3.24966791214041e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1R,Complement C1r subcomponent,38013,0.0217367503388094,0.00193320064877417,0.017947677067212,0.0255258236104068,3.34077120843531e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX7,Syntaxin-7,37598,0.0550047174236328,0.00489189816587841,0.0454165970185111,0.0645928378287545,3.36734545898345e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA9,Serpin A9,40228,0.0784866669545465,0.00698627555543798,0.0647935668658881,0.092179767043205,3.56630159120687e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGL1,Fibrinogen-like protein 1,37987,-0.0682957234374315,0.00609530056951173,-0.0802425125536745,-0.0563489343211885,5.1906124621122e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.129497524104842,0.0115708746066796,0.10681860987575,0.152176438333934,5.74766241285367e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1F,V-type proton ATPase subunit F,39925,0.0714987559558377,0.00640957112998463,0.0589359965410679,0.0840615153706076,8.71672735536622e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGS10,Regulator of G-protein signaling 10,37959,0.0649308049514891,0.00582424303081006,0.0535152886111014,0.0763463212918768,9.73440381482961e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0342291069064221,0.0030731306767035,-0.040252443032761,-0.0282057707800832,1.04382506389026e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F11,Coagulation factor XI,37810,0.0327290905228725,0.00293878557877278,0.0269690707884779,0.0384891102572672,1.10893902475444e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PVR,Poliovirus receptor,40471,0.0396554324996901,0.00356408333756488,0.0326698291580629,0.0466410358413172,1.18851063945106e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0349405198319377,0.00314358488162176,0.0287790934639591,0.0411019461999164,1.41188628305838e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0616034301751047,0.00554635752432567,0.0507325694274264,0.072474290922783,1.55252904060007e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLMH,Bleomycin hydrolase,40536,0.0347720086517104,0.00313314087673249,0.0286310525333148,0.0409129647701061,1.62579870915024e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD46,Membrane cofactor protein,40250,0.0308453044359446,0.00277945206399589,0.0253975783905126,0.0362930304813765,1.64207599871338e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL6A3,Collagen alpha-3(VI) chain,40536,0.0368884348091277,0.00332842025412902,0.0303647311110348,0.0434121385072205,1.92583728449841e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SF3B4,Splicing factor 3B subunit 4,40305,0.0787532495878353,0.00710953560805478,0.064818559796048,0.0926879393796227,2.05930446222663e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDA,Cytidine deaminase,37970,0.0492806642770798,0.00445358525458468,0.0405516371780938,0.0580096913760657,2.44345005013328e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD248,Endosialin,37998,-0.0430727654446501,0.00389393524475356,-0.0507048785243671,-0.0354406523649331,2.54936413536178e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGRN,Neugrin,37942,0.0236801420523227,0.00214131882682104,0.0194831571517534,0.0278771269528919,2.63332330855753e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL15,C-C motif chemokine 15,40536,0.0477078985682539,0.00431640616399604,0.0392477424868216,0.0561680546496861,2.6898344752095e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NID1,Nidogen-1,40355,0.0423731039910525,0.00383535797848245,0.0348558023532269,0.0498904056288781,2.83993403434845e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0415224155846401,0.00375972965866464,-0.0488914857156228,-0.0341533454536574,2.96982272017984e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIGR,Polymeric immunoglobulin receptor,40154,0.0376145672303766,0.00341135031179596,0.0309283206192565,0.0443008138414967,3.62043167909055e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0526390037583211,0.00477498191638003,0.0432800392022163,0.061997968314426,3.86699276711574e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.0939292243313008,0.0085238088672925,0.0772225589514075,0.110635889711194,3.88187315382466e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPK1,Thiamin pyrophosphokinase 1,37990,0.0289849552510759,0.00263203894021491,0.0238261589282547,0.0341437515738971,4.38369443115567e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FXN,"Frataxin, mitochondrial",40489,0.0787417665998673,0.00717032933929365,0.0646879210948517,0.0927956121048828,5.8924392387076e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOLA1,BolA-like protein 1,37541,0.0586006783431405,0.00533614564543883,0.0481418328780804,0.0690595238082006,6.18749868966752e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHI3L1,Chitinase-3-like protein 1,40054,0.0791361795402944,0.00721822646637502,0.0649884556661994,0.0932839034143894,7.24368032740151e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0485024041920975,0.00442626042810529,-0.0571778746311839,-0.0398269337530112,7.65646607536143e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERI1,3'-5' exoribonuclease 1,37714,0.0357507265289306,0.00327109940537905,0.0293393716943877,0.0421620813634736,1.09605800030876e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.0940221517386127,0.00861669412061496,0.0771334312622074,0.110910872215018,1.27152465904378e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0594161989589411,0.00544652379537401,0.048741012320008,0.0700913855978741,1.36507798693125e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMD,Osteomodulin,40422,-0.0468361601113809,0.00430051384930641,-0.0552651672560215,-0.0384071529667403,1.592939004171e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.061861976866936,0.00568181977461683,0.050725610108687,0.0729983436251849,1.65260192855016e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFCAB2,Dynein regulatory complex protein 8,37714,0.0367916282918208,0.00338240299493982,0.0301621184217387,0.0434211381619028,1.92952693543952e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH7,Protocadherin-7,37901,0.0368132400912431,0.00339048855873533,0.0301678825161219,0.0434585976663644,2.37768013218041e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEPH,Hephaestin,37990,0.0264088138515117,0.00243526119448459,0.0216357019103219,0.0311819257927015,2.74654154499094e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TF,Serotransferrin,38013,0.0229380038668383,0.00211857240530975,0.0187856019524311,0.0270904057812454,3.30910857012987e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AK1,Adenylate kinase isoenzyme 1,40359,0.0670761374977788,0.0062041365840267,0.0549160297930865,0.0792362452024712,3.77304016945827e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COLEC12,Collectin-12,40357,0.0267754443774628,0.00247908099872529,0.0219164456199613,0.0316344431349644,4.24836781162879e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0431227104105376,0.00399215812683354,0.0352980804819439,0.0509473403391313,4.35626463587289e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPA1,Inositol monophosphatase 1,40228,0.0637709327159677,0.00590627026087232,0.0521946430046579,0.0753472224272774,4.41492784195151e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG3,BAG family molecular chaperone regulator 3,40203,0.0415152173381866,0.00384574614657661,0.0339775548908965,0.0490528797854768,4.51573274574264e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0932887511154751,0.00864128997832468,0.0763518227579588,0.110225679472992,4.6770806208372e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0346161851645381,0.00320748154720078,-0.0409028489970516,-0.0283295213320246,4.82026018988705e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WAS,Wiskott-Aldrich syndrome protein,40044,0.0714398877635053,0.00662717905475769,0.0584506168161803,0.0844291587108304,5.33685513980787e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA4,Annexin A4,40279,0.0750372905690308,0.00696146498979309,0.0613928191890363,0.0886817619490252,5.37050864351908e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGR1,Prostaglandin reductase 1,37990,0.0831289860922126,0.00771712753878579,0.0680034161161925,0.0982545560682328,6.00131923064805e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL14,C-C motif chemokine 14,40309,0.0407206012513589,0.00378249993480541,0.0333069013791403,0.0481343011235775,6.20466115156375e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNGR2,Interferon gamma receptor 2,40228,0.0538650608861599,0.00500400752995426,0.0440572061274496,0.0636729156448703,6.28834715130485e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP8,Caspase-8,40434,0.0645973113438061,0.00600233703778901,0.0528327307497396,0.0763618919378725,6.43237593890391e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4D,C-type lectin domain family 4 member D,40341,0.0639398255510212,0.00594148151258848,0.0522945217863478,0.0755851293156947,6.4702735125843e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0628017445722358,0.00585957255669565,0.0513169823611123,0.0742865067833593,1.07455427171075e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0711964183990435,0.00664462620506319,0.0581729510371197,0.0842198857609674,1.1092301580893e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0517035438550155,0.00482685185690087,0.0422429142154898,0.0611641734945412,1.11229702346313e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0351961473624557,0.00328630463368815,0.028754990280427,0.0416373044444845,1.12704481770146e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK3,Dickkopf-related protein 3,40536,-0.0306068564563111,0.00285843302807427,-0.0362093851913367,-0.0250043277212856,1.15355768210015e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0547149510869549,0.00511146156288889,0.0446964864236927,0.0647334157502171,1.20295122808116e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF22,Kinesin-like protein KIF22,37562,0.12723713789769,0.0118966966554053,0.103919612453095,0.150554663342284,1.38013713276488e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0297789544669018,0.00278826959573334,0.0243139460592645,0.0352439628745391,1.61967891097921e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRK5,G protein-coupled receptor kinase 5,40042,0.0545329809555722,0.0051093214375154,0.044518710938042,0.0645472509731023,1.67673970424075e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMOTL2,Angiomotin-like protein 2,37855,0.0499469425897349,0.00467843416788178,0.0407772116206866,0.0591166735587832,1.68464477975635e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAGED1,Melanoma-associated antigen D1,39980,0.0501830943223626,0.00471863245923321,0.0409345747022655,0.0594316139424597,2.52083508533598e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO2,Gamma-enolase,40471,0.0677555901510558,0.00637935282271113,0.0552520586185419,0.0802591216835696,2.90793966061535e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DENR,Density-regulated protein,37598,0.0594717034053046,0.00559959540487379,0.048496496411752,0.0704469103988573,3.04956745407436e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0944247556942164,0.00889198890668505,0.0769964574371137,0.111853053951319,3.10119676039707e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS4,Galectin-4,40357,0.0543029188439897,0.00512400688161145,0.0442598653560312,0.0643459723319481,3.73150651733253e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCOF1,Treacle protein,37990,0.0311211042419206,0.00293772376271591,0.0253631656669974,0.0368790428168438,4.03721293032659e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0722286329738038,0.00681777777692638,0.0588657885310281,0.0855914774165795,4.0419042123628e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPE,Ribulose-phosphate 3-epimerase,37714,0.0720445556013664,0.00680321145096536,0.0587102611574743,0.0853788500452585,4.22472263668939e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX6,Syntaxin-6,39980,0.0705907368590334,0.00668518150979073,0.0574877810998436,0.0836936926182232,5.63587374947659e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPMT,Thiopurine S-methyltransferase,39980,0.0757510193509014,0.00718344908110182,0.0616714591519418,0.089830579549861,6.53949428104983e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0539253702214566,0.00511458439956015,-0.0639499556445945,-0.0439007847983187,6.63295046967375e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0387413988340589,0.00367557385628863,0.0315372740757331,0.0459455235923846,6.86237260797446e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPME1,Protein phosphatase methylesterase 1,40305,0.0625242733601217,0.00594327994161953,0.0508754446745474,0.074173102045696,8.48333179139115e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0810928894617891,0.00771628645799471,0.0659689680041195,0.0962168109194587,9.84567822842773e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.066333164349748,0.00631317420870928,0.0539593429006778,0.0787069857988181,1.01253035655214e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0541216941698858,0.00515288068055166,0.0440220480360046,0.0642213403037671,1.01391094799013e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0416132978306228,0.00396949365839472,0.0338330902601692,0.0493935054010764,1.30187958384629e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0413967503972619,0.0039499453391532,0.0336548575325216,0.0491386432620022,1.3418099456721e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.027333745041241,0.00260926343994639,-0.0324479013835359,-0.0222195886989461,1.3539324250455e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP6,Bone morphogenetic protein 6,40024,0.0430165108646102,0.00410896021294312,0.0349629488472417,0.0510700728819787,1.45855568796263e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIT,Citron Rho-interacting kinase,37572,0.0458897709437858,0.00438563467630696,0.0372939269782242,0.0544856149093475,1.59879068280657e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMOX1,Heme oxygenase 1,40184,-0.0476252332406051,0.00455331270906925,-0.0565497261503808,-0.0387007403308293,1.60786543847927e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL8,Interleukin-8,40209,0.0688042076329225,0.00657975665078053,0.0559078845973927,0.0817005306684523,1.65031629104464e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FST,Follistatin,40396,0.0526453424957186,0.00504192836491833,0.0427631629004787,0.0625275220909585,1.93564874630148e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLB,Beta-klotho,39961,-0.0744942425705085,0.00713820081461275,-0.0884851161671495,-0.0605033689738675,2.0613744397197e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRSF1,G-rich sequence factor 1,37402,0.0801534574411058,0.0076826618895955,0.0650954401374986,0.095211474744713,2.20872022712976e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0418305865000632,0.0040123677481484,0.0339663457136924,0.0496948272864341,2.29029262478955e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP25,Synaptosomal-associated protein 25,37541,0.0474829799961943,0.00455628694706033,0.038552657579956,0.0564133024124325,2.48714460450136e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0562609942056317,0.00540121525618468,0.0456746123035097,0.0668473761077536,2.52031854372714e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL20,C-C motif chemokine 20,40516,0.0895346979582203,0.00860913609505134,0.0726607912119197,0.106408604704521,2.98310081263269e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_E,,40341,0.0289877102647425,0.00279826193647536,0.0235031168692508,0.0344723036602342,4.5687476255644e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0624702991750912,0.00603436995108122,0.050642934070972,0.0742976642792103,5.058360046293e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0677888762547042,0.00655218704937545,0.0549465896379283,0.0806311628714801,5.43502076934826e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPL14,60S ribosomal protein L14,37628,0.0415876391656966,0.00402762515721802,0.0336934938575493,0.0494817844738439,6.71665889562446e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR3,Toll-like receptor 3,40516,0.0609774674972907,0.00591169966906761,0.0493905361459182,0.0725643988486632,7.22922108315526e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDGF,Hepatoma-derived growth factor,40471,0.0953387192199604,0.00926452183228603,0.0771802564286798,0.113497182011241,9.26556120898924e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPG,Macrophage-capping protein,40185,0.0578860018349767,0.00562825698193536,0.0468546181503834,0.06891738551957,9.87280155499553e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRP2,Neuropilin-2,40332,-0.0289531452291181,0.00282010977491412,-0.0344805603879498,-0.0234257300702864,1.18912505676716e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR2,TGF-beta receptor type-2,40411,0.0314085528234158,0.00306242377203658,0.0254062022302241,0.0374109034166075,1.32450220566043e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH5,Cadherin-5,40536,-0.0302409826412643,0.00294907876680112,-0.0360211770241944,-0.0244607882583341,1.34639456589258e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARA5,Scavenger receptor class A member 5,40471,0.0291422455835881,0.00284398808823947,0.0235680289306388,0.0347164622365375,1.45409777831606e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0416527054513112,0.00406709399467364,-0.0496242096808716,-0.0336812012217509,1.54256186517687e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK4,Serine/threonine-protein kinase 4,40359,0.0854396874605265,0.00834332863713477,0.0690867633317424,0.101792611589311,1.55616146130283e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARFIP1,Arfaptin-1,37959,0.0684443249050362,0.00668216443254328,0.0553472826172514,0.0815413671928211,1.56679661032159e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXN,Thioredoxin,37819,0.044259530323019,0.00433022201429466,0.0357722951750015,0.0527467654710366,1.96243276283951e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0537460740981509,0.00526181656595319,0.0434329136288827,0.0640592345674192,2.09667902316321e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD2,Sushi domain-containing protein 2,40332,-0.0283332583472445,0.00277982085342512,-0.0337817072199577,-0.0228848094745312,2.545490747268e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.041481953342427,0.00407012966788726,0.033504499193368,0.0494594074914861,2.57125024537238e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.0249089201474581,0.00244399933246316,0.0201186814558303,0.0296991588390859,2.6384832120157e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTA,Lymphotoxin-alpha,40341,0.0398218752825037,0.00390970884605081,0.0321588459442441,0.0474849046207633,2.73663021303555e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0566822383586743,0.00557066470442705,0.0457637355379972,0.0676007411793513,3.04853261712407e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.112129236075548,0.0110174970020469,0.0905349419515358,0.13372353019956,3.06291835829216e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0369540485699532,0.00363529427065152,0.0298288717994762,0.0440792253404302,3.35725919264984e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS27,Serine protease 27,40314,0.0399053140074329,0.00392849182994116,0.0322054700207483,0.0476051579941176,3.62243311692263e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APRT,Adenine phosphoribosyltransferase,40216,0.0477447078150717,0.00470092606435446,0.038530892728937,0.0569585229012065,3.68114631628466e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANBP1,Ran-specific GTPase-activating protein,37628,0.0524764816841767,0.0051748394697685,0.0423337963234304,0.062619167044923,4.46736578594333e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0299106014239126,0.00295202126234466,0.024124639749717,0.0356965630981081,4.86774473145817e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.0238530048221358,0.00236579862839978,0.0192160395104722,0.0284899701337993,7.79421923780024e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENAH,Protein enabled homolog,40044,0.0463323501638038,0.00459791172599225,0.0373204431808589,0.0553442571467486,8.2733379547477e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MARCO,Macrophage receptor MARCO,40359,0.0259693904980684,0.00257967440735076,0.0209132286596609,0.0310255523364759,9.11349197390447e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPQ,Carboxypeptidase Q,37986,0.0357477846332059,0.00355296895475899,0.0287839654818783,0.0427116037845335,9.91694869486299e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFRP1,Secreted frizzled-related protein 1,40178,0.0424738486285693,0.00422761387666714,0.0341877254303017,0.0507599718268369,1.11901310510394e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0528538712789759,0.00526270827618546,0.0425389630576524,0.0631687795002994,1.16363233294035e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREML1,Trem-like transcript 1 protein,37987,0.0514396758047012,0.00512466277799293,0.0413953367598351,0.0614840148495674,1.25921470079049e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAA10,N-alpha-acetyltransferase 10,37562,0.0501413099519713,0.0049973424912387,0.0403465186691434,0.0599361012347991,1.31997022538427e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0232751190171684,0.00232169881325012,0.0187245893431981,0.0278256486911386,1.3908723588971e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C7orf50,Uncharacterized protein C7orf50,37942,0.0213562174265453,0.00213581337225047,0.0171700232169344,0.0255424116361563,1.85595541046717e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0600816889265785,0.00600991511959538,0.0483022552921715,0.0718611225609854,1.90369895864409e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0395318667066842,0.00395872845929761,0.0317727589264609,0.0472909744869075,2.06378978669885e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0280182753654955,0.00280741858083159,0.0225157349470655,0.0335208157839254,2.18337286528922e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL19,C-C motif chemokine 19,40471,0.126852396076801,0.012715091295154,0.101930817138299,0.151773975015303,2.2595648003745e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C7,Complement component C7,37678,-0.030347845512983,0.00306206792769335,-0.0363494986512619,-0.024346192374704,4.4919979013234e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA6,Carbonic anhydrase 6,40295,-0.0610604753445735,0.00619037446600557,-0.0731936092979444,-0.0489273413912026,6.95548465602764e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0394340062655701,0.00399896774223209,0.0315960294907952,0.047271983040345,7.34080416172996e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0281563835260941,0.00285733863592078,0.0225559997996893,0.0337567672524988,7.6626546868906e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA2,Integrin alpha-2,37671,0.0323901159539881,0.00329246027173081,0.0259368938213957,0.0388433380865805,9.27632330494263e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL5,Insulin-like peptide INSL5,37901,0.089735769638867,0.00914046494747512,0.0718204583418158,0.107651080935918,1.12903352236986e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPAG1,Sperm-associated antigen 1,37959,0.0550162128162007,0.00560407697672727,0.0440322219418153,0.0660002036905862,1.13087895657262e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA2,Carbonic anhydrase 2,40291,0.0672739153901204,0.00685975040726823,0.0538288045918747,0.0807190261883662,1.21792967825285e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRL,Prolactin,40471,-0.0730061801813256,0.00744898714004066,-0.0876061949758053,-0.0584061653868459,1.29282187099964e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPO,Myeloperoxidase,40332,0.0444808789491245,0.00453917993566201,0.0355840862752269,0.053377671623022,1.31371249799061e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0552050650670063,0.00563639382285084,0.0441577331742187,0.066252396959794,1.3826820206029e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STXBP3,Syntaxin-binding protein 3,39980,0.0419808141029712,0.00429187933114025,0.0335687306139364,0.0503928975920061,1.57118058971099e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0275484863101595,0.00281650747106008,0.0220281316668818,0.0330688409534373,1.57231885762779e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.0300107419866147,0.00307090524778679,0.0239917677009526,0.0360297162722769,1.70688928576917e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGR2,Anterior gradient protein 2 homolog,39839,0.0960482715469372,0.00983597237275054,0.0767697656963461,0.115326777397528,1.84898262428896e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.027138022102875,0.00277862342018142,0.0216919201993194,0.0325841240064306,1.86596269310055e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0361245581362838,0.00369984704829912,0.0288728579216175,0.04337625835095,1.91732043947177e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A12,Protein S100-A12,40139,0.0724971722143507,0.00742857671090548,0.057937161860976,0.0870571825677255,1.95103636071632e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSCAM,Down syndrome cell adhesion molecule,37959,0.0332692038732586,0.00342843779895401,0.0265494657873088,0.0399889419592085,3.42884118158484e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0523492710739039,0.00539560418076789,0.0417738868795988,0.062924655268209,3.49637841168843e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMS,Spermine synthase,37541,0.0603772760927038,0.00622913588426577,0.0481681697595429,0.0725863824258647,3.84299053214486e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0395292432282484,0.00408414915375013,0.0315243108868981,0.0475341755695986,4.27360969350563e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL24,C-C motif chemokine 24,40396,0.0778435744249827,0.00804637310216354,0.0620726831447421,0.0936144657052232,4.45585027857582e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL1,Fc receptor-like protein 1,40359,0.0422486554758725,0.00437352122723453,0.0336765538704928,0.0508207570812522,5.11971382952239e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0514487255178161,0.00532628749133394,0.0410092020348016,0.0618882490008306,5.28706584825299e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOBR,Apolipoprotein B receptor,37628,-0.0398817676373514,0.00413310900229344,-0.0479826612818465,-0.0317808739928562,5.84791041070074e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0550882540922013,0.00571216152309572,0.0438924175069337,0.0662840906774689,6.14049552380272e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0239581409906582,0.00248627122555159,-0.0288312325927393,-0.0190850493885771,6.61121866433555e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XRCC4,DNA repair protein XRCC4,39961,0.0347812159235444,0.00361624641449228,0.0276933729511395,0.0418690588959492,7.72052337594089e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,40359,0.0327569896598581,0.00341301759104885,0.0260674751814024,0.0394465041383139,9.36652665290744e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0283622605457849,0.00296992255617095,0.0225412123356899,0.03418330875588,1.51876194265797e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELOB,Elongin-B,37562,0.0372862249400879,0.00390990886690068,0.0296228035609625,0.0449496463192132,1.73707106846121e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOL1,Apolipoprotein L1,37987,0.0602129364009113,0.00632485594265234,0.0478162187533127,0.0726096540485098,2.01990815271891e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0608314032705235,0.00639581543578562,0.0482956050163837,0.0733672015246633,2.20185327266192e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP12,Macrophage metalloelastase,40346,0.0477941741448636,0.00502770618714774,0.037939870018054,0.0576484782716732,2.2547403696442e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMM2,Phosphomannomutase 2,37562,0.0559635276502011,0.00588865073438648,0.0444217722108036,0.0675052830895986,2.37467761792879e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHCY,Adenosylhomocysteinase,40359,0.0625432452924992,0.00658377185972099,0.0496390524474461,0.0754474381375524,2.40009967842504e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0320274539117781,0.00337286982107108,0.0254166290624787,0.0386382787610774,2.49615405793958e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PZP,Pregnancy zone protein,38013,0.0601713924925842,0.00633913090773223,0.0477466959134291,0.0725960890717394,2.63780916524646e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0384417528990011,0.0040547342870527,0.0304944736963778,0.0463890321016244,2.9434060966721e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLTA,Clathrin light chain A,40042,0.0436216003026497,0.00460536732963165,0.0345950803365716,0.0526481202687277,3.13384855514611e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDF1,Endothelial differentiation-related factor 1,37959,0.0641719924151099,0.00677552458468869,0.0508919642291201,0.0774520206010997,3.22084930060234e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAX,Apoptosis regulator BAX,39934,0.082009624318867,0.0086703475959464,0.0650157430308121,0.099003505606922,3.55889257049683e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM,Paralemmin-1,37824,0.0269042527800853,0.00285243452820311,0.0213134811048073,0.0324950244553634,4.67600776383901e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0363562618147693,0.00386477759461573,0.0287812977293225,0.0439312259002161,5.91236294739931e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNM1,Dynamin-1,37901,0.10378763667472,0.0110386827842399,0.0821518184176102,0.12542345493183,6.19648076163049e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0379890149056402,0.0040461930750943,0.0300584764784553,0.045919553332825,7.04965396373333e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASS1,Argininosuccinate synthase,37562,0.0733958153877405,0.00782074719329606,0.0580671508888802,0.0887244798866007,7.33103106982553e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASGR2,Asialoglycoprotein receptor 2,37987,0.0235778441322174,0.00251329007526391,0.0186517955847001,0.0285038926797346,7.54068310637892e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0245780949923348,0.0026233303624704,0.0194363674818928,0.0297198225027768,8.45841414130378e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSR,"Glutathione reductase, mitochondrial",37944,0.0201506160292872,0.00215268161443516,0.0159313600649943,0.0243698719935802,9.15545976259235e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA11,Integrin alpha-11,40341,-0.0309545776668652,0.00330986870744399,-0.0374419203334554,-0.024467235000275,9.70388300798488e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0435700999451263,0.00465837495451561,0.0344396850342757,0.0527005148559769,9.83700869820065e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ULBP2,UL16-binding protein 2,40228,0.0338080828779613,0.00361844726556731,0.0267159262374494,0.0409002395184733,1.05648763835074e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMB1,Laminin subunit beta-1,37628,0.0268247807812111,0.00287650023119355,0.0211868403280717,0.0324627212343504,1.27852936047288e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CX3CL1,Fractalkine,40228,-0.0308659046737699,0.00331833366957087,-0.0373698386661288,-0.024361970681411,1.56088606032588e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRIB,Protein scribble homolog,37628,0.0843340628607601,0.00906897318976825,0.0665588754088143,0.102109250312706,1.63531023859789e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0567718422620112,0.00611357463132499,0.0447892359846142,0.0687544485394081,1.84752448844492e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0652033202322745,0.007034276132328,0.0514161390129117,0.0789905014516374,2.1075777872091e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POMC,Pro-opiomelanocortin,37628,0.0616188565441807,0.00664800354883146,0.048588769588471,0.0746489434998904,2.17167529191893e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0454416943491518,0.00490931425062913,0.0358194384179187,0.0550639502803849,2.44088688706546e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.030839091835072,0.00333343009598229,-0.0373726148231973,-0.0243055688469467,2.48995222414927e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLN4,Cerebellin-4,40489,0.0282280024906007,0.00305826621785733,0.0222338007036003,0.034222204277601,3.03540153594682e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLIT2,Slit homolog 2 protein,39961,0.0469741120605062,0.00509353113169864,0.0369907910423769,0.0569574330786356,3.27485390757069e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0293274963104939,0.00318104903851933,-0.0355623524259917,-0.023092640194996,3.42149294303646e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0340585031161526,0.00369927238234725,0.026807929246752,0.0413090769855532,3.7933416604562e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPPB,Natriuretic peptides B,40042,-0.114667259183512,0.012480240239303,-0.139128530052546,-0.090205988314478,4.50083609767655e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX5,Sorting nexin-5,37628,0.0267890576726309,0.00292279301923776,0.0210603833549248,0.0325177319903369,5.64951287408573e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0479932552441585,0.00523963611922633,0.0377235684504749,0.0582629420378421,5.96921591836011e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0593719039688427,0.00649887100005256,0.0466341168087397,0.0721096911289457,7.40974680759247e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6,Interleukin-6,40305,0.0646621021784219,0.0070837467579618,0.0507779585328168,0.0785462458240271,7.78546810033024e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0486226712014715,0.00533172193506947,0.0381724962087354,0.0590728461942077,8.4351681529361e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0484364417860175,0.00531330304373568,0.0380223678202955,0.0588505157517394,8.90111524624012e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPT,Dermatopontin,40536,0.023440776028534,0.00257251206874849,0.018398652373787,0.028482899683281,9.02073536298588e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFD,Vascular endothelial growth factor D,40483,-0.0294153217227647,0.00323572277291474,-0.0357573383576776,-0.0230733050878518,1.09598128008931e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG4,Regenerating islet-derived protein 4,40379,0.042912261086655,0.00472526421101736,0.033650743233061,0.0521737789402491,1.19469610805297e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD209,CD209 antigen,40382,-0.03428676885124,0.00377699613749337,-0.041689681280727,-0.026883856421753,1.23536347088682e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYGD,Gamma-crystallin D,37942,0.0848100932262796,0.00934170533726648,0.0665003507652373,0.103119835687322,1.24990433658502e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLIF,Cobalamin binding intrinsic factor,40330,0.0643534751697696,0.00709311560677749,0.0504509685804857,0.0782559817590534,1.29498709651926e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTN,Pleiotrophin,40042,0.0442239491659519,0.0048796721065451,0.0346597918371235,0.0537881064947803,1.41865554973601e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BST2,Bone marrow stromal antigen 2,40471,0.0471250540458898,0.0052002177095132,0.0369326273352439,0.0573174807565357,1.42435688450013e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0312318535432952,0.00345254823460812,0.0244648590034633,0.0379988480831271,1.65136633031205e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRK1,Protein BRICK1,39961,0.0387880794982416,0.00429149994542611,0.0303767396052064,0.0471994193912768,1.77515048111556e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0766034466791744,0.00850044803634879,0.0599425685279308,0.093264324830418,2.30337620449577e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,39980,0.030684226513292,0.00340836805136464,0.0240038251326173,0.0373646278939667,2.45534151440888e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0272344661863906,0.00302933288343264,0.0212969737348627,0.0331719586379186,2.73697281817422e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSTL3,Follistatin-related protein 3,40293,0.0272700332143016,0.0030348554271648,0.0213217165770586,0.0332183498515446,2.85802201677821e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRR3,Small proline-rich protein 3,37942,0.0622297052861297,0.00693300028929976,0.0486410247191021,0.0758183858531572,3.17845706782998e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBD,Thrombomodulin,40359,0.0241844996038673,0.00269659971314389,0.0188991641661053,0.0294698350416294,3.33421409779689e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.043872865702209,0.00489551618319542,0.034277653983146,0.0534680774212721,3.6176753632447e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0661694822593322,0.00739166069011727,0.0516818273067023,0.080657137211962,3.95336531618803e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAM,Signal transducing adapter molecule 1,37900,0.032600816753478,0.00365585459500826,0.0254353417472618,0.0397662917596941,5.38106890604696e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD80,T-lymphocyte activation antigen CD80,37990,0.0295203009385065,0.00331191936312607,0.0230289389867794,0.0360116628902336,5.57705255217519e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0420256404322619,0.00472029966249628,0.0327738530937692,0.0512774277707546,6.0044688854611e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0294104025495328,0.00332013637021289,-0.03591786983515,-0.0229029352639155,8.9957081449004e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS7_LGALS7B,Galectin-7,40270,0.0344881587480689,0.00390056365451532,0.0268430539852188,0.0421332635109189,1.03925486789937e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL2A1,Collagen alpha-1(II) chain,37628,0.0708724509253336,0.0080227838859584,0.0551477945088551,0.0865971073418121,1.13754623814754e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0407737702814293,0.00462138511867925,0.031715855448818,0.0498316851140407,1.2513361480622e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL21,C-C motif chemokine 21,40422,0.0364217823805223,0.00412942872499574,0.0283281020795307,0.044515462681514,1.2603895353431e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIPF,Gastric triacylglycerol lipase,37628,0.0513479187580185,0.00582648655091835,0.0399280051182186,0.0627678323978185,1.37143474010736e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0326008635932088,0.00370137811861593,0.0253461624807216,0.039855564705696,1.40902725512581e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSNK1D,Casein kinase I isoform delta,37598,0.0546430725074425,0.00620510400416999,0.0424810686592693,0.0668050763556156,1.45570947823618e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMA4,Laminin subunit alpha-4,40422,0.0280443793442964,0.00318575496123742,0.0218002996202711,0.0342884590683218,1.46571569879217e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0316404618602418,0.00360211333408801,0.0245803197254293,0.0387006039950543,1.77149696348834e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0574560527426818,0.00654161882652296,0.0446344798426968,0.0702776256426668,1.78494724845141e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4M,C-type lectin domain family 4 member M,37969,-0.0413373195891553,0.00472129535633873,-0.0505910584875792,-0.0320835806907314,2.2706814924839e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0186578943432599,0.00213242908253434,0.0144783333414926,0.0228374553450272,2.35342583573306e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNB2,Plexin-B2,40472,0.0197834661431387,0.0022653290060738,0.015343421291234,0.0242235109950433,2.71765195533301e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0191310555035726,0.00219279017605084,0.0148331867585129,0.0234289242486322,2.93359180340207e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6L2,Seizure 6-like protein 2,40305,-0.0200999105214068,0.00230646749065685,-0.0246205868030942,-0.0155792342397193,3.20275556549739e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PER3,Period circadian protein homolog 3,37598,0.100142433652758,0.0114972497478716,0.0776078241469293,0.122677043158586,3.39491214476697e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0301582135189141,0.00346309927897674,0.0233705389321197,0.0369458881057085,3.4451429385899e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSF,Cathepsin F,40411,0.0338102634079552,0.00388549458834671,0.0261946940147956,0.0414258328011147,3.58531286005843e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300E,CMRF35-like molecule 2,40436,0.0336489209056893,0.00388179997724996,0.0260405929502794,0.0412572488610993,4.79760346967442e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0530073366081271,0.00613016746238625,0.04099220838185,0.0650224648344041,5.78797189469336e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0410304481170684,0.00474921601647497,0.0317219847247775,0.0503389115093594,6.19108284195813e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BSG,Basigin,40502,0.0169444011232816,0.0019622380477718,0.0130984145496488,0.0207903876969143,6.40347063659141e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBS,Cystathionine beta-synthase,37628,0.0427147218594264,0.00495178066191004,0.0330092317620827,0.0524202119567701,7.06603081758417e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP7,Dipeptidyl peptidase 2,40251,0.0484959848420527,0.00563605618016557,0.0374493147289282,0.0595426549551772,8.36978348291633e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIMAP8,GTPase IMAP family member 8,37482,0.0433923780254631,0.00504446941246735,0.0335052179770271,0.0532795380738991,8.72488447019954e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0187363098064033,0.00217915075370635,0.0144651743291388,0.0230074452836677,8.9945880042037e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0288121138696148,0.00335618575115983,0.0222339897973415,0.0353902379418881,9.93601804788862e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLGN,Calmegin,37572,0.0371358127724411,0.00433146988544635,0.0286461317969662,0.0456254937479159,1.11548855841766e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,40273,0.0279799710084872,0.00327012492322483,0.0215705261589665,0.0343894158580078,1.27173624551536e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPTLC1,Serine palmitoyltransferase 1,37942,0.0299257103393294,0.00349834838118615,0.0230689475122045,0.0367824731664543,1.31331692109203e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRZB,Secreted frizzled-related protein 3,40176,0.0221181057376037,0.00258734177680396,0.0170469158550679,0.0271892956201395,1.35928775586233e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.054816667925007,0.00642756060919025,0.0422186491309941,0.0674146867190199,1.61525018490201e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP3,Stromelysin-1,40332,-0.0400035738018076,0.00469526081185612,-0.0492062849930456,-0.0308008626105696,1.73718625848486e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,39961,0.060587144117655,0.00711184352859438,0.04664793080161,0.0745263574337,1.75271868794397e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYM,Ketimine reductase mu-crystallin,37541,0.0639905480298255,0.00751688765759459,0.0492574482209401,0.0787236478387109,1.8797363164426e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0272374585385003,0.00320164145595663,0.0209622412848253,0.0335126757921753,1.93466138590017e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300A,CMRF35-like molecule 8,37671,0.0245106251723638,0.00288069276876016,0.0188644673455939,0.0301567829991337,1.94870039966569e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAPK2,Death-associated protein kinase 2,37598,0.0433137013906493,0.00510083306566006,0.0333160685819556,0.0533113341993431,2.25726947470188e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPING1,Plasma protease C1 inhibitor,37981,0.0153599144964978,0.00181032931277802,0.0118116690434529,0.0189081599495428,2.38770677550011e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSM,Oncostatin-M,40268,0.0597592060185377,0.00704844144173002,0.0459442607927468,0.0735741512443285,2.48330318806025e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBP1,Z-DNA-binding protein 1,37598,0.0332385976897425,0.00392339439390285,0.0255487446776929,0.0409284507017921,2.66901227526282e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,39980,0.0377488970597294,0.00445818035513394,0.0290108635636669,0.046486930555792,2.7329397406785e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0473222317156952,0.00559231114183381,0.0363613018777009,0.0582831615536894,2.89740049136687e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SBSN,Suprabasin,37977,-0.0276610343320036,0.00327210361012046,-0.0340743574078397,-0.0212477112561675,3.11146141981445e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHCHD6,MICOS complex subunit MIC25,37900,0.0238754275783302,0.00282470357520097,0.0183390085709364,0.0294118465857241,3.14593153259976e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD93,Complement component C1q receptor,39725,-0.025924456661987,0.00306835856849999,-0.0319384394562469,-0.019910473867727,3.20118393278374e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEL1L,Protein sel-1 homolog 1,37628,0.0267034606379008,0.00316740193882248,0.0204953528378087,0.0329115684379929,3.7900572406276e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KITLG,Kit ligand,40359,-0.0297970852326315,0.00353749961810517,-0.0367305844841176,-0.0228635859811454,3.9726550093365e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0369697417361738,0.0043900188754459,0.0283653047402998,0.0455741787320478,4.03728990104847e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCAN,Versican core protein,40471,-0.0245908948064289,0.00292191002728619,-0.0303178384599098,-0.0188639511529479,4.21987598986482e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0388503387830062,0.00463448614018051,0.0297667459482524,0.04793393161776,5.60507105376611e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA7,Thyroxine-binding globulin,38013,0.0152163901709198,0.00182007520669952,0.0116490427657888,0.0187837375760509,6.86035699691846e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0161382090584226,0.00193174423989,-0.019924427768607,-0.0123519903482382,7.12671382349861e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0828117935027389,0.00992771659836422,0.063353468969945,0.102270118035533,8.04603186319494e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0306547885573392,0.00368884279695429,0.0234246566753088,0.0378849204393696,1.03161041604789e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AZU1,Azurocidin,39809,0.0628592517715966,0.00756551127823034,0.0480308496662651,0.077687653876928,1.04806858216889e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18BP,Interleukin-18-binding protein,40403,0.02460264387454,0.0029632375786991,0.0187946982202898,0.0304105895287902,1.0992354676253e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0675523923510923,0.008137757925717,0.051602386816687,0.0835023978854977,1.11571809849457e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSDE1,Cold shock domain-containing protein E1,37562,0.0946510603356327,0.0114097268456184,0.0722879957182207,0.117014124953045,1.18473935380656e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0393484041192622,0.00474509474866473,0.0300480184118793,0.048648789826645,1.19740745524704e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE3,Eosinophil cationic protein,40288,0.0874472805840531,0.0105597736962415,0.0667501241394197,0.108144437028687,1.31625383785258e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL2,Fc receptor-like protein 2,40442,0.0391846930862327,0.00473208375948989,0.0299098089176325,0.0484595772548329,1.32110739277519e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINI2,Serpin I2,37901,0.0451115608017694,0.00545073114659611,0.034428127754441,0.0557949938490977,1.39019616602151e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP9,Caspase-9,37598,0.0503515912669902,0.00608429234363561,0.0384263782734644,0.062276804260516,1.39971312388879e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0346689202501158,0.00419941280651653,0.0264380711493434,0.0428997693508882,1.65392693244997e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.02081779880154,0.00252257942254446,-0.0257620544697271,-0.0158735431333528,1.69231978483133e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAM1,Neural cell adhesion molecule 1,40403,-0.0221238133772343,0.00268552437128379,-0.0273874411449505,-0.0168601856095181,1.88309051834232e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN3,Calsyntenin-3,37942,0.0245310818582601,0.00297842194076758,0.0186933748543557,0.0303687888621646,1.93909081318421e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0206666372665143,0.0025113336142142,0.0157444233826544,0.0255888511503741,2.02631762441448e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0354142307517133,0.00430561381497614,-0.0438532338290666,-0.0269752276743601,2.09879149782694e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0530856580963206,0.00645740317100907,0.0404291478811428,0.0657421683114984,2.17429342401658e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0227245227376212,0.00276877445542865,-0.0281513206702614,-0.0172977248049811,2.43137842353559e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0375070746102194,0.00457581163416752,0.0285384838072511,0.0464756654131878,2.66035689534035e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS22,Brain-specific serine protease 4,37598,0.0282478169883214,0.00344568938445032,0.0214942657947988,0.0350013681818441,2.669043613434e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRN,Progranulin,40262,0.0193140251752331,0.00235793888018668,0.0146924649700672,0.023935585380399,2.78562056204157e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0407915492178968,0.00501539707455963,0.0309613709517599,0.0506217274840337,4.49242539210857e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.0208210503288835,0.00256572927655173,-0.0258498797109249,-0.0157922209468421,5.20880900007295e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C5,Complement C5,38013,0.0120494884851015,0.00148846788006892,0.00913209144016638,0.0149668855300366,6.19982955085199e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM4,Intercellular adhesion molecule 4,40341,-0.0415156952807599,0.0051319969074171,-0.0515744092192974,-0.0314569813422224,6.41635440939657e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSC,Dipeptidyl peptidase 1,40349,0.0334557498877355,0.00413802273892729,0.025345225319438,0.041566274456033,6.66298937874066e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD276,CD276 antigen,40357,-0.028240064923972,0.00349749078384144,-0.0350951468603013,-0.0213849829876428,7.26412558910429e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,39980,0.028241402510926,0.00349916680968808,0.0213830355639373,0.0350997694579146,7.48607782664907e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHPS,Deoxyhypusine synthase,37900,0.0323475824153403,0.00401241540003306,0.0244832482312755,0.0402119165994051,8.14466824692363e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFP,Alpha-fetoprotein,40182,0.0544194610198166,0.00675184542036609,0.0411858439958991,0.0676530780437342,8.17801562692033e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRG2,Bone marrow proteoglycan,37998,-0.0409400636886601,0.00508476694061745,-0.0509062068922703,-0.0309739204850499,8.8560199729581e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEPACAM2,HEPACAM family member 2,37942,-0.0318799660773196,0.00396808011548949,-0.039657403103679,-0.0241025290509602,1.02048929104117e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD1,Programmed cell death protein 1,40455,0.0341496555470543,0.00425295481409605,0.0258138641114261,0.0424854469826826,1.04516804726891e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF1,Macrophage colony-stimulating factor 1,40422,0.0211135615510348,0.00263061068256544,0.0159575646132065,0.026269558488863,1.07564004767685e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2orf69,UPF0565 protein C2orf69,37572,0.0471740268466565,0.00587876365077285,0.0356516500911417,0.0586964036021713,1.10578372315814e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARF2,Scavenger receptor class F member 2,40471,-0.023175374422933,0.00288938915237073,-0.0288385771615796,-0.0175121716842864,1.12221401484732e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300C,CMRF35-like molecule 6,40471,0.0265449098835,0.00331411425704636,0.0200492459396891,0.0330405738273109,1.22885182624933e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0501368858392717,0.00626595751437457,0.0378556091110975,0.0624181625674458,1.31582890952387e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A11,Protein S100-A11,40207,0.034953982933198,0.00437088781427597,0.0263870428172171,0.0435209230491789,1.36287026718855e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPE,Carboxypeptidase E,40360,-0.0297160144440211,0.00371669452943755,-0.0370007357217187,-0.0224312931663235,1.38105008141197e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0899974544004132,0.0112723788900039,0.0679035917760056,0.112091317024821,1.51545361804389e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MATN2,Matrilin-2,40379,0.0230121108958105,0.00288398327081859,0.0173595036850061,0.0286647181066149,1.57143433672798e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0299983927520687,0.00377252402928639,0.0226042456546674,0.03739253984947,1.96123478295603e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSTN,Growth/differentiation factor 8,40042,0.0394765088540397,0.00497349735540109,0.0297284540374536,0.0492245636706259,2.20481535745541e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA3,Protein disulfide-isomerase A3,37671,0.019752384171216,0.00248863694881016,0.0148746557515481,0.0246301125908839,2.23696018039441e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0448755857010973,0.00566581327040434,0.0337705916911048,0.0559805797110899,2.52276671880485e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CR1,Complement receptor type 1,37959,0.0278147218383623,0.0035266579839159,0.0209024721898871,0.0347269714868375,3.33228009734608e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX2,Sorting nexin-2,37900,0.0599196351166045,0.00759994671456872,0.0450237395560498,0.0748155306771592,3.40788216773333e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCAM1,Vascular cell adhesion protein 1,40372,-0.0206797750700386,0.00262719753935146,-0.0258290822471675,-0.0155304678929098,3.73087575920069e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0212818582765593,0.00270871330629334,0.0159727801962243,0.0265909363568942,4.18950168966008e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGKZ,Diacylglycerol kinase zeta,40044,0.0267416572531735,0.00341188526739971,0.0200543621290701,0.0334289523772769,4.88002420850193e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0290309413868365,0.00372210958942736,0.0217356065915589,0.0363262761821141,6.60426188096284e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.0183602960687928,0.00235412080846871,-0.0229743728533914,-0.0137462192841941,6.6094819614937e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD59,CD59 glycoprotein,39665,0.0171298816317981,0.00219799776113043,0.0128218060199825,0.0214379572436137,6.94309802904669e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANSC1,MANSC domain-containing protein 1,40411,-0.0206885518098364,0.00266428316191796,-0.0259105468071957,-0.0154665568124772,8.64791384185031e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.0295889642701304,0.00381716526051237,0.0221073203595261,0.0370706081807346,9.74258998065381e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRDT,Bromodomain testis-specific protein,37562,0.0281305248474364,0.00363056314785238,0.0210146210776457,0.0352464286172271,9.99988898821679e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN2,Calsyntenin-2,40516,-0.0293643141748554,0.00379663844153768,-0.0368057255202692,-0.0219229028294415,1.10121866398956e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMNB2,Lamin-B2,37942,0.0206170606209808,0.00266563432098113,0.0153924173518578,0.0258417038901038,1.11244787909012e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP2,Retinol-binding protein 2,40305,-0.057029453711074,0.00739440270862084,-0.0715224830199709,-0.0425364244021772,1.30663938491874e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAT,Catalase,37786,0.0408776985928382,0.00530145516234564,0.0304868464746407,0.0512685507110356,1.3401845640868e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPARCL1,SPARC-like protein 1,40346,-0.0206821870437374,0.00268284747716611,-0.025940568098983,-0.0154238059884918,1.34235871403705e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0211789996951263,0.00274733587697673,-0.0265637780140007,-0.015794221376252,1.34377730603638e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP6,Gastrotropin,40017,0.041890957384806,0.00543406309225218,0.0312401937239917,0.0525417210456203,1.34488733574527e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.0408222066736423,0.00531382481214917,0.0304071100418299,0.0512373033054547,1.65408522523126e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0277010555166252,0.00361367656343737,0.0206182494522879,0.0347838615809624,1.88255454755008e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX6,Peroxiredoxin-6,40489,-0.0443566036286017,0.00581104587249676,-0.0557462535386954,-0.0329669537185081,2.41934250041945e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH1,Cadherin-1,39806,0.0297407485815795,0.00389918681299477,0.0220983424281097,0.0373831547350492,2.53501105153375e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RALY,RNA-binding protein Raly,37900,0.035860769706501,0.00470526297604112,0.0266384542734604,0.0450830851395416,2.67671929356823e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRG,Histidine-rich glycoprotein,37934,0.0233751177647564,0.00306811724854519,0.0173616079576078,0.0293886275719049,2.73259690952397e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC16A1,Monocarboxylate transporter 1,39961,0.044489758324232,0.00584195837867691,0.0330395199020252,0.0559399967464387,2.77665308578967e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL4,ADAMTS-like protein 4,37628,0.01744420303211,0.00229340656759151,0.0129491261596307,0.0219392799045894,3.01284015178074e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.030164048002707,0.00397338301017777,0.0223762173027586,0.0379518787026554,3.33801827489314e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A14,Protein S100-A14,37959,0.0398043237740155,0.00524554366730062,0.0295230581861063,0.0500855893619247,3.45533229934575e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LBP,Lipopolysaccharide-binding protein,40403,-0.0429102432794245,0.00566027550448721,-0.0540043832682195,-0.0318161032906296,3.61870332842831e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFC1,Cryptic protein,39980,0.033990180573317,0.00449012782476251,0.0251895300367825,0.0427908311098515,3.94214790704184e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CENPF,Centromere protein F,37714,0.0403169869750302,0.00532814168518927,0.0298738292720592,0.0507601446780012,4.07711582265504e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0263837880717272,0.00348680375709541,0.0195496527078202,0.0332179234356342,4.08157049556657e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COPB2,Coatomer subunit beta',37562,0.0318235646117872,0.0042146172425838,0.023562914816323,0.0400842144072515,4.61306288008713e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNDP1,Beta-Ala-His dipeptidase,40403,0.0333846244911491,0.00444169075801655,0.0246789106054367,0.0420903383768615,5.93819656361766e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0333700367597464,0.00445510536284523,0.0246380302485698,0.0421020432709231,7.31145040149932e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP1,"Fatty acid-binding protein, liver",40357,0.067569618112595,0.00903380319018879,0.049863363859825,0.085275872365365,7.84105473244384e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0309403065918766,0.00413992714258635,0.0228260493924073,0.0390545637913458,8.20510272807424e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN4,Contactin-4,40332,-0.017645007741708,0.00236340521903363,-0.0222772819710139,-0.0130127335124021,8.70036717171861e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0274926996109352,0.00368326796689278,0.0202734943958254,0.0347119048260451,8.80947319985091e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0299825099069579,0.0040165912523759,0.0221099910523011,0.0378550287616147,8.87866533545482e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0312589304212983,0.0041885069242482,-0.0394684039928247,-0.0230494568497718,8.89348252299987e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOC,Brother of CDO,40042,-0.0171289192560473,0.00229737227752987,-0.0216317689200058,-0.0126260695920887,9.39638894732623e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHISA5,Protein shisa-5,37998,0.0180474602398561,0.00242351593736342,0.0132973690026237,0.0227975514770884,1.01398812814148e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNA1,Ephrin-A1,40303,0.0197369292731751,0.00265396508865056,0.0145351576994199,0.0249387008469302,1.08451074750064e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0557264153709642,0.00751802882185407,-0.0704617518617982,-0.0409910788801303,1.30297849404767e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPCAM,Epithelial cell adhesion molecule,40358,-0.0719159485911518,0.00970324850148366,-0.0909343156540598,-0.0528975815282439,1.31120886657329e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0315439098549959,0.00425861489662834,0.0231970246576043,0.0398907950523874,1.35741583773904e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PI3,Elafin,40074,0.0384915323483604,0.00520901189931209,0.0282818690257087,0.0487011956710121,1.54938260273691e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B2M,Beta-2-microglobulin,38013,0.0227942646789254,0.00308937314839821,0.0167390933080649,0.0288494360497859,1.6966199501045e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEP1B,Meprin A subunit beta,40359,0.0848729773800289,0.0115121297864549,0.0623092029985772,0.107436751761481,1.75717467162301e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0395821536930596,0.00537236013681713,0.0290523278248981,0.0501119795612212,1.81970734546065e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAM,Basal cell adhesion molecule,40332,-0.0169586477857882,0.00230325820436956,-0.0214730338663525,-0.0124442617052238,1.88785560910276e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGT,Angiotensinogen,37987,0.0173547429764468,0.00235866291481671,0.0127317636634061,0.0219777222894875,1.97620680769434e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0274189084404952,0.00373224701385418,0.020103704293341,0.0347341125876494,2.13351464498887e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0233931317232543,0.0031880770382008,-0.0296417627181279,-0.0171445007283807,2.27830547645273e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD101,Immunoglobulin superfamily member 2,37901,0.0303370234178149,0.00414552540712567,0.0222117936198486,0.0384622532157812,2.65929710694537e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPA,Apolipoprotein(a),37735,-0.125088240236699,0.017117873567474,-0.158639272428949,-0.0915372080444505,2.87771702002667e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL1,Angiopoietin-related protein 1,40136,0.020976316670478,0.00287670033301637,0.0153379840177659,0.0266146493231901,3.2044886622442e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM3,Myomesin-3,37671,-0.0640254439019513,0.00878445691521474,-0.0812429794557721,-0.0468079083481304,3.31237237563007e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0361337528470505,0.00497705212015469,0.0263787306915473,0.0458887750025537,4.0522393184029e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0235002458449696,0.00323951191651524,0.0171508024885997,0.0298496892013395,4.25982432720353e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR2,Complement factor H-related protein 2,37911,0.0403571447177464,0.00556714418782564,0.0294455421096082,0.0512687473258847,4.42216870127354e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0364306154892312,0.00502697890534944,0.0265777368347463,0.0462834941437161,4.46051535851395e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRK1,NKG2-D type II integral membrane protein,37942,0.0325738037070906,0.0044959352468255,0.0237617706233126,0.0413858367908686,4.5534926858026e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO1,Roundabout homolog 1,40379,0.0169549047791335,0.00234111966988125,0.0123663102261663,0.0215434993321008,4.61583362594364e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTX2,Neuronal pentraxin-2,37998,-0.0230523417884592,0.00318389442173396,-0.0292927748550578,-0.0168119087218607,4.71835857170008e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0160808012271422,0.00222580120718518,0.0117182308610592,0.0204433715932251,5.24632071009668e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0391658193177805,0.00542463314765466,0.0285335383483774,0.0497981002871837,5.48552172674003e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON1,Serum paraoxonase/arylesterase 1,37987,-0.0181907505642063,0.00252170187614157,-0.0231332862414438,-0.0132482148869689,5.73544500484868e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL9,C-X-C motif chemokine 9,40422,0.0474507875704665,0.0065845663722668,0.0345450374808236,0.0603565376601094,6.00344218539082e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0185163741074872,0.00257507778369533,0.0134692216514443,0.02356352656353,6.79105325887903e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRLB,Fc receptor-like B,39980,0.042690473450354,0.00593925048276383,0.0310495425041369,0.0543314043965711,6.88138118767171e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.033453191225295,0.00465626261664945,0.024326916496662,0.0425794659539279,7.04891506362938e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALCAM,CD166 antigen,40536,0.0135320177702056,0.00188621678104756,0.0098350328793524,0.0172290026610589,7.59250392089176e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPL,Periplakin,37598,0.0230525862716041,0.00321754305421085,0.0167462018853508,0.0293589706578573,8.21378195281476e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0167975375662598,0.00235212826337761,0.0121873661700397,0.0214077089624799,9.64101173841468e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.0142848676042733,0.00200150916951785,-0.0182078255765282,-0.0103619096320183,1.00347322334871e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALPP,"Alkaline phosphatase, placental type",40305,0.0714002442187207,0.0100134775649822,0.0517738281913557,0.0910266602460858,1.04387259265406e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD1C,T-cell surface glycoprotein CD1c,40411,0.0165815992315179,0.00232634690250056,0.0120219593026168,0.021141239160419,1.06397563739474e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNC,Tenascin,40403,-0.0327124785284398,0.00459623394847359,-0.0417210970674481,-0.0237038599894316,1.14802533570557e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAP,Prolyl endopeptidase FAP,40536,0.018717777592936,0.00263014126298249,0.0135627007174904,0.0238728544683817,1.1525514196083e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0302303044027057,0.00425902207564955,0.0218826211344325,0.0385779876709788,1.32127536009251e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0309083149490484,0.00435963156102002,0.0223634370894491,0.0394531928086476,1.41306455343945e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST5,Cystatin-D,40070,0.0378181768647731,0.00536343993578342,0.0273058345906376,0.0483305191389086,1.84942664038535e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0191310740542414,0.00271860799961371,0.0138026023749986,0.0244595457334843,2.04278330414374e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK7,Kallikrein-7,37352,0.0265636406900018,0.00378005626886473,0.0191547304030269,0.0339725509769767,2.21129378664191e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGMB,RGM domain family member B,40471,0.0177336621693079,0.00252412309335174,0.0127863809063385,0.0226809434322773,2.21614574379467e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.0596987444621557,0.00852525389074458,0.0429892468362963,0.0764082420880151,2.61384705401785e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAM,Integrin alpha-M,40332,-0.0215473403027934,0.00308048569083589,-0.0275850922568317,-0.015509588348755,2.76265383288009e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0194992723034992,0.00278995279548131,0.0140309648243559,0.0249675797826426,2.89957349518083e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L15,Bcl-2-like protein 15,37598,0.0384089584209062,0.00550954275856349,0.0276102546141217,0.0492076622276906,3.28897047876487e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST7,Cystatin-F,40376,0.0623392770571772,0.00894884893561667,0.0447995331433685,0.0798790209709859,3.38416715123719e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0260985433024088,0.00375178933902247,0.0187450361979247,0.0334520504068928,3.65924853742647e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.027790238493964,0.00399725132377757,0.0199556258993599,0.035624851088568,3.75860519432981e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0178859452644103,0.00257703648159112,0.0128349537604917,0.0229369367683289,4.05727888203012e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0233609673954856,0.00336745631957298,0.0167607530091226,0.0299611817818487,4.15200622195123e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0541084029795158,0.00780429284255041,0.0388119890081169,0.0694048169509145,4.27765249113098e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP3,"Fatty acid-binding protein, heart",37990,0.0319358447326645,0.00463097578514969,0.0228591321937711,0.0410125572715579,5.58059861344815e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFIC,Nuclear factor 1 C-type,37959,0.0293046326450051,0.00425676275315905,0.0209613776488134,0.0376478876411969,6.06566942311725e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0251484257096492,0.00365579926586445,0.0179830591485549,0.0323137922707435,6.29056807906199e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0247835888507804,0.0036028164475251,0.0177220686136312,0.0318451090879296,6.29621919582833e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.016772197812366,0.0024388725081799,-0.0215523879283986,-0.0119920076963334,6.38605949005309e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN10,Ataxin-10,39961,0.0482304273322614,0.00704454125207071,0.0344231264782028,0.06203772818632,7.85207256854399e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRH,Corticoliberin,39947,0.0578461724547303,0.00845545779061162,0.0412734751851315,0.0744188697243291,8.14268528588049e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0267426547267821,0.00392197119189036,0.019055591190677,0.0344297182628872,9.57763233071105e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OLFM4,Olfactomedin-4,37177,0.0818011916107672,0.0120048649332337,0.0582716563416291,0.105330726879905,9.91945805926577e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA5,Protein disulfide-isomerase A5,37482,0.0407749899070456,0.00599235783137375,0.029029968557553,0.0525200112565381,1.05835215326361e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MBL2,Mannose-binding protein C,37810,-0.0706267067814862,0.0103902118193403,-0.0909915219473933,-0.0502618916155792,1.11025202712411e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0177475995829629,0.00261621368159756,0.0126198207670317,0.0228753783988941,1.21265562110726e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA1,Annexin A1,37608,0.0274281925197467,0.00404464311397528,0.0195006920163551,0.0353556930231382,1.24131847145115e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0247812323632013,0.0036567259326328,0.017614049535241,0.0319484151911616,1.27208428681063e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDF15,Growth/differentiation factor 15,40536,0.0283192633900652,0.00418417782114932,0.0201182748606125,0.0365202519195178,1.34918915112576e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PVALB,Parvalbumin alpha,40417,0.0743080931948687,0.0109872135059703,0.0527731547231668,0.0958430316665705,1.39716300631462e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.048941781962413,0.00723700426558526,0.0347572536018659,0.0631263103229601,1.41105734394458e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAMP5,Vesicle-associated membrane protein 5,40042,0.0368285447723141,0.00545192071271111,0.0261427801754003,0.0475143093692278,1.4773618447345e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PADI4,Protein-arginine deiminase type-4,39934,0.0456487968935595,0.00675762024634404,0.0324038612107252,0.0588937325763939,1.47763640753414e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKAP4,Cytoskeleton-associated protein 4,40457,0.0171609974271423,0.00254349429088526,0.0121757486170072,0.0221462462372774,1.56091181492058e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAS2,Growth arrest-specific protein 2,37714,0.0352283681364762,0.00522349634994183,0.0249903152905903,0.0454664209823622,1.6023569544418e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP4,Guanylate-binding protein 4,39961,0.0323323754699769,0.00479610337084963,0.0229320128631116,0.0417327380768422,1.62420533335619e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LACRT,Extracellular glycoprotein lacritin,37863,0.0349373191779585,0.00519195140137367,0.0247610944312662,0.0451135439246509,1.77610865080718e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYZL2,Lysozyme-like protein 2,37482,0.0235526498637377,0.00350066847585546,0.016691339651061,0.0304139600764144,1.79145828890715e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSR,Insulin receptor,37598,0.0110818437723836,0.00164755024399996,0.00785264529414367,0.0143110422506235,1.81287014615817e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0221017042261124,0.00328745237018742,0.0156582975805451,0.0285451108716798,1.83964582720461e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0170373456168091,0.00253844443168625,0.012061994530704,0.0220126967029141,2.00042442549811e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QA,Complement C1q subcomponent subunit A,40442,-0.0148250200655713,0.00221132985446799,-0.0191592265803286,-0.010490813550814,2.09404348491022e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0391770035648899,0.0058521544762727,0.0277067807913954,0.0506472263383844,2.23891844115258e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0238997585717792,0.00357048819966956,0.0169016017004269,0.0308979154431316,2.26414419976964e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN5,Contactin-5,40367,-0.0241148815278718,0.00360465584396499,-0.0311800069820432,-0.0170497560737004,2.30727448311441e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGBL1,Integrin beta-like protein 1,37998,0.0227641481238509,0.0034038602504529,0.0160925820329632,0.0294357142147386,2.35524791669155e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GC,Vitamin D-binding protein,38013,0.0168800817863704,0.00253168654067809,0.0119179761666414,0.0218421874060995,2.70223658761487e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE1,Ribonuclease pancreatic,37987,0.0156595440100479,0.00235322275568912,0.0110472274088972,0.0202718606111985,2.95183621453509e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNXB,Tenascin-X,40332,-0.0164057769034975,0.00247802347802882,-0.021262702920434,-0.011548850886561,3.69439407247294e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0503013678993822,0.00760785856013156,0.0353899651215244,0.0652127706772401,3.94404047317455e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1B,Interleukin-1 beta,39946,0.0362428713353681,0.00549106416106409,0.0254803855796825,0.0470053570910538,4.23546173040562e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAFA5,Chemokine-like protein TAFA-5,40305,0.0230037536343746,0.00348752430234605,0.0161682060017763,0.0298393012669728,4.35728624040173e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFB,Vascular endothelial growth factor B,37598,0.018342692249548,0.00278337767690665,0.012887272002811,0.023798112496285,4.56340062008231e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGA4,Pepsin A-4,37987,0.0436491887526834,0.00662613531374198,0.0306619635377491,0.0566364139676177,4.64050496486741e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RSPO3,R-spondin-3,40489,0.0183046105562467,0.0027792448555766,0.0128572906393166,0.0237519304731769,4.65313424122109e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC3B,Tetranectin,37681,0.0135245246778065,0.00205370780884417,0.0094992573724719,0.017549791983141,4.70744940749321e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0304552106872154,0.004625521980941,0.0213891876045711,0.0395212337698598,4.72118895072081e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0440427109717508,0.00669672379023522,0.0309171323428897,0.0571682896006118,4.98971719897271e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0349917620427007,0.00532166304398133,0.0245613024764973,0.0454222216089041,5.03792092673373e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RCOR1,REST corepressor 1,40042,0.0285893545206547,0.00436040650323882,0.0200429577743066,0.0371357512670027,5.67860215664048e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMOD1,Leiomodin-1,37959,-0.0231776009456095,0.00353724327194216,-0.0301105977586161,-0.0162446041326029,5.8653980677699e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0647571270337911,0.00988951015242548,0.0453736871350372,0.0841405669325451,6.04612496678671e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C4BPB,C4b-binding protein beta chain,40411,0.0262363873637368,0.00400967359442401,0.0183774271186657,0.0340953476088079,6.20193535357813e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0424885807456296,0.006500300541412,0.0297479916844621,0.0552291698067972,6.53631492566591e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0271643512500552,0.00416232689438775,0.0190061905370552,0.0353225119630552,6.94674151828745e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,37942,0.151606475266413,0.0232841243901193,0.105969591461779,0.197243359071046,7.72169591504643e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR15L,Protein GPR15L,37901,0.038239594032501,0.0058799973157884,0.0267147992935557,0.0497643887714463,8.13350997998923e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLIN3,Perilipin-3,40359,0.0267995090315095,0.00412833914045326,0.0187079643162211,0.0348910537467979,8.74458529180283e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP10,Bone morphogenetic protein 10,37671,-0.0181696784824079,0.00279940339962446,-0.0236565091456719,-0.012682847819144,8.85736204123543e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0165286072110127,0.00254716712613246,-0.0215210547782323,-0.0115361596437931,8.94898744368081e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL15A1,Collagen alpha-1(XV) chain,37998,0.0163076357026137,0.00252685880573221,0.0113549924433786,0.0212602789618488,1.12853079353204e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0184256265857731,0.00286170160842135,0.0128166914332673,0.024034561738279,1.23933192222506e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0454979562484491,0.0070835939100036,0.031614112184842,0.0593818003120561,1.38219833113094e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN8,Septin-8,37921,0.0199517864263401,0.00310637505256243,0.0138632913233177,0.0260402815293624,1.38237027424915e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D17,TBC1 domain family member 17,39961,0.0286719274676476,0.00447500836427556,0.0199009110736675,0.0374429438616277,1.52567235867022e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENSA,Alpha-endosulfine,37900,0.0329878823352225,0.0051489823462041,0.0228958769366625,0.0430798877337825,1.5367594747133e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0170746392824795,0.00266549207216398,0.0118502748210381,0.0222990037439209,1.53755082148383e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0355254768072589,0.00555053904270526,0.0246464202835566,0.0464045333309612,1.59358683508953e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSN,Gelsolin,37928,-0.0118361223227716,0.00185300132625317,-0.0154680049222278,-0.00820423972331539,1.74110897372573e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSLN,Mesothelin,40271,0.0336298523912857,0.00526769458303641,0.0233051710085343,0.0439545337740371,1.77132265171912e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIMAP7,GTPase IMAP family member 7,37671,-0.020154216998816,0.00316335493401447,-0.0263543926694843,-0.0139540413281476,1.93832675403467e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0368791134046488,0.00580391105141946,0.0255034477438666,0.0482547790654309,2.16465992897262e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0450378029666063,0.00708825900182362,0.031144815323032,0.0589307906101806,2.16716168505592e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0267003673761252,0.00421627467907429,0.0184364690051396,0.0349642657471108,2.47396512236433e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2,Apoptosis regulator Bcl-2,37901,0.0333015213253055,0.00527345978073967,0.0229655401550558,0.0436375024955553,2.78787619474988e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.0129635438486382,0.00205557729608801,0.00893461234830573,0.0169924753489707,2.92934105474741e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0248277461639284,0.00393732463353539,0.017110589882199,0.0325449024456578,2.9578978231597e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN2,Prefoldin subunit 2,39961,0.0344268127738277,0.00546454002520998,0.0237163143244162,0.0451373112232393,3.05597906048013e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0248777160758885,0.00395457805027264,0.0171267430973541,0.0326286890544228,3.24157980059876e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA1,Carbonic anhydrase 1,40003,0.0382708968016633,0.00608833972506962,0.0263377509405269,0.0502040426627998,3.34578784644132e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0257876123316868,0.00410615650943638,0.0177395455731915,0.0338356790901821,3.48473372601891e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN4B,Sodium channel subunit beta-4,37628,0.025717389982538,0.00409591870690553,0.0176893893170032,0.0337453906480728,3.51942178545741e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0221784980859171,0.00353259585556855,0.0152546102090028,0.0291023859628315,3.53188663767043e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD7,T-cell antigen CD7,37567,0.0261671718787619,0.00418812812268171,0.0179584407583058,0.034375902999218,4.28765909707586e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSBP1,Heat shock factor-binding protein 1,37628,0.0582892525353673,0.00933085922748056,0.0400007684495054,0.0765777366212292,4.31468354320457e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YAP1,Transcriptional coactivator YAP1,37942,0.0161939136905874,0.00259814962128522,0.0111015404328684,0.0212862869483064,4.71618611089148e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSH,Pro-cathepsin H,40013,0.0438951581200529,0.00704760555011245,0.0300818512418325,0.0577084649982733,4.83394759543175e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY75,Lymphocyte antigen 75,40341,0.0235559668481397,0.00378693477278666,0.0161335746934778,0.0309783590028015,5.08541984598585e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.0367927065535343,0.00591637133463828,0.0251966187376433,0.0483887943694253,5.16158752948825e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCP1,Plastin-2,37998,0.0284813529519364,0.00459144918339587,0.0194821125524805,0.0374805933513923,5.69616235867476e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMH,Granzyme H,40042,0.0449976841800167,0.0072640284093979,0.0307601884975968,0.0592351798624366,5.99033559744333e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR2,Folate receptor beta,40471,-0.01770899238688,0.00286533712875942,-0.0233250531592484,-0.0120929316145115,6.54776779874027e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0232281010699387,0.00376105053409162,0.0158564420231192,0.0305997601167583,6.77004470578448e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN1,Tetraspanin-1,40042,0.0183395445591764,0.00297224897109825,0.0125139365758238,0.0241651525425289,6.98633021527919e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRPB1,Signal-regulatory protein beta-1,40335,0.0269433341946938,0.00436865398170426,0.0183807723905534,0.0355058959988341,7.10925230621237e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.025774245054066,0.004202682323714,0.0175369876995865,0.0340115024085454,8.8794374384509e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0288858890092119,0.00473076777806911,-0.0381581938542274,-0.0196135841641965,1.04561845327045e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0186948655094126,0.00306304047755883,0.0126913061733973,0.0246984248454279,1.06776999559903e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0249594875831481,0.00409464829195591,0.0169339769309146,0.0329849982353817,1.11523032622995e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL3,Fc receptor-like protein 3,40044,0.0325104107071647,0.00533357828243528,0.0220565972735916,0.0429642241407378,1.11719372448003e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP1,Caspase-1,39961,0.0398360899341765,0.00654427586098932,0.0270093092466375,0.0526628706217156,1.17633671284758e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MST1,Hepatocyte growth factor-like protein,37787,0.0365119187279727,0.00600059346406178,0.0247507555384116,0.0482730819175338,1.19892927983073e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300LF,CMRF35-like molecule 1,40489,0.0359140862092476,0.00590644361815135,0.024337456717671,0.0474907157008242,1.22529941988845e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.0347694515691517,0.00571876434875163,0.0235606734455985,0.0459782296927049,1.23069982359705e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD200,OX-2 membrane glycoprotein,40341,-0.015389481653151,0.00253174370418531,-0.0203516993133542,-0.0104272639929477,1.23999629509957e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN5,CCN family member 5,40332,0.0231986381239458,0.00381655881463523,0.0157181828472607,0.0306790934006308,1.24149456504671e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGCR6,Protein DGCR6,37541,0.0269807943475362,0.00444087310220318,0.018276683067218,0.0356849056278545,1.26983325444882e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.017843976283079,0.00295322193285754,-0.0236322912714798,-0.0120556612946782,1.55479585210775e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB44,Ras-related protein Rab-44,37900,0.0234567871521185,0.00388907548269189,0.0158341992060424,0.0310793750981947,1.66751417570775e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,37942,0.0171375491951912,0.00284381603032285,0.0115636697757584,0.022711428614624,1.72179541252268e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYAR,Cell growth-regulating nucleolar protein,39980,0.0306952922027096,0.00511850702920581,0.0206630184254662,0.040727565979953,2.05550935474525e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.0176785033029318,0.00295041266832042,-0.0234613121328398,-0.0118956944730238,2.12909466826634e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0320471167966688,0.00536469051051752,0.0215323233960544,0.0425619101972831,2.37771460088636e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0279385487614408,0.00468116601028425,0.0187634633812837,0.0371136341415979,2.45788266191708e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CABP2,Calcium-binding protein 2,37572,0.0381054990497462,0.00638489229003193,0.0255911101612836,0.0506198879382088,2.46266136215144e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VGF,Neurosecretory protein VGF,37959,0.0177031454938173,0.00297507099950899,0.0118720063347797,0.0235342846528549,2.73951866350788e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFAP1,Actin filament-associated protein 1,37671,0.0491307211863419,0.00826037818868251,0.0329403799365241,0.0653210624361596,2.78708709043198e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCT,Secretin,37572,0.0266655457779941,0.00448624679455318,0.0178725020606699,0.0354585894953183,2.85484705123744e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0157244765151708,0.0026464403379275,0.0105374534528329,0.0209114995775088,2.87829088950174e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GM2A,Ganglioside GM2 activator,37714,0.0222779978685748,0.0037543112330726,0.0149195478517525,0.0296364478853971,3.03059397026422e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF3,Trefoil factor 3,40309,0.0308319526364277,0.00519738582477234,0.0206450764198739,0.0410188288529815,3.05113512578971e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PREB,Prolactin regulatory element-binding protein,40044,0.0171006477824793,0.00288951666461294,0.011437195119838,0.0227641004451207,3.32370696732117e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLVRB,Flavin reductase,40332,0.0381017852355185,0.00645370234679416,0.025452528635802,0.0507510418352351,3.6232259424452e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIF,Leukemia inhibitory factor,39961,0.0300705744808006,0.0051238094066813,0.0200279080437053,0.040113240917896,4.47933652611434e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNG,Interferon gamma,40044,0.0648600971528357,0.0110750045917687,0.0431530881529691,0.0865671061527024,4.82409262405865e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OBP2B,Odorant-binding protein 2b,40184,-0.0377081874497014,0.00644193198838736,-0.0503343741469406,-0.0250820007524622,4.90757624876636e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0200769001463866,0.00343326117099219,0.0133477082512419,0.0268060920415313,5.10064121311244e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCN,Decorin,40042,-0.0129817158235755,0.00222048464563726,-0.0173338657290245,-0.00862956591812649,5.12538876302663e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.024867203096061,0.00425509634501558,0.0165272142598305,0.0332071919322916,5.19480681753018e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA7,Carbonic anhydrase 7,37714,-0.0200586345464544,0.0034368791587609,-0.0267949176976257,-0.013322351395283,5.46223222169151e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAN,Brevican core protein,40228,-0.0190085474488394,0.00326018082613522,-0.0253985018680644,-0.0126185930296144,5.63347639504051e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA12,Carbonic anhydrase 12,40305,-0.0183013571345108,0.00314086134926462,-0.0244574453790695,-0.0121452688899522,5.75756615705515e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0479516296832431,0.00825612842266254,0.0317696179748245,0.0641336413916617,6.46884097669604e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC6A,C-type lectin domain family 6 member A,39980,0.0264728599984878,0.00455906720346792,0.0175370882796906,0.0354086317172849,6.49843863865944e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0313110752331447,0.00539970545123435,0.0207276525487254,0.041894497917564,6.81391812823112e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDM1,Nuclear protein MDM1,37572,0.017703197206918,0.00305400232626978,0.0117173526474292,0.0236890417664068,6.91798515615267e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",40310,0.0382939888363838,0.00661944991069357,0.0253198670114244,0.0512681106613432,7.38478741610061e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0202267031921527,0.00350350829794304,0.0133598269281844,0.0270935794561211,7.91989710281257e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF8,SLAM family member 8,39980,0.030069884270281,0.00521154641488016,0.0198552532971159,0.0402845152434461,8.0850044579225e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGER,Advanced glycosylation end product-specific receptor,40311,0.0227208351223265,0.00394278485749553,0.0149929768016352,0.0304486934430177,8.43473367438517e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.0118906263543529,0.00206603134878789,-0.0159400477979772,-0.00784120491072862,8.83617936991993e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0365669895287822,0.00635952660500064,0.0241023173829809,0.0490316616745834,9.09070965521526e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0199837892627692,0.00348088754188779,0.0131612496806691,0.0268063288448693,9.61434658804856e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.0246443496653198,0.00429716796945091,0.0162219004451961,0.0330667988854436,9.92534144288895e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JAM2,Junctional adhesion molecule B,40471,0.0145606031343969,0.00254002424187749,0.00958215562031706,0.0195390506484768,1.00762607161662e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F3,Tissue factor,40393,-0.0156424098199423,0.00273276241574095,-0.0209986241547946,-0.0102861954850901,1.05898411509067e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0228870088118169,0.00399969942551845,-0.0307264196858331,-0.0150475979378008,1.0706416850715e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0385680329859836,0.00674582051875195,-0.0517898412027374,-0.0253462247692298,1.10515191984592e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A13,Protein S100-A13,37598,0.0194322056527151,0.00340069723614818,0.0127668390698647,0.0260975722355656,1.12624363233347e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.0200716386807329,0.00352172530223888,0.0131690570883447,0.0269742202731211,1.22420855608732e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBA,Lysosomal acid glucosylceramidase,37572,0.0293343570189566,0.00515974958056026,0.0192212478410584,0.0394474661968547,1.33421902370001e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF1C,Kinesin-like protein KIF1C,37562,0.020855574356855,0.00367231059851824,0.0136578455837593,0.0280533031299508,1.38247135085049e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CILP,Cartilage intermediate layer protein 1,37998,0.0298023484199344,0.0052499539392107,0.0195124386990815,0.0400922581407874,1.40145296922495e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMIGO2,Amphoterin-induced protein 2,40305,0.0124157009037097,0.00219233160247946,0.00811873096284996,0.0167126708445694,1.51117447523285e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMBS,Porphobilinogen deaminase,40489,0.0250182399080533,0.00442242296915517,0.0163502908885092,0.0336861889275974,1.56549453186141e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRLF1,Cytokine receptor-like factor 1,40422,0.0144457692917456,0.00255749635824873,0.00943307642957806,0.0194584621539131,1.64705403109648e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROCR,Endothelial protein C receptor,37562,-0.0203141280228424,0.00361233520269803,-0.0273943050201306,-0.0132339510255543,1.90901612514519e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTB,Lymphotoxin-beta,37900,0.0194495724180958,0.00345964577831874,0.012668666692591,0.0262304781436005,1.9269380225214e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC1,Sialoadhesin,40422,0.0236701267233153,0.00421408001607978,0.0154105298917989,0.0319297235548317,1.97638945614864e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL1A1,Collagen alpha-1(I) chain,40536,-0.0141838576879235,0.00252847751226162,-0.0191396736119563,-0.0092280417638907,2.06083054061363e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMPD3,AMP deaminase 3,37942,0.0396591732585343,0.00707744092723807,0.0257873890411476,0.0535309574759209,2.14051454068336e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN3,CCN family member 3,40522,0.0183691745703902,0.00328547671825869,0.0119296402026032,0.0248087089381772,2.29409420394643e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0194949637618775,0.00348671159273744,0.0126610090401121,0.0263289184836429,2.2998762954508e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RETN,Resistin,40283,0.0225290088075448,0.00403562089318986,0.0146191918568927,0.030438825758197,2.40925673496955e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6,Seizure protein 6 homolog,37572,-0.016977363565419,0.00305573186934817,-0.0229665980293414,-0.0109881291014966,2.81551579401298e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.0226983586275748,0.00409750233403201,0.014667254052872,0.0307294632022775,3.08139079966767e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLYR1,Putative oxidoreductase GLYR1,37900,0.0327343070648546,0.00591654262901961,0.0211378835119762,0.0443307306177331,3.21277276980559e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF3,Granulocyte colony-stimulating factor,40044,0.0262918231739386,0.00475980012794525,0.0169626149231659,0.0356210314247113,3.37198105109601e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPS10,40S ribosomal protein S10,37562,-0.0227436195394874,0.00413406138835996,-0.030846379860673,-0.0146408592183019,3.83593260806167e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.0301151475233156,0.00548465922476484,0.0193652154427765,0.0408650796038547,4.07572050109158e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.017806199631115,0.00325584392394302,0.0114247455401866,0.0241876537220433,4.60619331299155e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPHS1,Nephrin,37598,0.0184984362636516,0.00338645941290404,0.0118609758143597,0.0251358967129435,4.78092669737694e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,40341,0.0249915964279727,0.00458056494452927,0.0160136891366953,0.03396950371925,4.9424419235443e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA2,Ephrin type-A receptor 2,39759,0.0162923906923178,0.0029977800659107,0.0104167417631328,0.0221680396215027,5.56913417105705e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0330447734108659,0.00608046531311729,0.0211270613971561,0.0449624854245758,5.58798076406459e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0270377602779776,0.00497834314767959,0.0172802077085256,0.0367953128474296,5.69887764687219e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA12,Serpin A12,39903,0.0604067826100273,0.0111276688382402,0.0385965516870765,0.0822170135329781,5.76802266821777e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MATN3,Matrilin-3,40203,-0.0165035777015461,0.00304127951204701,-0.0224644855451583,-0.010542669857934,5.83109844400864e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDF2,Growth/differentiation factor 2,40359,0.0188305250637861,0.00347670893079586,0.0120161755594262,0.025644874568146,6.17656199021787e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EBI3_IL27,Interleukin-27,40453,-0.016346795964066,0.0030343173806962,-0.0222940580302305,-0.0103995338979014,7.25327948224362e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0118537859180701,0.00220393575891983,0.0075340718305872,0.0161735000055529,7.61950572757533e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC16,Mucin-16,40305,0.0980086784938272,0.0182247845614783,0.0622881007533297,0.133729256234325,7.64833478506566e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB37,Ras-related protein Rab-37,40044,0.0436482091198977,0.00812374484687365,0.0277256692200254,0.0595707490197701,7.8585402349942e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.0112495752068745,0.0020963072850397,0.00714081292819665,0.0153583374855523,8.16662884853621e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0462940060204355,0.00862848958121998,0.0293821664412444,0.0632058455996267,8.19658190037034e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMB,Granzyme B,40341,0.0328709199210193,0.00612733861152585,0.0208613362424286,0.04488050359961,8.2250259526712e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0169265531927181,0.00315702469497687,0.0107387847905634,0.0231143215948728,8.36521279188931e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0213338060253679,0.00398755407247064,0.0135182000433255,0.0291494120074103,8.91547722881981e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0279906221141972,0.00523918745837533,0.0177218146957815,0.0382594295326129,9.29406372009927e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRC1,Macrophage mannose receptor 1,37987,0.0147115631282136,0.00275465157116181,0.00931244604873649,0.0201106802076908,9.41243153210771e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.0236056813361092,0.0044215205526423,0.0149395010529303,0.0322718616192881,9.50768141107431e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH15,Cadherin-15,40435,0.0229892902861204,0.00431168951117438,0.0145383788442186,0.0314402017280221,9.85377554193783e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH3,Cadherin-3,40471,0.0183688331280984,0.00344927558160577,0.0116082529881511,0.0251294132680457,1.02081066349996e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0171033478334074,0.00321263579945252,-0.0234001140003344,-0.0108065816664805,1.03270060028071e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR5,Complement factor H-related protein 5,37785,0.0216715065176273,0.00407434907460494,0.0136857823314016,0.029657230703853,1.06019174201881e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNR,Tenascin-R,40228,-0.0219507911060232,0.00412831560378807,-0.0300422896894478,-0.0138592925225985,1.068531316948e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.019553082729084,0.00367911366115315,-0.0267641455049442,-0.0123420199532238,1.08631430959386e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0203670401472449,0.00384007251659375,0.0128404980147212,0.0278935822797686,1.1519157368981e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH6,Cadherin-6,40359,-0.0194850001460219,0.00369182208131155,-0.0267209714253926,-0.0122490288666513,1.32401584358608e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC10A,C-type lectin domain family 10 member A,40228,-0.0184962131073557,0.00350841947725557,-0.0253727152827766,-0.0116197109319347,1.36760817523264e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTPN,Myotrophin,40042,0.0169648041680021,0.00322761524110875,0.010638678295429,0.0232909300405753,1.49048173662187e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0226300545910787,0.00430599370744272,0.014190306924491,0.0310698022576665,1.49929843294877e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AOC3,Membrane primary amine oxidase,40403,-0.0155441907212737,0.00295861992814172,-0.0213430857804315,-0.00974529566211591,1.5085550951912e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK11,Kallikrein-11,40260,0.0151687148676757,0.00289136905113625,0.0095016315274487,0.0208357982079028,1.57267930513925e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK6,Kallikrein-6,40387,0.0155121700752718,0.00296088909156537,0.00970882745580371,0.02131551269474,1.634834286326e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCG3,Secretogranin-3,40379,-0.0170075567629091,0.00324726738128379,-0.0233722008302254,-0.0106429126955929,1.64839430410828e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL28,C-C motif chemokine 28,40278,0.0303410499553498,0.00580736024241305,0.0189586238802202,0.0417234760304794,1.76759928550334e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.014836366599068,0.00284131856945098,-0.0204053509951919,-0.00926738220294411,1.80018824648365e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0334015515502313,0.00640715092116272,-0.0459595673557102,-0.0208435357447523,1.88384891212729e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.0170343697812225,0.00327049254152121,0.0106242043998409,0.023444535162604,1.9274711137674e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.0169435940561405,0.00325354171455875,-0.0233205358166757,-0.0105666522956054,1.94054716285618e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.015349134789597,0.00294947793713964,0.00956815803280332,0.0211301115463907,1.97512079250898e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGA,Fibrinogen alpha chain,37698,0.0155846303652651,0.00300205782786145,0.00970059702265665,0.0214686637078735,2.11903349840332e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKD2,Serine/threonine-protein kinase D2,37562,0.0240644380413879,0.00463583047495241,0.0149782103104811,0.0331506657722946,2.123335121849e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.01338673307673,0.00258077888931257,-0.0184450596997826,-0.00832840645367738,2.16808973465651e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.0128799152741912,0.00248438064246531,0.00801052921495915,0.0177493013334232,2.19438685422194e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17D,Interleukin-17D,40044,0.0172294890629197,0.00333945686317581,0.0106841536110951,0.0237748245147442,2.50822676411521e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD3,Extracellular superoxide dismutase,37987,-0.0297425684150558,0.00576587470088915,-0.0410436828287985,-0.0184414540013131,2.5261576045737e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.0189733498897785,0.00367938632547788,0.0117617526918418,0.0261849470877151,2.54504201757341e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0194159879073456,0.00376753570878644,0.0120316179181242,0.026800357896567,2.59288183678868e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0120646929850641,0.0023471620357873,0.00746425539492096,0.0166651305752072,2.77822120276949e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN2,Ataxin-2,37541,0.0577767332950478,0.0112609203306032,0.0357053294470656,0.07984813714303,2.92751836328782e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNLY,Granulysin,40332,0.0253096248073199,0.00494019149864411,0.0156268494699775,0.0349924001446624,3.03901044209257e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.0131645962962645,0.00257527148262669,0.00811706419031615,0.0182121284022128,3.22595535746051e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.0136890050263456,0.00268727447653038,0.00842194705234606,0.0189560630003451,3.54680446358611e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3D,Protein FAM3D,37901,0.0409020652465563,0.00803123553707703,0.0251608435938853,0.0566432868992272,3.5744884486812e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEDD9,Enhancer of filamentation 1,37598,0.0164199320482582,0.00322784873053289,0.0100933485364137,0.0227465155601027,3.68865797426383e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.020560563824116,0.00404519302509443,0.012631985494931,0.0284891421533011,3.7640068020348e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP2,Guanylate-binding protein 2,40044,0.0294560099835788,0.00580128268760778,0.0180854959158675,0.04082652405129,3.86842098817165e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFLAM,Pikachurin,37901,0.0152412758186749,0.00300368078560136,0.00935406147889625,0.0211284901584536,3.94320571710034e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0514662579556227,0.0101439845163959,0.0315840483034867,0.0713484676077587,3.95748135079986e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0283567214242297,0.0055947640662891,0.0173909838543031,0.0393224589941564,4.05590472431718e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF5,Eukaryotic translation initiation factor 5,37562,0.0224814216368621,0.00444163320174025,0.0137758205614512,0.031187022712273,4.2156068903727e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG3,Desmoglein-3,40419,0.0164701060359138,0.00325769992197163,0.0100850141888494,0.0228551978829782,4.33454450304353e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPEP1,Dipeptidase 1,40192,-0.0249249276071077,0.00494389594511549,-0.0346149636595341,-0.0152348915546813,4.66890333545376e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR1,Folate receptor alpha,40299,0.0138951813645463,0.00276071567077651,0.00848417864982438,0.0193061840792683,4.8769462123213e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD6,Programmed cell death protein 6,40359,-0.0341722145132621,0.00679605907137282,-0.0474924902931528,-0.0208519387333713,5.00386737162795e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD27,CD27 antigen,40411,0.0198098725318118,0.00395830349046259,0.0120515976905051,0.0275681473731185,5.65631570957893e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.010168699421823,0.00203572194170528,-0.0141587144275654,-0.00617868441608067,5.94316734127575e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUCA1,Tissue alpha-L-fucosidase,40437,0.0394721330238847,0.00790272387419517,0.0239827942304622,0.0549614718173072,5.95332533255908e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.0129735893693389,0.00259943805979858,0.0078786907721337,0.0180684879665442,6.07309947701052e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UROS,Uroporphyrinogen-III synthase,37572,0.03422022220369,0.00685691680788491,0.0207806652602356,0.0476597791471445,6.09594364097847e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPM3,Tropomyosin alpha-3 chain,37562,-0.020709432046327,0.00415076502853555,-0.0288449315022567,-0.0125739325903973,6.13736518589987e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1A,Protein phosphatase 1A,39980,0.015077278681551,0.0030235937794799,0.00915103487377035,0.0210035224893316,6.21326442291935e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD58,Lymphocyte function-associated antigen 3,40335,-0.00857574175089676,0.0017212374495493,-0.0119493671520134,-0.00520211634978012,6.34895822015433e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0150048869720981,0.0030129976764535,0.00909941152624927,0.020910362417947,6.42353528101583e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PADI2,Protein-arginine deiminase type-2,40044,0.0272116540668378,0.00546949139956269,0.0164914509236949,0.0379318572099806,6.58844361287515e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD109,CD109 antigen,40332,-0.0161479815438645,0.00325235567432878,-0.0225225986655489,-0.00977336442218007,6.94098694946663e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEK,Angiopoietin-1 receptor,40411,0.0103913107144154,0.00209382195854347,0.00628741967567021,0.0144952017531606,7.01844388529518e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0418752769022876,0.00844178913188243,-0.0584211836007771,-0.025329370203798,7.10724367524148e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPC1,Glypican-1,40489,0.0141476036177881,0.00285672665416511,0.00854841937562449,0.0197467878599517,7.40559232577692e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNPEP,Aspartyl aminopeptidase,37942,0.0287131131175159,0.00580232339056145,0.0173405592720155,0.0400856669630164,7.56687389428418e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB1A1,Uteroglobin,40384,0.0272474706056023,0.00552117293491257,0.0164259716531737,0.038068969558031,8.09241477733711e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0235264812806065,0.00477580383313767,0.0141659057676567,0.0328870567935564,8.48747053340321e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECE1,Endothelin-converting enzyme 1,39961,0.0168969506728768,0.00343226263391357,0.0101697159104062,0.0236241854353474,8.61135861816302e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRISP3,Cysteine-rich secretory protein 3,37875,-0.0129223191095197,0.00263367081119025,-0.0180843138994526,-0.0077603243195868,9.37650326569849e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0238014560552941,0.00485763192106893,0.014280497489999,0.0333224146205892,9.70403818973638e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD1,Bromodomain-containing protein 1,37714,-0.0148411179264547,0.00303214065254034,-0.0207841136054338,-0.00889812224747566,9.96642499926663e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD99,CD99 antigen,40332,-0.00924274606668856,0.0018901581098593,-0.0129474559620128,-0.00553803617136433,1.01856967463227e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.0158614982209009,0.00325132161503754,0.0094889078554273,0.0222340885863745,1.07941126624237e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0126244286252284,0.00258869246138763,0.00755059140090862,0.0176982658495481,1.08885340154419e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP3,Dual specificity protein phosphatase 3,39961,0.0402691224282055,0.00825748396460505,0.0240844538575796,0.0564537909988314,1.08954424259944e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAEP,Glycodelin,40228,-0.0621880488709346,0.0127933310359881,-0.0872629777014713,-0.0371131200403979,1.1793351530015e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMMD9,COMM domain-containing protein 9,37900,0.0186207267756946,0.00383407345548748,0.0111059428029391,0.0261355107484501,1.20736294528537e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSAB1,Tryptase alpha/beta-1,40498,0.0249265195682225,0.00513337088100119,0.0148651126414602,0.0349879264949848,1.21043380820203e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0672774572177572,0.0138608580585959,0.0401101754229093,0.0944447390126051,1.22313319065783e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK14,Kallikrein-14,40489,-0.0216561911804193,0.00447188813849217,-0.030421091931864,-0.0128912904289746,1.29255410124927e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD48,CD48 antigen,40396,0.0138106111227621,0.00285531871990627,0.00821418643174586,0.0194070358137784,1.33176907094292e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HYAL1,Hyaluronidase-1,40214,0.0107898443143355,0.00223791640789849,0.00640352815485447,0.0151761604738166,1.43899079256202e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G1B,Phospholipase A2,40514,-0.0196710193166765,0.00408135565254603,-0.0276704763956667,-0.0116715622376863,1.45069363688726e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK8,Kallikrein-8,39801,0.0166374194023475,0.00345657271334506,0.00986253688419116,0.0234123019205038,1.49893719307608e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0257614472081196,0.00536922388075209,-0.0362851260143937,-0.0152377684018455,1.61726865672231e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD14,Monocyte differentiation antigen CD14,40048,0.0193616056237941,0.00404364646263106,0.0114360585570372,0.0272871526905509,1.69867217003355e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.0204294338173399,0.00426900041289846,0.0120621930080589,0.0287966746266209,1.72341056868711e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG4,Desmoglein-4,40250,0.0236854066573957,0.00495036213084165,0.0139826968809461,0.0333881164338454,1.72893331070728e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRUNE2,Protein prune homolog 2,37714,0.0137824281405165,0.00288939488627631,0.00811921416341493,0.0194456421176181,1.86182792452597e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRAL,GDNF family receptor alpha-like,37477,-0.0288553876170767,0.00605075234887976,-0.0407148622208811,-0.0169959130132724,1.87248019962422e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.0122426047321322,0.00257034672825542,0.00720472514475161,0.0172804843195128,1.92395557922665e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0132631540412399,0.0027984923246567,0.00777810908491275,0.018748198997567,2.16235576072761e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIT,Vitrin,37990,0.0170381964075103,0.00359554130651827,0.00999093544673449,0.0240854573682861,2.17279248482794e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO1,Alpha-enolase,40299,0.0365534591005587,0.00771610035371346,0.0214299024072803,0.0516770157938371,2.18465722595945e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSPN,Persephin,40341,0.0457566596271694,0.00968014075888013,0.0267835837397643,0.0647297355145744,2.29974861708886e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0223949114106796,0.00474187067771316,-0.0316889779389974,-0.0131008448823618,2.35016341022612e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LUZP2,Leucine zipper protein 2,37900,0.0205875014040143,0.00436243395324791,0.0120371308556485,0.0291378719523802,2.39077803878299e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYTL1,Cytokine-like protein 1,37998,0.0105850192242773,0.0022434959134272,0.00618776723396004,0.0149822712145946,2.40446144042882e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,37598,-0.0148542759217714,0.00314933532580163,-0.0210269731603426,-0.00868157868320018,2.42239433427442e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSHB,Follitropin subunit beta,37628,0.032189489539347,0.00682920249960916,0.018804252640113,0.045574726438581,2.45982357509594e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0185210242969331,0.00394130105882958,-0.026245974372239,-0.0107960742216271,2.63817728556445e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNPY2,Protein canopy homolog 2,40042,0.027934147884571,0.00595535625146735,0.016261649631695,0.039606646137447,2.74726676069356e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITM2A,Integral membrane protein 2A,40341,-0.0266028512634514,0.00575945732336941,-0.0378913876172555,-0.0153143149096474,3.88645808162691e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NELL1,Protein kinase C-binding protein NELL1,40411,-0.0190530724136458,0.00413344660342594,-0.0271546277563606,-0.0109515170709309,4.06790089553668e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.030897983938653,0.00670636083533915,0.0177535167013883,0.0440424511759177,4.11799277615033e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOSB,Protein fosB,39961,0.0175182260026804,0.00380781849097821,0.0100549017603631,0.0249815502449977,4.24623295953116e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPK13,Mitogen-activated protein kinase 13,37482,0.018563957689822,0.00403683144490998,0.0106517680577985,0.0264761473218456,4.29248748139338e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO2,Roundabout homolog 2,40471,0.0104194882131918,0.002266246099898,0.00597764585739172,0.0148613305689919,4.30474865741715e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELAVL4,ELAV-like protein 4,37541,0.0391792942408561,0.00852674234194894,0.0224668792506362,0.0558917092310761,4.37058295284362e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA9,Carbonic anhydrase 9,40489,-0.0201254639619513,0.00438075397106822,-0.028711741745245,-0.0115391861786576,4.38005387139938e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOC,Myocilin,40332,-0.0204484448818132,0.00446256943238365,-0.0291950809692851,-0.0117018087943412,4.63582695174217e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0150555114331503,0.00328791756325669,0.00861119300916721,0.0214998298571334,4.70634967772786e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD160,CD160 antigen,40516,0.0203197442458594,0.00444864998000977,0.0116003902850402,0.0290390982066785,4.9695927214141e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIL1,Nucleotide exchange factor SIL1,37628,0.0142887993003675,0.00312983269625728,0.00815432721570325,0.0204232713850318,5.03161618936771e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLASP1,CLIP-associating protein 1,37482,0.0318429969899563,0.00698129312084935,0.0181596624730916,0.045526331506821,5.1328713788425e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0277728157462811,0.00610645290457052,0.0158041680533228,0.0397414634392393,5.45378786282833e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.0158929803159558,0.00350910720086398,0.00901513020226242,0.0227708304296492,5.9676763591773e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPO,Erythropoietin,40341,0.0343398985820943,0.00762441434542459,0.0193960464650621,0.0492837506991265,6.71803140881162e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0217373985595957,0.004834891634303,0.0122610109563619,0.0312137861628296,6.98557942211495e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS5,Transmembrane protease serine 5,40159,-0.0165150143703246,0.00367622174621952,-0.0237204089929148,-0.00930961974773428,7.09313494982334e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0172799431400723,0.0038472992684763,0.00973923657385879,0.0248206497062859,7.13298213251026e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLL4,Delta-like protein 4,37628,0.0370439841036064,0.00824840395008321,0.0208771123614434,0.0532108558457695,7.14756204119436e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX18,Sorting nexin-18,37901,0.0199012544580588,0.00444005273919904,0.0111987510892286,0.0286037578268889,7.44839215204078e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.0255677537837992,0.00571629069674738,0.0143638240181744,0.0367716835494241,7.77543066845397e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP9,Matrix metalloproteinase-9,40312,0.0265565635316765,0.00595043704689269,0.0148937069197668,0.0382194201435862,8.1391903056419e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0255805735157684,0.00574946197400241,0.0143116280467237,0.0368495189848131,8.6873254921663e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALPI,Intestinal-type alkaline phosphatase,37598,0.0525880071906966,0.0118613496807824,0.0293397618163631,0.0758362525650302,9.34410515188055e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.0142334111972526,0.00321718627614336,-0.0205390962984936,-0.00792772609601165,9.74451934046524e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1R1,Interleukin-1 receptor type 1,40303,-0.00961420140865765,0.00217319108635724,-0.0138736559379178,-0.00535474687939746,9.75349041342329e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1D,V-type proton ATPase subunit D,40305,0.01130858833017,0.00255951136730918,0.00629194605024399,0.016325230610096,1.00158124374344e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDI2,Protein DDI1 homolog 2,37671,0.0337200764510711,0.00763293571960565,0.0187595224406441,0.0486806304614982,1.00546579293791e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL19,Interleukin-19,39924,0.029229650674169,0.00661743688274971,0.0162594743839796,0.0421998269643584,1.00729088362119e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.0156031117749239,0.00353290301961474,0.00867862185647904,0.0225276016933688,1.00968865078144e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",37541,0.0265963833030522,0.00602480511563223,0.014787765276413,0.0384050013296914,1.02063856100823e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CR2,Complement receptor type 2,40403,0.0199555760300512,0.00452548507935634,0.0110856252745127,0.0288255267855896,1.04239382559192e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF16,Fibroblast growth factor 16,37598,0.0211532922939585,0.00480263067844668,0.0117401361642031,0.030566448423714,1.06855487174996e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EP300,Histone acetyltransferase p300,37598,0.0128357129214621,0.00291524293799803,0.007121836762986,0.0185495890799383,1.07624330044939e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPA2,Replication protein A 32 kDa subunit,37598,0.0140149911366011,0.00318878259231082,0.00776497725567193,0.0202650050175303,1.11594275445113e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.025417504779213,0.00578565602323196,0.0140776189736784,0.0367573905847477,1.12564423726615e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PI16,Peptidase inhibitor 16,37987,-0.0105436115183208,0.00240263318893547,-0.0152527725686343,-0.00583445046800724,1.15074900616644e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SATB1,DNA-binding protein SATB1,37959,0.0128931224841253,0.00294298131096112,0.00712487911464148,0.0186613658536091,1.19040851924907e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XG,Glycoprotein Xg,40458,0.0127419723425901,0.00291491424990859,0.00702874041276921,0.0184552042724109,1.24286034269119e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGMA,Repulsive guidance molecule A,40471,-0.0131545622312562,0.00301174989563008,-0.0190575920266911,-0.00725153243582124,1.26322914059469e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK4,Kallikrein-4,40489,-0.0258556690180868,0.0059211233495951,-0.0374610707832931,-0.0142502672528804,1.26938037567935e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB2A2,Mammaglobin-A,37562,-0.0136871261711239,0.00313591426580508,-0.0198335181321018,-0.00754073421014591,1.28309073066512e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB6,Integrin beta-6,40044,0.0127934354606936,0.00294169106130626,0.00702772098053332,0.0185591499408539,1.3762313798552e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0240393983604049,0.00554774793574334,0.0131658124063479,0.0349129843144618,1.4789348597976e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKAP12,A-kinase anchor protein 12,37671,-0.0092123630158416,0.00212901082836395,-0.0133852242394349,-0.00503950179224825,1.52220997126415e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAN,Neurocan core protein,40471,-0.015677443981527,0.00362864284316692,-0.0227895839541342,-0.00856530400891987,1.56634734265709e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDN1,Endothelin-1,37628,0.0122888192459312,0.00284515243647987,0.00671232047043065,0.0178653180214317,1.57732566175703e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNU13,NHP2-like protein 1,37562,0.02629919569146,0.00609863906617673,0.0143458631217536,0.0382525282611664,1.62741933329301e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MILR1,Allergin-1,40044,-0.0209420946936366,0.00486910384820561,-0.0304855382361196,-0.0113986511511537,1.71050762131689e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHB6,Ephrin type-B receptor 6,40192,0.013026486455941,0.00303767621351976,0.0070726410774423,0.0189803318344398,1.8111321388164e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBS4,Thrombospondin-4,40355,0.0187504937288272,0.00439004446081927,0.0101460065856214,0.0273549808720329,1.95605709217653e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LHB,Lutropin subunit beta,39980,0.0353063359376583,0.00827061859994649,0.0190959234817631,0.0515167483935534,1.97616795275593e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMG4,Proteasome assembly chaperone 4,37598,0.0235125558522763,0.0055127231383311,0.0127076185011473,0.0343174932034052,2.01170120297184e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.014280317720076,0.00334984647020945,0.00771461863846546,0.0208460168016865,2.02886010763417e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0216461350909221,0.0050954230567392,-0.0316331642821309,-0.0116591058997132,2.17028452488874e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0249084179191078,0.00587421549546207,0.0133949555480022,0.0364218802902135,2.24510367948835e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO4,Roundabout homolog 4,37628,-0.00739274328945662,0.00174849584297583,-0.0108197951416893,-0.003965691437224,2.37306201744768e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.020012385174851,0.00474349185097882,0.0107151411469325,0.0293096292027695,2.47083596033133e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.0136303710746524,0.00323557983530797,-0.019972107551856,-0.00728863459744882,2.53776318255555e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST6,Cystatin-M,39992,0.0195933555167768,0.00466149994244544,0.0104568156295837,0.0287298954039698,2.64604184414834e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP8,Neutrophil collagenase,40442,0.0298861998958844,0.0071271510047599,0.015916983926555,0.0438554158652138,2.76419718977066e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0148596065661772,0.00355393987588796,0.00789388440943684,0.0218253287229177,2.91557346381644e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00797797770025409,0.00190893567476174,-0.0117194916227871,-0.00423646377772108,2.94266308070584e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0215080908410514,0.00517237537806541,0.0113702351000433,0.0316459465820596,3.22667399165592e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRDL2,Chordin-like protein 2,40359,0.0229912972524466,0.00554496429610946,0.012123167232072,0.0338594272728211,3.39586327566933e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD5,Sushi domain-containing protein 5,37604,-0.0138561576221962,0.00334293895597133,-0.0204083179759,-0.00730399726849238,3.42087489308397e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0290839657888944,0.00702871831731979,0.0153076778869476,0.0428602536908412,3.52326256924644e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSTL1,Follistatin-related protein 1,37628,-0.00907180870599661,0.00219945216018831,-0.0133827349399657,-0.00476088247202753,3.73697171989029e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.0602905078387194,0.0146540714376113,0.0315685278210012,0.0890124878564376,3.90398465957483e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,L1CAM,Neural cell adhesion molecule L1,40411,-0.0113298856484712,0.00275444495859483,-0.0167285977673171,-0.00593117352962536,3.91981477513831e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0139622484911958,0.00339701174861653,0.00730410546390736,0.0206203915184841,3.97355152820395e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLU,Clusterin,38013,0.0132593996294875,0.00322747314789408,0.00693355225961508,0.0195852469993599,4.00938639711574e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINI1,Neuroserpin,37642,0.0127356288753158,0.00311405312946875,0.00663208474155711,0.0188391730090746,4.34444014246396e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL15,Interleukin-15,40341,0.0130003218165558,0.00319346704582267,0.00674112640674341,0.0192595172263683,4.70562195759217e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICOSLG,ICOS ligand,40305,0.00756893636758426,0.00186003645893727,0.00392326490806721,0.0112146078271013,4.73950475614987e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,39961,0.0152563453043597,0.0037566535875095,0.00789330427284107,0.0226193863358783,4.90709164193328e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARG1,Arginase-1,40227,0.0208930160249145,0.00514553374738622,0.0108077698800375,0.0309782621697915,4.92215200146103e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0214932741017239,0.0052941299447087,0.0111167794100949,0.031869768793353,4.93853896249278e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC7A,C-type lectin domain family 7 member A,40516,0.0231311712532057,0.00570543756488153,0.0119485136260379,0.0343138288803735,5.05362371775053e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0245434251340698,0.00605682171317278,0.0126720545762511,0.0364147956918884,5.10323453498875e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECM1,Extracellular matrix protein 1,37655,0.014611060066183,0.00361301540853546,0.00752954986545348,0.0216925702669125,5.28439108365842e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM2,Myomesin-2,37562,-0.0185759036502087,0.00459507843526704,-0.0275822573833321,-0.00956954991708533,5.31717896222508e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.0172736268455592,0.00427328190749761,0.00889799430686391,0.0256492593842545,5.32448823118051e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMS1,PMS1 protein homolog 1,37572,0.0205376495397834,0.00508450295271484,0.0105720237524623,0.0305032753271045,5.39244568366305e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG1B,Lithostathine-1-beta,40536,0.0219410258257772,0.00544200454330525,0.0112746969208989,0.0326073547306555,5.56085281519517e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPTC,Opticin,40305,-0.0176698859543032,0.00438538666201228,-0.0262652438118473,-0.00907452809675916,5.62125286238045e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERC2,ERC protein 2,37572,0.0302648436295859,0.0075226128928055,0.0155205223596871,0.0450091648994846,5.77389679271278e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX5,Syntaxin-5,37598,0.0164531221917115,0.00409409010645668,0.00842870558305638,0.0244775388003666,5.88339236151387e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF1,Trefoil factor 1,40261,0.0302606239413365,0.00756784700549173,0.0154276438105727,0.0450936040721003,6.40139106258653e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0406536041324244,0.0101680293714563,0.0207242665643701,0.0605829417004787,6.41222255639634e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIFR,Leukemia inhibitory factor receptor,40341,-0.00953190715015896,0.00238531558276237,-0.0142071256923732,-0.00485668860794472,6.46910643889481e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA4,Apolipoprotein A-IV,38013,0.0143439891819773,0.00358992297612598,0.00730774014877037,0.0213802382151842,6.48645783674382e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00603312044579122,0.00151122422633535,0.00307112096217393,0.0089951199294085,6.57517709005688e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALB1,Calbindin,40305,0.0164380606413724,0.00412643242084304,0.00835025309652009,0.0245258681862248,6.81820970023143e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FMR1,Synaptic functional regulator FMR1,39980,0.0136243486870346,0.00342338231279009,0.00691451935396605,0.0203341780201032,6.92892037629296e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAA4,Serum amyloid A-4 protein,38013,0.0126761065444654,0.00318514665962419,0.00643321909160196,0.0189189939973288,6.9345179451681e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM5,Intercellular adhesion molecule 5,40359,0.0170644940524771,0.00429702004156352,0.00864233477101256,0.0254866533339416,7.18144529569656e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAP,Cartilage-associated protein,37572,0.018775362742398,0.00473511708365341,0.00949453325843726,0.0280561922263586,7.37447228227516e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0238755413030814,0.0060603121550489,0.0119973294791856,0.0357537531269773,8.20195248935161e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF2,Trefoil factor 2,40396,0.0217909495281719,0.00554942511060454,0.010914076311387,0.0326678227449568,8.64801993235152e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.0135804113977363,0.0034745918362145,0.00677021139875585,0.0203906113967167,9.32669773428952e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0145728022377834,0.00372963205930477,0.00726272340154605,0.0218828810740207,9.3788511686826e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.022706412907272,0.00581476661592132,0.0113094703400662,0.0341033554744778,9.4717437776719e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RCC1,Regulator of chromosome condensation,37900,0.0194391832886648,0.0049921078600498,0.00965465188296719,0.0292237146943624,9.90882513119327e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYMP,Thymidine phosphorylase,40257,0.0252357453844446,0.00649016362306411,0.0125150246832389,0.0379564660856502,0.000101358927514247
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JUN,Transcription factor AP-1,40044,0.0195054358077575,0.00505738095520994,0.00959296913554605,0.029417902479969,0.000115330890902116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0290801711928424,0.00756312622909043,0.0142564437838252,0.0439038986018597,0.000121129036465826
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.0119215095792886,0.00311304649177122,-0.0180230807031602,-0.00581993845541706,0.000128985209307364
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NME1,Nucleoside diphosphate kinase A,37598,-0.00822044885269341,0.0021473344400755,-0.0124292243552414,-0.00401167335014543,0.000129676737751777
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TK1,"Thymidine kinase, cytosolic",37714,0.0166663107069545,0.00437410236140087,0.0080930700786088,0.0252395513353002,0.000139467751513285
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0204340682002861,0.0053845192719726,0.00988041042721982,0.0309877259733524,0.000148225099266772
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0191450457091035,0.00505341377085684,0.00924035471822415,0.029049736699983,0.000152197358403041
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0179382479092377,0.00473642296557606,0.00865485889670863,0.0272216369217668,0.000152868747529316
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.016535690061499,0.00437616680631741,0.0079584031211169,0.0251129770018811,0.000158303315341452
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.0231032812231913,0.00612373928713941,-0.0351058102259845,-0.011100752220398,0.000162051454744902
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP9,Fatty acid-binding protein 9,40341,0.0204776568005378,0.0054438214360073,0.00980776678596348,0.0311475468151121,0.000169413834897759
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDHB15,Protocadherin beta-15,37900,-0.0147701809719915,0.00393701712763649,-0.022486734542159,-0.00705362740182396,0.000176435588285838
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0141028999779136,0.00376086512951158,-0.0214741956317563,-0.00673160432407096,0.000177661245241384
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC13A1,Solute carrier family 13 member 1,37900,0.0227065426931989,0.00606847004078475,0.0108123414132608,0.034600743973137,0.000183521892671045
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.0110094846502655,0.00294367004359506,0.00523989136481916,0.0167790779357118,0.000184642180362385
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.0125130388133908,0.00335381026006367,-0.0190865069231156,-0.00593957070366598,0.000191533570222697
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.0106369394053389,0.00285555532980152,0.00504005095892794,0.0162338278517499,0.000196140689750157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.0114277663918231,0.00306929411177586,0.00541194993274243,0.0174435828509038,0.000197350051184041
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0129527727254073,0.00348176354289041,0.00612851618134213,0.0197770292694725,0.000199894214616514
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0146754382729208,0.00395610684834106,0.00692146885017228,0.0224294076956692,0.000208473643517578
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0142915416680863,0.00385890581986246,0.00672808626115586,0.0218549970750167,0.000213364497978818
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSHB,Thyrotropin subunit beta,40359,0.0302002448196595,0.00816689428068841,0.0141931320295102,0.0462073576098088,0.000218133437149324
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPOCK1,Testican-1,40228,0.0090486893661363,0.00244777559995506,0.00425104919022438,0.0138463295420482,0.000219160823681356
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL6,Fc receptor-like protein 6,40341,0.024299545999133,0.00657872161343508,0.0114052516368003,0.0371938403614658,0.000221792244163372
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLIC5,Chloride intracellular channel protein 5,37572,-0.0116534779564911,0.00315627455509554,-0.0178397760844783,-0.00546717982850378,0.000223256953199915
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C8B,Complement component C8 beta chain,38013,0.0109989579124344,0.00297912569364451,0.00515987155289111,0.0168380442719776,0.000223362385383977
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENG,Endoglin,40536,-0.00612587706871414,0.00166012039338429,-0.00937971303974735,-0.00287204109768093,0.000224976398237262
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB39B,Ras-related protein Rab-39B,37562,0.0321167643263503,0.00871439413913471,0.0150365518136462,0.0491969768390543,0.000229187870198554
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL3,Myosin light chain 3,37628,-0.0245798808994706,0.00668705713631005,-0.0376865128866383,-0.0114732489123029,0.000238102818339668
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0193481421155411,0.00526495582958429,0.00902882868955592,0.0296674555415263,0.000238898245714794
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL5A1,Collagen alpha-1(V) chain,37671,0.0142546508114972,0.00388147256462154,0.00664696458483895,0.0218623370381554,0.000241150320693937
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAV,Integrin alpha-V,40489,-0.00584966641310014,0.00159363594427992,-0.00897319286388878,-0.0027261399623115,0.000242727227827171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.00948238440075001,0.00258434760702524,0.00441706309098054,0.0145477057105195,0.000244282816882734
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM26,Tripartite motif-containing protein 26,37482,0.019739991973596,0.00538174644215314,0.00919176894697589,0.0302882150002162,0.000245474040549662
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH1,Protocadherin-1,40475,0.00775744205452927,0.00212083231211496,0.00360061072278394,0.0119142733862746,0.000255269476059821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0194414135527046,0.00531553261181344,-0.029859857471859,-0.00902296963355026,0.000255713778653874
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0256588834113755,0.00701723395751851,0.0119051048546392,0.0394126619681118,0.00025661882401426
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLPS,Colipase,40311,0.0243591101057202,0.00667530833090799,0.0112755057771406,0.0374427144342999,0.000263967771928985
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RLN2,Prorelaxin H2,37643,0.0497817861862222,0.0137733023099929,0.0227861136586362,0.0767774587138082,0.000302201695773535
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTN2,Alpha-actinin-2,37562,-0.0193167126221044,0.00534719140657469,-0.0297972077789908,-0.00883621746521797,0.000304396374070073
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBLN2,Fibulin-2,37998,-0.0108718772362746,0.00301146431689798,-0.0167743472973946,-0.00496940717515454,0.00030710897484776
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.0100276852462487,0.00277792735982626,0.00458294762098921,0.0154724228715081,0.0003075795889441
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMI,N-myc-interactor,37857,0.0252033164910524,0.00699356424426276,0.0114959305722974,0.0389107024098074,0.000314750225879189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.0126825118555964,0.00352019590805927,0.00578292787580026,0.0195820958353926,0.000315976674708205
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0136098494103081,0.00378235378030364,-0.0210232628197032,-0.00619643600091292,0.000321509252926642
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.0122594696630108,0.00341132624762427,0.00557327021766723,0.0189456691083544,0.000326951434000733
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0137272219588354,0.00383671804305611,-0.0212471893232253,-0.00620725459444537,0.000347673320702096
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.00931918708343583,0.00260517698774829,-0.0144253339794225,-0.00421304018744918,0.000348535629736939
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH23,Cadherin-23,37942,-0.00923612970792477,0.00258298821662966,-0.0142987866125189,-0.00417347280333065,0.000350441314728353
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHNAK2,Protein AHNAK2,37628,0.0100104952470887,0.00280016567781997,0.00452217051856153,0.0154988199756158,0.000351527173949301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA1549,UPF0606 protein KIAA1549,37714,0.0247177337742805,0.00693535828293047,0.0111244315397368,0.0383110360088242,0.00036650554540682
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGA,Glycoprotein hormones alpha chain,40332,0.0309834214348421,0.00872206263321012,0.0138881786737503,0.0480786641959339,0.000382979276144094
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL9A2,Collagen alpha-2(IX) chain,37714,0.0160790611191472,0.00453808339550615,0.00718441766395511,0.0249737045743392,0.000396752802349834
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL34,Interleukin-34,39934,0.0123822417377743,0.00349591263078673,0.00553025298143232,0.0192342304941163,0.000398394115728805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.0151670770989102,0.00430339868662193,0.00673241567313119,0.0236017385246891,0.000425786531256607
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0149683899379467,0.0042679359508635,-0.0233335444016392,-0.00660323547425425,0.000454419454754249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AREG,Amphiregulin,40305,0.0168827239017352,0.00481756605061749,0.00744029444252494,0.0263251533609455,0.000458883696813614
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM1,Myomesin-1,37541,0.0160621896024209,0.00458456333688003,0.00707644546213607,0.0250479337427058,0.000460654969667941
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDK1,Cyclin-dependent kinase 1,37482,0.012527919829548,0.00358091047298275,0.00550933530250181,0.0195465043565942,0.000469392648564216
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX3,Syntaxin-3,37942,0.0132264143281779,0.00378095373002698,0.00581574501732504,0.0206370836390308,0.000469973514551894
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0168581038838664,0.00482295580774628,0.0074051105006837,0.0263110972670491,0.000474694491722476
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.0195806996049672,0.00563345746672052,-0.0306222762397394,-0.00853912297019495,0.000510720102942837
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0138796570732213,0.00399661693015368,-0.0217130262563225,-0.0060462878901201,0.000516621422804825
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.0108579591816453,0.00313889888191575,0.00470571737309039,0.0170102009902001,0.000543295915334373
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0115105224889847,0.00334214698023413,0.00495991440772583,0.0180611305702436,0.000574852128547348
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.00946385529844583,0.00275659221236425,-0.0148667760346798,-0.0040609345622119,0.000598095379430203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PODXL,Podocalyxin,40305,0.00504498009913832,0.00147908841957337,0.00214596679677451,0.00794399340150213,0.000649171866128928
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.0140907092580879,0.00413796346743897,0.00598030086190755,0.0222011176542683,0.000663060254661876
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUP50,Nuclear pore complex protein Nup50,37562,-0.0118134305809036,0.00347744548555859,-0.0186292237325985,-0.00499763742920879,0.000682920658020263
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA3,GDNF family receptor alpha-3,40194,-0.00943667465569427,0.00277845143735191,-0.014882439472904,-0.00399090983848452,0.000684525126728347
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0128878567222221,0.00379552746836626,0.00544862288422423,0.02032709056022,0.000686969601615217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAFB2,Scaffold attachment factor B2,37959,0.00916190773243343,0.00270608432291884,0.00385798245951251,0.0144658330053544,0.000712070222138627
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.0088892555412391,0.00262726122366295,0.00373982354285971,0.0140386875396185,0.000717797923535328
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EXTL1,Exostosin-like 1,37562,0.0157944775929683,0.00466993570437781,0.00664140361238785,0.0249475515735488,0.000721280339286221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00882566033757095,0.00260974508026957,-0.0139407606948993,-0.00371055998024258,0.000722194642605917
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEO1,RNA polymerase-associated protein LEO1,37959,0.0102152381641592,0.00302741175681396,0.0042815111208038,0.0161489652075145,0.000742258263444273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0203005102747453,0.00601664542451435,-0.0320931353067934,-0.00850788524269716,0.000742837169943093
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MKI67,Proliferation marker protein Ki-67,37598,0.0124529817030397,0.00369144481532092,0.00521774986501073,0.0196882135410687,0.000744412158652642
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,0.0127899896796506,0.00379731305506289,0.00534725609172729,0.0202327232675738,0.000758494279240557
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSAPL1,Proactivator polypeptide-like 1,37901,-0.0165995594374332,0.00494251197095248,-0.0262868829005001,-0.00691223597436636,0.00078576631929834
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN1,Nectin-1,37598,0.0104626437649903,0.00312158790477052,0.00434433147164006,0.0165809560583405,0.000805417661776079
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FDX1,"Adrenodoxin, mitochondrial",37562,0.0205497209826379,0.00615160923001905,0.00849256689180053,0.0326068750734752,0.000838478840086254
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00813642042272522,0.00243675990801911,-0.0129124698424427,-0.00336037100300777,0.00084297644863369
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEFL,Neurofilament light polypeptide,39903,0.0137969181379128,0.00415905252043772,0.00564517519785485,0.0219486610779707,0.000910944391149944
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFD,Complement factor D,38013,0.00615299115648309,0.00185759377914706,0.00251210734935484,0.00979387496361133,0.00092759400941317
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0578245543811408,0.0175072060881028,0.0235104304484593,0.0921386783138222,0.000959025008216745
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA7A,Semaphorin-7A,40490,0.00861223494207651,0.00261975291411523,0.00347751923041066,0.0137469506537424,0.00101326381386232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYB5A,Cytochrome b5,37482,0.0235323771936077,0.00718265259167072,0.00945437811393311,0.0376103762732823,0.00105459364572875
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAT1,Diamine acetyltransferase 1,37562,-0.016704569553313,0.0051134191690975,-0.0267268711247441,-0.00668226798188186,0.00109046159410616
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.02791650543894,0.00858245590614993,0.0110948918628862,0.0447381190149939,0.00114585992243716
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA4,Carboxypeptidase A4,37410,0.0139447277414961,0.00429237082303905,0.00553168092833959,0.0223577745546527,0.00116219258628837
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.0184620055631225,0.0056838632974583,0.00732163350010427,0.0296023776261408,0.00116403454297401
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBPMS,RNA-binding protein with multiple splicing,37598,0.020457027649026,0.00631990139400215,0.00807002091678178,0.0328440343812702,0.00121125804742891
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00797448981458862,0.00246410048068868,0.00314485287243881,0.0128041267567384,0.00121349316766516
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.018978095017498,0.00586495715583697,-0.0304734110429384,-0.00748277899205751,0.00121583970316698
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWF,von Willebrand factor,40536,-0.0224863454365327,0.00696298048432252,-0.0361337871858048,-0.00883890368726051,0.00124293272697814
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN2B,Sodium channel subunit beta-2,37572,-0.00934840429095853,0.00290219815924651,-0.0150367126830817,-0.00366009589883538,0.0012799033694218
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TERF1,Telomeric repeat-binding factor 1,37598,-0.00933005226071999,0.0029064080981592,-0.015026612133112,-0.00363349238832796,0.00132977122660231
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPP1,Osteopontin,40497,-0.0148890476603762,0.00463841098361705,-0.0239803331882656,-0.00579776213248678,0.00133021284817201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.01846738006782,0.0057620073158315,0.00717384572879027,0.0297609144068498,0.00135320501309894
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0189537531578839,0.00591373497929975,0.00736283259845643,0.0305446737173114,0.00135367247309992
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0216775679230375,0.00678056113906841,0.00838766809046344,0.0349674677556116,0.00139130652141302
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF7,SLAM family member 7,40341,-0.0179626354257728,0.00562255522349002,-0.0289828436638132,-0.00694242718773234,0.00140227286496815
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.00973476732515982,0.00306213745853482,-0.0157365567438881,-0.00373297790643157,0.0014808600955934
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POF1B,Protein POF1B,37598,0.0144234287611625,0.00453714447269916,0.00553062559467216,0.0233162319276529,0.00148143921171377
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARTN,Artemin,40044,0.0137856249628371,0.00434533659836775,0.00526876523003632,0.0223024846956379,0.00151420318373062
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TUBB3,Tubulin beta-3 chain,37541,-0.00864272778146945,0.00272430565956751,-0.0139823668742218,-0.00330308868871713,0.00151507000515387
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC12A,C-type lectin domain family 12 member A,37598,0.00631104025312227,0.00200090943276198,0.00238925776490879,0.0102328227413358,0.00161364213230859
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.0149451759364645,0.00474581134901389,-0.0242469661805318,-0.00564338569239732,0.00164125059767487
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDA1,DET1- and DDB1-associated protein 1,37562,0.0125382571708563,0.00398886727830676,0.004720077305375,0.0203564370363375,0.00167419743344577
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00961495774942405,0.00307004458909776,0.00359767035479245,0.0156322451440557,0.0017408224649423
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0184335308414581,0.00590447508628142,0.00686075967234647,0.0300063020105697,0.00179976380046196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LXN,Latexin,40183,-0.0201540333809894,0.00645640738728309,-0.0328085918600643,-0.00749947490191457,0.00180224213974101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST1,Cystatin-SN,36179,0.0316693177412729,0.0101733677323274,0.0117295169859111,0.0516091184966346,0.00185664749548221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOB,Apolipoprotein B-100,37987,0.0067775259174784,0.00217856562380082,0.0025075372948288,0.011047514540128,0.00186840206012326
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN8,Tetraspanin-8,37901,0.031560461556209,0.0101488167321907,0.0116687807611153,0.0514521423513027,0.00187625796686342
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR1,Cadherin-related family member 1,39961,0.0132515302692678,0.00428340609336628,0.00485605432626987,0.0216470062122657,0.00198035377664441
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0201333876048124,0.00651019492949455,0.00737340554300306,0.0328933696666217,0.00198827563872899
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.00915232619338885,0.00297640469269661,0.0033185729957035,0.0149860793910742,0.00210962410795425
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAL,Galanin peptides,40422,-0.0186581667046246,0.00607943656848981,-0.0305738623788646,-0.00674247103038456,0.002150921210307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD2,T-cell surface antigen CD2,37562,0.0114631293323229,0.00373806302321005,0.00413652580683119,0.0187897328578146,0.00216952109932412
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTNNA1,Catenin alpha-1,37541,-0.010866122097302,0.00355471009142796,-0.0178333538765008,-0.00389889031810321,0.00224146732362264
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.011001938278061,0.00360949274432925,0.00392733249917569,0.0180765440569463,0.00230705181389795
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0171650313062374,0.00563255025716808,0.00612523280218798,0.0282048298102868,0.00231235383760897
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPH1,Neurexophilin-1,39961,0.0111283026317059,0.00367277652715536,0.00392966063848141,0.0183269446249304,0.00245002962673983
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMOD4,Tropomodulin-4,37482,-0.0124116736800456,0.00409886393797803,-0.0204454469984826,-0.00437790036160869,0.00246597193642505
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKCQ,Protein kinase C theta type,40044,0.0130466424099726,0.00433008048762441,0.00455968465422878,0.0215336001657165,0.00259072451285339
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP290,Centrosomal protein of 290 kDa,37714,0.0156863066364055,0.0052170672539471,0.00546085481866915,0.0259117584541418,0.00264569770775932
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIM,Vimentin,40042,0.03469911985797,0.0115439568761352,0.012072964380745,0.0573252753351949,0.00265282433423515
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX1,Peroxiredoxin-1,39953,-0.026082143698132,0.00868196667963907,-0.0430987983902246,-0.00906548900603946,0.00266727813171026
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0115847000557095,0.00387400801920609,0.00399164433806558,0.0191777557733535,0.00279070302197396
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRXN3,Neurexin-3,37572,0.0101634834379237,0.00340994128161067,0.0034799985259668,0.0168469683498806,0.00288263564497531
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0154703472839515,0.00519263013500231,0.00529279221934701,0.0256479023485561,0.00289441168256987
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.014918250930831,0.00501432411031374,0.00509017567461607,0.0247463261870459,0.00293317996980648
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100G,Protein S100-G,37959,-0.0128926007474691,0.00434791497505659,-0.02141451409858,-0.00437068739635814,0.0030297795456067
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0188920570103568,0.00638903366519144,-0.031414562994132,-0.0063695510265816,0.00311252629125862
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM171B,Protein FAM171B,37900,0.0079969951444572,0.00270666290626623,0.00269193584817539,0.013302054440739,0.00313658851707914
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0143131537043543,0.00485639672387449,-0.0238316912831483,-0.00479461612556029,0.00321049811934339
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSB,Lupus La protein,39961,0.0173501543419135,0.00588746977285004,0.00581071358712738,0.0288895950966995,0.00321389440883722
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK1,Kallikrein-1,40209,-0.0363446707373397,0.0124237507055899,-0.060695222120296,-0.0119941193543835,0.0034448385410337
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOC1,Apolipoprotein C-I,37981,0.0103037028324968,0.00353172241565142,0.00338152689782002,0.0172258787671736,0.00353461294623368
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAMDC2,MAM domain-containing protein 2,37990,-0.00964662280324413,0.00331586616445621,-0.0161457204855783,-0.00314752512090996,0.00362907786699142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00417495677376459,0.00143782052299343,0.00135682854869748,0.00699308499883171,0.00369413639133894
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00916616194295966,0.00316252552766178,-0.0153647119771767,-0.00296761190874258,0.00375635384006292
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM19,Probable RNA-binding protein 19,37562,-0.0135685726468108,0.0046854292695544,-0.0227520140151374,-0.0043851312784842,0.003786877893582
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.0121592548693838,0.00420065740034789,0.00392596636470196,0.0203925433740657,0.003801621359443
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.00808130976266321,0.00279530565752596,-0.0135601088514141,-0.00260251067391233,0.00384614298703389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP4,Dipeptidyl peptidase 4,40068,0.00839604021534414,0.00290991597270941,0.00269260490883369,0.0140994755218546,0.00391550595037399
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0251673851981507,0.00872643728922394,0.00806356811127182,0.0422712022850297,0.00393254478400236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0183103810745382,0.00635275454035079,0.00585898217545062,0.0307617799736257,0.00395365191127375
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDC1,Syndecan-1,40359,0.0112092607482494,0.00389806715396674,0.00356904912647458,0.0188494723700242,0.00403802620849887
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CENPJ,Centromere protein J,37714,0.0205458479051783,0.00717505441192733,0.00648274125780074,0.0346089545525559,0.00419631151053297
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTG,Protogenin,40489,0.00701324675835777,0.00245099036278232,0.00220930564730442,0.0118171878694111,0.0042232926538149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,-0.00878202433963751,0.00307080354887956,-0.0148007992954414,-0.00276324938383358,0.00424398702608917
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA3,Carbonic anhydrase 3,40500,0.0169511213607788,0.00594668499265804,0.00529561877516907,0.0286066239463886,0.00437039754112866
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNN,Tenascin-N,37998,0.0121802921912987,0.00427440777459146,0.00380245295309946,0.020558131429498,0.00438422117737613
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0174209492749509,0.00611515077318122,-0.0294066447903861,-0.00543525375951571,0.00439501663969399
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAG,S-arrestin,37541,-0.0148915986139598,0.00523141638457217,-0.0251451747277213,-0.00463802250019835,0.00442615851955166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0139998724630086,0.00492107670614192,0.00435456211897043,0.0236451828070468,0.00444952640167973
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00561128493524621,0.0019770050802556,-0.00948621489254719,-0.00173635497794523,0.00454277077586249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DRAXIN,Draxin,40228,0.0119600619555436,0.0042164854342062,0.0036957505044994,0.0202243734065877,0.00456690384064412
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3GL3,Endophilin-A3,37643,0.0230113433333264,0.00811726612083099,0.00710150173649762,0.0389211849301551,0.00459149308097059
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0246715430910565,0.00870695412583156,0.00760591300442661,0.0417371731776863,0.00461056084463302
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH4,Myosin-4,37562,-0.0131780684731493,0.00465827488624167,-0.0223082872501829,-0.00404784969611558,0.00467705830712528
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0104411194174508,0.00369726852842228,-0.0176877657331584,-0.00319447310174311,0.00474965023880278
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNL1,Thioredoxin-like protein 1,37525,0.0263376454246113,0.00934315321364529,0.00802506512586647,0.044650225723356,0.00482572407704233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSPN,Claspin,39925,0.00937466924090352,0.00332674657106422,0.00285424596161765,0.0158950925201894,0.00483897434639633
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.00805547850173448,0.00285943937273865,0.00245097733116672,0.0136599796723022,0.00485104741595964
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCB,Calcitonin gene-related peptide 2,37942,0.0109594883443068,0.0038989989920448,0.00331745031989905,0.0186015263687146,0.00494825523435062
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP164,Centrosomal protein of 164 kDa,40044,0.0175203539014485,0.00624297797117088,0.00528411707795359,0.0297565907249434,0.00501590728089495
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASN,Vasorin,40116,-0.0074777119337592,0.00267413451198556,-0.0127190155772509,-0.00223640829026749,0.00517525988469949
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00878428855368132,0.00314315682638116,-0.0149448759333884,-0.00262370117397423,0.00520177731753131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0122951043946476,0.00441364082810323,-0.02094584041773,-0.0036443683715653,0.00534740308961516
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC12A2,Solute carrier family 12 member 2,37562,-0.00776560465761389,0.00279913097160668,-0.013251901361963,-0.0022793079532648,0.00554003929832976
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMBN,Ameloblastin,40044,-0.00803597946663299,0.00289709773016517,-0.0137142910177567,-0.00235766791550926,0.00554710206621287
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTF4,Neurotrophin-4,39980,0.0110302542548321,0.00397991654967787,0.00322961781746348,0.0188308906922007,0.00558687212375847
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,-0.0120400396397054,0.00436487046800865,-0.0205951857570024,-0.00348489352240846,0.00581519752299254
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRR4,Proline-rich protein 4,37577,-0.0185684132874502,0.00673509903930399,-0.031769207404486,-0.00536761917041437,0.00584217103873922
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.00732685774340891,0.00266660088945634,0.00210032000007449,0.0125533954867433,0.00601059399773171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.00896850264787295,0.00326957713049428,-0.0153768738236417,-0.00256013147210417,0.00609465246510227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC14A,C-type lectin domain family 14 member A,40332,-0.00839853669392233,0.00306286519387567,-0.0144017524739186,-0.00239532091392602,0.0061124985942352
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSAP,Gamma-secretase-activating protein,39980,0.0238462398354185,0.00871388715580949,0.00676702101003189,0.0409254586608051,0.00621522942239899
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00611540106535115,0.0022431002291966,0.00171892461612583,0.0105118775145765,0.00641152064781599
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH22,Cadherin-22,37714,-0.00786736127047261,0.0028865009802916,-0.0135249031918441,-0.00220981934910107,0.00642747449317845
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.0175440746092384,0.00644919115011402,-0.0301844892634619,-0.00490365995501495,0.00652982259876637
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.00784979724477721,0.00288649723540346,0.00219226266338643,0.013507331826168,0.00654538525545212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD33,Myeloid cell surface antigen CD33,40411,0.0209773241673582,0.00772773759174848,0.0058309584875312,0.0361236898471852,0.00664373576196685
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL11,Interleukin-11,40044,0.0169142363391245,0.00623277000668176,0.00469800712602828,0.0291304655522208,0.00665976226128003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH7B,Myosin-7B,37482,-0.0121197539192004,0.00447357766961359,-0.0208879661516431,-0.00335154168675778,0.00675366764245988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLI2,Zinc finger protein GLI2,37598,-0.00890802940241672,0.00329377959843297,-0.0153638374153453,-0.0024522213894881,0.00684951873962047
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.0116663880991459,0.00432091921055689,-0.0201353897518374,-0.00319738644645443,0.00694329874735755
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00872536412075912,0.00323430726332318,0.00238612188464569,0.0150646063568725,0.00698958904265924
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSC1,Hamartin,37598,0.0200751364587969,0.00745946363994619,0.00545458772450241,0.0346956851930915,0.007127903054859
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.0100576472918206,0.00373901847914295,-0.0173861235109408,-0.0027291710727004,0.00715604085442783
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKD1,Polycystin-1,37990,0.00679146147351061,0.00252491779670707,0.00184262259196475,0.0117403003550565,0.00715878047756278
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUK1,Guanylate kinase,37562,-0.0105737114500482,0.00393152977572345,-0.0182795098104662,-0.00286791308963025,0.00716572317649122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEG1,Protein LEG1 homolog,37231,-0.0182816888071667,0.00680515347319702,-0.0316197896146329,-0.00494358799970056,0.00723096344262363
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR101,Probable G-protein coupled receptor 101,37541,-0.0169856864202044,0.00632755255027901,-0.0293876894187512,-0.00458368342165752,0.00727514431629781
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPEP2,Dipeptidase 2,40305,-0.00747466113248711,0.00279185483929317,-0.0129466966175017,-0.0020026256474725,0.00742923261896713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0762821622898398,0.0284981017759055,0.0204258828090652,0.132138441770615,0.00744173414912631
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00681372292190632,0.00254841343324269,-0.011808613251062,-0.00181883259275064,0.0075107237634059
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTTG1,Securin,37714,0.010813090976289,0.00404670970369569,0.00288153995704547,0.0187446419955326,0.00754770929090031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDRG1,Protein NDRG1,39961,0.0178025876945927,0.00670195783059049,0.0046667503466353,0.03093842504255,0.00790779397580645
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHB4,Ephrin type-B receptor 4,40536,-0.00636365438029162,0.00239883293160335,-0.0110653669262342,-0.00166194183434906,0.00799025474283249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELENOP,Selenoprotein P,38013,-0.00584067174808996,0.00220498843055238,-0.0101624490719726,-0.00151889442420729,0.00808610269940661
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0177062502554428,0.00668530905760104,0.00460304450254477,0.0308094560083408,0.00809367697979907
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.0123753800585403,0.00467732848908876,0.00320781621992631,0.0215429438971542,0.00815874293659677
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6L,Seizure 6-like protein,40411,-0.00706931857060628,0.00267263123392264,-0.0123076757890947,-0.0018309613521179,0.00817520353535702
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN7,Septin-7,37714,0.0135243744558668,0.00513869510317166,0.00345253205365036,0.0235962168580833,0.00850148093086139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17A,Interleukin-17A,40028,0.0109535815631588,0.00416434134164203,0.00279147253354038,0.0191156905927771,0.00853865574116169
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX2,Peroxiredoxin-2,37763,0.0160833434123372,0.00612063025564384,0.00408690811127533,0.0280797787133992,0.00860561475497725
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.0146274780311493,0.00563525081143679,-0.0256725696215655,-0.00358238644073323,0.00945015273835406
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCN1,Transcobalamin-1,37766,0.00835867339673426,0.00322682330338242,0.00203409972210472,0.0146832470713638,0.00959766882648571
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLNS1A,Methylosome subunit pICln,37572,0.00850647371627226,0.00328861037607493,0.00206079737916539,0.0149521500533791,0.00970214884020316
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.0116707445294531,0.00451439888663583,0.00282252271164691,0.0205189663472594,0.00974049041886406
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.00923144043137595,0.00357435474362093,0.00222570513387894,0.016237175728873,0.00981414205066015
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QSOX1,Sulfhydryl oxidase 1,37761,0.0112862097533808,0.00437814302913625,0.0027050494162738,0.0198673700904879,0.00995227697487449
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA10,Annexin A10,39961,0.020700476600274,0.00804424165707586,0.00493376295240532,0.0364671902481427,0.0100817585542022
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0238351595991416,0.00927533824481336,0.00565549663930736,0.0420148225589757,0.0101883118987586
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDK2,Protein sidekick-2,37671,0.00957360198333678,0.00372700711897871,0.00226866803013851,0.0168785359365351,0.0102186466303322
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0155096230957781,0.00604705258108922,0.00365740003684318,0.0273618461547129,0.0103338262768753
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFR4,Fibroblast growth factor receptor 4,37671,0.0133599935131204,0.00522568932457252,0.00311764243695828,0.0236023445892826,0.0105811637816729
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACE,Angiotensin-converting enzyme,37987,-0.00635758381012905,0.00249286081816936,-0.011243591013741,-0.00147157660651711,0.0107734354518676
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.0106280982689551,0.00416914501129329,-0.0187996224910899,-0.00245657404682023,0.0108074968827031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACRV1,Acrosomal protein SP-10,37598,0.00877722871450086,0.0034472735745391,0.00202057250840423,0.0155338849205975,0.0109035702692006
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIRREL2,Kin of IRRE-like protein 2,39961,0.00993773830043846,0.00391125645910808,0.00227167564058662,0.0176038009602903,0.0110694322461609
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MELTF,Melanotransferrin,37990,0.00723283325893412,0.00285065249236299,0.00164555437390266,0.0128201121439656,0.0111836679015786
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL14,C-X-C motif chemokine 14,40044,0.0151839851219085,0.0059966926054537,0.00343046761521926,0.0269375026285978,0.0113491928980553
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEF,Thyrotroph embryonic factor,37562,0.0106663670533508,0.00421569001469386,0.00240361462455085,0.0189291194821508,0.0114126842115977
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TJP3,Tight junction protein ZO-3,37541,-0.0108743942303447,0.00430660614663997,-0.0193153422777591,-0.00243344618293036,0.011579907519295
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.007462178825169,0.00295577074321739,-0.0132554894818751,-0.00166886816846292,0.0115943311363338
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNW1,Interferon omega-1,37562,-0.00908510017073187,0.00360338323635027,-0.0161477313139784,-0.00202246902748533,0.0117049837613118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00759945199488017,0.00301710227886099,-0.0135129724614477,-0.00168593152831264,0.0117857934203092
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0101448765399602,0.0040298722348187,-0.0180434261202048,-0.00224632695971551,0.011833640643337
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.0120455718885568,0.00479736081232266,-0.0214483990807093,-0.00264274469640443,0.0120551680930229
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,40208,0.00984066376980966,0.0039288525796342,0.00214011271372662,0.0175412148258927,0.0122649576019484
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.00626451383624173,0.00251106241677677,0.00134283149935926,0.0111861961731242,0.0126140734418232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CORO6,Coronin-6,37541,-0.00886312065889559,0.00357051200704274,-0.0158613241926994,-0.00186491712509182,0.0130657775388007
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM3,Intercellular adhesion molecule 3,40536,-0.00610280743194999,0.00245868909254199,-0.0109218380533323,-0.00128377681056768,0.0130697693380455
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGFAC,Hepatocyte growth factor activator,37849,0.00700685662186967,0.00282586546723626,0.0014681603060866,0.0125455529376527,0.0131672676029136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCP2,Non-specific lipid-transfer protein,39980,0.0188561102003286,0.0076072623263304,0.003945876040721,0.0337663443599361,0.0131968095007638
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RALB,Ras-related protein Ral-B,37598,0.00715062233741153,0.00289668966458879,0.0014731105948175,0.0128281340800056,0.0135788072903999
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERVV_1,,37562,-0.0116740206663054,0.0047331035203935,-0.0209509035662766,-0.00239713776633412,0.0136582111248949
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPS,Calcyphosin,37942,0.0228591264994655,0.00927484460181121,0.0046804310799155,0.0410378219190154,0.0137275756931474
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANSC4,MANSC domain-containing protein 4,37562,0.0158165083750106,0.00643225482760379,0.00320928891290714,0.028423727837114,0.0139477395629021
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLH1,Glutamate carboxypeptidase 2,37598,0.0258156163328476,0.0105313850299096,0.00517410167422478,0.0464571309914703,0.0142469292821008
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.0120207906070665,0.00491470733471368,-0.0216536169831053,-0.00238796423102771,0.014462932498705
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBQ1,Hemoglobin subunit theta-1,40489,-0.0140482199147192,0.00575386810345198,-0.0253258013974851,-0.00277063843195333,0.0146360588161894
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0164636947516673,0.00674768548494619,-0.0296891583021618,-0.00323823120117274,0.014702106455919
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CADPS,Calcium-dependent secretion activator 1,37572,-0.0107173218676526,0.00440859462861341,-0.0193581673397349,-0.00207647639557026,0.0150702511928324
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA4,Ephrin type-A receptor 4,37671,0.0066887492420117,0.00275305100065792,0.00129276928072217,0.0120847292033012,0.0151296846732388
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.009525491919992,0.00392108667030733,0.00184016204618963,0.0172108217937944,0.0151413943538604
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRELP,Prolargin,40357,0.00547000410899819,0.00225974478986507,0.00104090432086266,0.00989910389713371,0.0155047984059475
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPN1,Epsin-1,37714,0.0104745399767242,0.00433021053632411,0.00198732732552894,0.0189617526279194,0.0155789752382736
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYO6,Unconventional myosin-VI,37959,0.00883421241804821,0.00366205580671792,0.00165658303688109,0.0160118417992153,0.0158626795565564
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00902624131324988,0.00374614535541402,-0.0163686862098614,-0.0016837964166384,0.015989208995241
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAD1,Glutamate decarboxylase 1,37482,-0.00608602615693592,0.00253141275623602,-0.0110475951591585,-0.00112445715471332,0.0162217095673332
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP6,Guanylate-binding protein 6,37562,-0.011086240670655,0.00464801163242025,-0.0201963434701987,-0.00197613787111136,0.0170859231724515
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,0.00806020795184601,0.0033805904077294,0.00143425075269637,0.0146861651509956,0.0171250994367461
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL33,Interleukin-33,40044,0.00898149521765731,0.00377540498789032,0.00158170144139228,0.0163812889939223,0.0173740520354003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INHBB,Inhibin beta B chain,37671,0.0119039610724178,0.00503233275027605,0.00204058888187674,0.0217673332629589,0.0180203063013916
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.0120666778284306,0.00510898112242297,-0.0220802808283797,-0.00205307482848161,0.0181982254597317
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRDL1,Chordin-like protein 1,40396,0.00701413160960765,0.00297138943312578,0.00119020832068113,0.0128380548985342,0.0182595246618114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.0210441803162843,0.00897177983017059,0.00345949184914993,0.0386288687834187,0.0190112845903301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD3,Bromodomain-containing protein 3,37562,0.0110624818484583,0.00473811131605086,0.0017757836689986,0.020349180027918,0.0195695521856633
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR4,Complement factor H-related protein 4,37973,0.0167030932514959,0.00715960395127603,0.0026702695069949,0.030735916995997,0.0196646607428377
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSLNL,Mesothelin-like protein,37572,-0.00857150982150218,0.00368035021476503,-0.0157849962424416,-0.00135802340056272,0.0198745429625246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NINJ1,Ninjurin-1,39980,0.0127186564959437,0.00549228801291656,0.00195377199062727,0.0234835410012602,0.0205859730808465
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA3G,Semaphorin-3G,37671,0.00976921248711399,0.00422281223866717,0.00149250049932634,0.0180459244749016,0.0207138595364404
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0112001079748714,0.00484856193206281,0.00169692658802833,0.0207032893617145,0.0209020179458592
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ODAM,Odontogenic ameloblast-associated protein,39934,0.0120576700940694,0.00522108639135267,0.00182434076701816,0.0222909994211206,0.0209335004244099
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00666038449093856,0.0028862145081734,0.00100340405491869,0.0123173649269584,0.0210338715940213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA1,Alpha-1-antitrypsin,37779,-0.00182091742235889,0.000792593426049306,-0.00337440053741554,-0.000267434307302254,0.0216104282465179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KEL,Kell blood group glycoprotein,39961,0.00793611137368438,0.0034706656778433,0.00113360664511152,0.0147386161022572,0.0222311261881844
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.0056472543203929,0.00247391864352392,0.000798373779086021,0.0104961348616998,0.0224631494085178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGF,Beta-nerve growth factor,40228,0.00271000637191349,0.00118738877726188,0.000382724368480202,0.00503728837534678,0.0224834448526436
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WIF1,Wnt inhibitory factor 1,40489,-0.00760655018782531,0.0033332229326517,-0.0141396671358226,-0.00107343323982799,0.0224999790772094
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.00821233430414285,0.0036123541792363,0.00113212011283971,0.015292548495446,0.0230180052427136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.0153515454764353,0.00675382107913279,0.00211405616133506,0.0285890347915356,0.0230408320533794
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00915882192737337,0.00404491738223198,-0.017086859996548,-0.0012307838581987,0.0235732423360476
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLC,Galectin-10,40333,-0.0145025551642559,0.00640888347272235,-0.0270639667707917,-0.00194114355772008,0.0236563313039988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17RA,Interleukin-17 receptor A,40332,0.00960305167555466,0.00427263820422216,0.00122868079527922,0.0179774225558301,0.0246173169840734
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37942,0.0156361044979988,0.00696333088408649,0.00198797596518928,0.0292842330308083,0.0247526841128783
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QL2,Complement C1q-like protein 2,37598,0.00940569849034176,0.00419968227853501,0.00117432122441313,0.0176370757562704,0.0251321592480868
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00707935416206703,0.00316446230549124,-0.0132817002808299,-0.000877008043304196,0.0252908253040273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKKL1,Dickkopf-like protein 1,40305,-0.0191067675691767,0.00856118373275781,-0.035886687685382,-0.00232684745297134,0.0256427397005495
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF5,Fibroblast growth factor 5,40044,-0.00696459940966691,0.00314752643345758,-0.0131337512192438,-0.000795447600090054,0.0269312840238407
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,37714,0.0117456325260987,0.00531856909014543,0.00132123710941364,0.0221700279427837,0.0272320739692416
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00982765087666267,0.00445899776919516,-0.0185672865042852,-0.00108801524904015,0.0275411485663599
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAU,Urokinase-type plasminogen activator,40332,-0.00629119577185045,0.00285995295129987,-0.0118967035563982,-0.000685687987302714,0.0278386381970459
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.00826241702499759,0.00375856820747714,0.000895623338342403,0.0156292107116528,0.0279431995296264
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL25,Interleukin-25,37429,0.00750094435557082,0.00341948268799808,0.00079875828709459,0.014203130424047,0.0282825439578146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B4,Protein ATP1B4,37482,-0.0090794150648125,0.00414012333957132,-0.0171940568103723,-0.00096477331925271,0.0283228228241452
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTN3,Myeloblastin,39897,0.0100461547086373,0.00458489703720557,0.00105975651571438,0.0190325529015602,0.0284564942840044
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0154216848398299,0.00704484263990907,-0.0292295764140517,-0.00161379326560815,0.0286090032857874
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1,Integrin beta-1,40333,-0.00466680470427346,0.00213194999394228,-0.00884542669240032,-0.000488182716146591,0.0286125005842962
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD70,CD70 antigen,40341,-0.00886751753058886,0.00405171179605873,-0.016808872650864,-0.000926162410313739,0.0286414889405517
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.00619882794859856,0.00283968666230229,0.000633042090486064,0.0117646138067111,0.0290588344646223
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MN1,Transcriptional activator MN1,37572,-0.0126945399664605,0.00584048065613371,-0.0241418820524826,-0.00124719788043843,0.0297572439633785
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMNB1,Lamin-B1,37874,0.011924669293395,0.00556582831051803,0.00101564580477969,0.0228336927820104,0.0321729051730449
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,0.0152498412928868,0.0071622352909908,0.00121186012254479,0.0292878224632287,0.03325284479819
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGN,Mimecan,40332,0.00843687689797142,0.00396571336837112,0.000664078695964027,0.0162096750999788,0.0333976571026143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NLGN2,Neuroligin-2,37541,-0.0100490470018474,0.00473361066905209,-0.0193269239131895,-0.000771170090505284,0.0337797984732397
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,40405,0.010512548430128,0.00496804960764084,0.000775171199151973,0.0202499256611041,0.0343575943667972
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGS8,Regulator of G-protein signaling 8,40044,0.0137207241393481,0.00648949106982729,0.00100132164248657,0.0264401266362095,0.0345055717962776
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00693943690177647,0.00328217106186094,-0.0133724921830239,-0.000506381620529033,0.0345099713936857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXDC2,Plexin domain-containing protein 2,37942,-0.00551074272961013,0.00261125365668001,-0.0106287998967029,-0.000392685562517314,0.0348438235307676
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHAD,Chondroadherin,37671,0.0109671395689488,0.00525119499064455,0.00067479738728549,0.0212594817506121,0.0367715172202943
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RG,Cytokine receptor common subunit gamma,37900,0.00788187444546189,0.00377634875207714,0.000480230891390692,0.0152835179995331,0.0368917275943849
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.0112443946758117,0.00539633836489004,-0.0218212178709961,-0.000667571480627172,0.0372060660474154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C9orf40,Uncharacterized protein C9orf40,37901,0.0167311171928805,0.00805112885061813,0.000950904645668979,0.0325113297400921,0.0377183107458918
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00600821296785413,0.00290737284952015,0.000309762182794628,0.0117066637529136,0.0387932262304184
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY96,Lymphocyte antigen 96,40228,0.00697023292665628,0.00337838233624464,0.000348603547616793,0.0135918623056958,0.039111233117897
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUCA2A,Guanylin,40276,-0.0067191277030734,0.00326145341900341,-0.0131115764043201,-0.000326679001826714,0.0393992139791014
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.0065944554058478,0.00320578498591855,0.000311116833447434,0.0128777939782482,0.0397011942946847
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASA1,Ras GTPase-activating protein 1,39961,0.0065282613191343,0.00317546801789131,0.000304344004067341,0.0127521786342013,0.0398144249826966
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.00762617492112445,0.00372157565588471,0.000331886635590414,0.0149204632066585,0.0404609782394832
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNLZ,DNL-type zinc finger protein,37541,-0.0190735289790358,0.00932368972630118,-0.0373479608425861,-0.000799097115485443,0.0408052399641299
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,37900,0.0114989070844748,0.0056240399996758,0.000475788685110189,0.0225220254838393,0.0409138280530538
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRTN,Neurturin,40044,0.00987388281905327,0.00483214808579042,0.000402872570904052,0.0193448930672025,0.0410322625788832
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00509877389276708,0.00250098090954897,-0.0100006964754831,-0.000196851310051096,0.0414991575015408
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB116,Beta-defensin 116,37541,-0.0157776957187905,0.00775276924956406,-0.030973123447936,-0.000582267989644924,0.0418604639619239
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A16,Protein S100-A16,39934,0.012296648592485,0.00605973714135392,0.000419563795431347,0.0241737333895387,0.0424511328218373
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0111575953943416,0.00550083204661121,0.000375964582983624,0.0219392262056995,0.0425448042897838
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,40408,-0.00478997064613857,0.00236217817366338,-0.0094198398665188,-0.000160101425758342,0.0425995934746521
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.0111840069629394,0.00551896145854047,0.000366842504200122,0.0220011714216788,0.0427363317663663
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BEX3,Protein BEX3,37482,-0.00947833392035475,0.00467748863473323,-0.0186462116444319,-0.000310456196277615,0.0427469653039734
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRISP2,Cysteine-rich secretory protein 2,40489,-0.0120291148194295,0.00596723072326441,-0.0237248870370277,-0.000333342601831259,0.0438310326307335
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00438628497941116,0.00217800011512331,0.000117404753769471,0.00865516520505284,0.0440363655654687
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYT1,Synaptotagmin-1,37942,0.00769065339797247,0.00382415173428359,0.000195315998776624,0.0151859907971683,0.0443374616983078
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDSN,Corneodesmosin,40456,-0.00844549547547981,0.00420646921701369,-0.0166901751408267,-0.00020081581013298,0.0446877303001793
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTO1,Protein LTO1 homolog,40044,0.00805658229022066,0.00401793271080388,0.000181434177045057,0.0159317304033963,0.0449636129392135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBX2,Chromobox protein homolog 2,37562,-0.00806214279218461,0.00402687577576312,-0.0159548193126803,-0.000169466271688897,0.0452962807439448
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00528522756596165,0.00264188734744477,0.000107128364969908,0.0104633267669534,0.04545822306291
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP7,Retinoid-binding protein 7,37901,0.0114131341829997,0.00570760770554471,0.000226223080132067,0.0226000452858673,0.0455597312158746
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.0111799789901157,0.00559781109300671,0.000208269247822591,0.0221516887324089,0.0458202140281523
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.0107680155402434,0.00540068751621928,0.000182668008453653,0.0213533630720332,0.0461915494726763
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.00900300088124403,0.004522693214516,0.000138522180792668,0.0178674795816954,0.0465392923137701
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP4,Bone morphogenetic protein 4,40203,-0.00878962699459525,0.00442165621979421,-0.0174560731853919,-0.000123180803798592,0.0468446230575064
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRP15,RRP15-like protein,37541,-0.0176793794823119,0.00893433973777536,-0.0351906853683516,-0.000168073596272206,0.0478580932735004
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNL1,Interferon lambda-1,39961,0.00873366304302639,0.00441776518731411,7.48432758907302e-05,0.0173924828101621,0.0480659336688195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,37901,0.00999858507293192,0.00505856899316804,8.37898463225649e-05,0.0199133802995413,0.0481113380610477
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNG,Uracil-DNA glycosylase,37900,0.00654140728920193,0.0033134323012224,4.7079978806026e-05,0.0130357345995978,0.0483784331474008
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOP56,Nucleolar protein 56,37562,0.0213195789252977,0.0108333522964558,8.62084242443731e-05,0.0425529494263511,0.049093949569132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.00720829844816893,0.00366783621135195,1.93394739191107e-05,0.0143972574224187,0.0494031672493535
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.00834562472585355,0.00424939061297422,1.68191244240834e-05,0.016674430327283,0.0495555277602885
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MERTK,Tyrosine-protein kinase Mer,40516,-0.0049964719274743,0.00254866633626458,-0.00999185794655288,-1.08590839572025e-06,0.0499632685077856
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRCAM,Neuronal cell adhesion molecule,40359,0.00531711217116173,0.00272594392611641,-2.57379240264418e-05,0.0106599622663499,0.051127165144561
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.0129969308096996,0.00668090826911605,-9.76493977678117e-05,0.0260915110171671,0.0517500897911151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIF1L,Allograft inflammatory factor 1-like,37628,0.0110140547305205,0.00567504604208724,-0.000109035511970534,0.0221371449730114,0.052305436773958
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCLRE1C,Protein artemis,37482,-0.00602372184986749,0.00310968513892779,-0.012118704722166,7.12610224309906e-05,0.0527566428806113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00928448267205853,0.00479880677335438,-0.0186901439478331,0.000121178603716054,0.0530426907054544
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA4C,Semaphorin-4C,40305,-0.0053310273614893,0.00275733602642188,-0.0107354059732762,7.3351250297584e-05,0.053204996669163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RYR1,Ryanodine receptor 1,37562,-0.0065344511835637,0.00338371378589387,-0.0131665302039157,9.76278367882839e-05,0.0534863185803069
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSLP,Thymic stromal lymphopoietin,40042,0.0114710808112043,0.00594189282162288,-0.000175029119176582,0.0231171907415851,0.0535576807284953
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP1,Methionine aminopeptidase 1,39961,0.00575373852445319,0.00299439673598665,-0.000115279078080655,0.011622756126987,0.0546867890223051
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.00597338144356325,0.00310928398332818,-0.000120815163759972,0.0120675780508865,0.0547318008262674
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF75D,Zinc finger protein 75D,37714,0.0111819382665565,0.00582577708373833,-0.000236584817570587,0.0226004613506837,0.054956428784023
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP152,Centrosomal protein of 152 kDa,37482,0.00776521775373924,0.00406656770469743,-0.000205254947467719,0.0157356904549462,0.0562161774758273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COPE,Coatomer subunit epsilon,39961,0.00898468958696006,0.0047114655792644,-0.000249782948398163,0.0182191621223183,0.0565411139610994
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTP1,Glutathione S-transferase P,39871,-0.01297125690234,0.0068048095697747,-0.0263086836590984,0.000366169854418404,0.0566441908999479
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.0060720299467745,0.0031866964714056,-0.0123179550307295,0.000173895137180473,0.0567460691978079
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN4,Prefoldin subunit 4,37482,0.010102993466162,0.00532219727766499,-0.000328513198061334,0.0205345001303854,0.0576819549478747
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLK,STE20-like serine/threonine-protein kinase,37714,0.0143883949471381,0.00760910764485103,-0.000525456036769911,0.0293022459310461,0.0586536217213014
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCC,Netrin receptor DCC,37572,0.0042952311698831,0.00228572797099734,-0.000184795653271686,0.00877525799303788,0.060245837030346
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD5L,CD5 antigen-like,37934,0.00854687549890817,0.00454959692568469,-0.000370334475433822,0.0174640854732502,0.060320609203794
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX1B,Syntaxin-1B,37572,0.0078978445755423,0.00420491595472808,-0.000343790695724738,0.0161394798468093,0.06037039385097
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00539575319570345,0.00287727319249122,-0.0110352086529862,0.000243702261579339,0.060773478784175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLMP,CXADR-like membrane protein,40489,0.00371973568601414,0.00198576771204628,-0.00017236902959656,0.00761184040162484,0.0610592525762588
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.015314932212266,0.00818504036413181,-0.000727746901432347,0.0313576113259644,0.0613551003878427
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.010552344607325,0.00564628108033332,-0.0216190555247784,0.000514366310128272,0.0616588012789875
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.0129668653881187,0.00695486015117192,-0.0265983912844156,0.000664660508178285,0.0622833975811957
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0104317602852002,0.00560735498631579,-0.000558655487978737,0.0214221760583792,0.0628554740356344
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,40424,-0.00378617097925863,0.00204518020942836,-0.00779472418973821,0.000222382231220949,0.0641498545110857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,40380,0.0085671722463681,0.00463056599203443,-0.000508737098019386,0.0176430815907556,0.0643126009738418
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF20B,Kinesin-like protein KIF20B,37541,0.0141621281540145,0.007656881464152,-0.000845359515723464,0.0291696158237524,0.0643945002325839
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMA1,Laminin subunit alpha-1,37562,-0.0101367816746889,0.00549671748675738,-0.0209103479487334,0.000636784599355513,0.0651835634398049
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOH,Beta-2-glycoprotein 1,40332,0.00631679622523143,0.00345518485938898,-0.00045536609917097,0.0130889585496338,0.0675371072105978
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TG,Thyroglobulin,37900,-0.0207750948683764,0.0114815700297941,-0.0432789721267728,0.00172878239001997,0.0704065764258283
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.0129441370277292,0.00716046980895232,-0.00109038379781738,0.0269786578532757,0.0706720026471654
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REST,RE1-silencing transcription factor,37482,-0.00634511764805326,0.00351091130445224,-0.0132265038047796,0.000536268508673125,0.070745333156069
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA11,Carbonic anhydrase-related protein 11,39980,0.00578398048343259,0.00322738642373906,-0.00054169690709597,0.0121096578739612,0.0731274151990245
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.00624661913511509,0.00348988336843976,-0.000593552267026834,0.013086790537257,0.0734887741557979
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.00911753493973522,0.00509623983574507,-0.000871095138325107,0.0191061650177956,0.0736264585408949
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0158406809078321,0.00887211316966808,-0.00154866090471729,0.0332300227203816,0.0742122188085904
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZPR1,Zinc finger protein ZPR1,37541,0.0169658500665101,0.00952696277123624,-0.00170699696511294,0.0356386970981331,0.0749642884339686
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARB1,Scavenger receptor class B member 1,39961,0.0102914714066296,0.00577922136773429,-0.00103580247412959,0.0216187452873888,0.0749693922193946
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL36A,Interleukin-36 alpha,37598,-0.0102718691939837,0.00578633552566883,-0.0216130868242946,0.0010693484363272,0.0758889614872615
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00460331230096038,0.00259388347079603,-0.000480699301799841,0.00968732390372061,0.0759741341262478
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00549793580171336,0.00310129715135294,-0.0115764782183651,0.000580606614938394,0.076287446887126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTM4,Glutathione S-transferase Mu 4,37562,-0.0124104024689717,0.00701478362420099,-0.0261593783724056,0.00133857343446224,0.0768873812313145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.0108305137068222,0.00613139308579395,-0.0228480441549784,0.00118701674133394,0.0773514593182913
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVPL,Envoplakin,37714,-0.00595102530444435,0.00337927859590422,-0.0125744113524166,0.000672360743527921,0.0782556508607451
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00506929588027952,0.0028794476805332,-0.000574421573565541,0.0107130133341246,0.0783446560690113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH12,Protocadherin-12,37959,0.0043819296777019,0.00250368357824572,-0.000525290135659702,0.00928914949106351,0.0801077067643936
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.0125703480157941,0.00722280909737306,-0.0267270538466453,0.00158635781505712,0.0818175618968317
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTN4,Alpha-actinin-4,40044,0.00550090339426465,0.00317143645817826,-0.000715112063764747,0.0117169188522941,0.0828465492263597
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTN,Titin,37562,-0.0110795321418757,0.00642723747895074,-0.0236769176006191,0.00151785331686777,0.0847602201954235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTPP1,dCTP pyrophosphatase 1,40359,0.00529820531024313,0.00309058856346125,-0.000759348274140923,0.0113557588946272,0.0864925685545959
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0137805849204493,0.00804005240854616,-0.00197791780030114,0.0295390876411998,0.0865539914872912
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF21,Immunoglobulin superfamily member 21,37628,0.00653768749958168,0.0038265428714862,-0.000962336528531275,0.0140377115276946,0.0875652690882227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA2,GDNF family receptor alpha-2,40305,0.00351555016924875,0.00206701197183007,-0.000535793295538191,0.00756689363403569,0.0890023237994602
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.0048950501540033,0.00287962735468874,-0.0105391197691932,0.000749019461186636,0.0891746151160301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00876900683498766,0.00516875598469217,-0.0188997685649843,0.00136175489500899,0.0898071977609596
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0198555657370173,0.0117248156407199,-0.0031250729187936,0.0428362043928283,0.0903869529224368
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0188245372675029,0.0111368846054867,-0.00300375655925105,0.0406528310942568,0.0909960324836451
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.0107235206599707,0.00635364539440152,-0.00172962431305624,0.0231766656329977,0.0914777135158185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGLC2,Immunoglobulin lambda constant 2,37978,0.0039906140552279,0.00237072431648915,-0.00065600560509084,0.00863723371554664,0.092342244736883
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTA2,"Actin, aortic smooth muscle",40042,-0.00716018025539898,0.00425782045851821,-0.0155055083540947,0.00118514784329671,0.0926560065792189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBS2,Thrombospondin-2,40332,0.00582763140056654,0.00348647549171848,-0.00100586056320168,0.0126611233643348,0.0946433626635306
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUMF1,Formylglycine-generating enzyme,37598,0.010971262692474,0.00656627604962588,-0.00189863836479276,0.0238411637497407,0.0947751024916391
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.00565499215363329,0.00339229738625102,-0.000993910723418714,0.0123038950306853,0.0955319745970216
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAPPA,Pappalysin-1,40044,0.00765133141219225,0.00458988681158038,-0.00134484673850529,0.0166475095628898,0.095534917780327
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00375017584326189,0.00225403294940887,-0.000667728737579506,0.00816808042410328,0.0961796759480953
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKLR,Pyruvate kinase PKLR,40374,0.0107536446112692,0.00647942158102556,-0.00194602168754092,0.0234533109100793,0.0970023220358025
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00618957163910478,0.00375314604984753,-0.00116659461859637,0.0135457378968059,0.0991370019226604
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00842790161698663,0.00511162196789938,-0.0184466806740694,0.00159087744009615,0.099218215730951
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1B,Protein phosphatase 1B,37598,0.0102332250822896,0.00620680625763616,-0.00193211518267732,0.0223985653472564,0.0992309046917977
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BSND,Barttin,37482,-0.005534930299,0.00335837480623877,-0.012117344919228,0.001047484321228,0.0993567033338409
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRC,Chymotrypsin-C,40360,0.0100582386864926,0.00610995293747553,-0.00191726907095946,0.0220337464439446,0.0997411924160437
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL22,Interleukin-22,37900,0.0104706583931263,0.00637800754862007,-0.00203023640216907,0.0229715531884216,0.10067936519848
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSMB,Beta-microseminoprotein,40236,0.0110490450713032,0.00674870748087557,-0.00217842159121291,0.0242765117338193,0.101606728218815
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.00409452506767035,0.00250149267340167,-0.000808400572196925,0.00899745070753762,0.101688674454412
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.0110025033136126,0.00675550759602206,-0.00223829157459067,0.0242432982018158,0.10340287038146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCL2,Phosducin-like protein 2,37482,0.00858893925733348,0.00528145576843161,-0.00176271404879248,0.0189405925634594,0.103921800446237
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBQLN3,Ubiquilin-3,37562,-0.00714433730194207,0.00441898760220407,-0.0158055530022621,0.00151687839837791,0.105959292398901
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.0150392803277671,0.00934396334436369,-0.0333534484827199,0.00327488782718575,0.107527273713812
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCN2,Transcobalamin-2,40497,0.00466577627044045,0.00290904739858211,-0.00103595663078048,0.0103675091716614,0.108759178275195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,-0.00383073981986695,0.00239094651523993,-0.00851699498973721,0.000855515350003302,0.109134503041185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00397342024301389,0.00249249886278328,-0.000911877528041335,0.00885871801406911,0.110922125656635
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH17,Cadherin-17,40359,-0.0104984640803961,0.0065985362576277,-0.0234315951453464,0.00243466698455421,0.111622868468818
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00366846652715228,0.00231095797435365,-0.00819794415688543,0.000861011102580869,0.112440409367796
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00846892633491548,0.00537587532912893,-0.00206778931017722,0.0190056419800082,0.115198081477799
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHIT1,Chitotriosidase-1,40398,0.022868295639229,0.0145440342828672,-0.00563801155519066,0.0513746028336487,0.11588950868308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00702154296423763,0.0044727674939187,-0.00174508132384303,0.0157881672523183,0.116475762816977
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA5,Annexin A5,39896,0.00466884238984892,0.00298113879549726,-0.00117418964932571,0.0105118744290235,0.117339342424629
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL36G,Interleukin-36 gamma,37551,0.010562333447812,0.00674859803276085,-0.00266491869639923,0.0237895855920233,0.117580053329269
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00342123423406893,0.00218934393149189,-0.000869879871655181,0.00771234833979304,0.118152998766301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP13,Collagenase 3,39961,-0.00501205427202244,0.00321318117279983,-0.0113098893707101,0.00128578082666522,0.118817677234314
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JCHAIN,Immunoglobulin J chain,40044,-0.00939248399523255,0.00602811033690565,-0.0212075802555676,0.00242261226510253,0.11922648747824
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RELB,Transcription factor RelB,37598,0.00782866052524083,0.00504588947831274,-0.00206128285225214,0.0177186039027338,0.120807735569871
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00572083828186686,0.00369025162763121,-0.00151205490829031,0.012953731472024,0.121103714092397
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00520723699121064,0.00337258512058598,-0.00140302984513788,0.0118175038275592,0.122610584340232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRING1,SREBP regulating gene protein,37482,0.00867015895290817,0.00564044221133813,-0.00238510778131456,0.0197254256871309,0.124282893375317
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP1,DNA topoisomerase 1,37901,0.0160414554523105,0.0104360851974599,-0.004413271534711,0.036496182439332,0.124288854372476
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPLA2,Acyl-protein thioesterase 2,37541,0.0162687226809285,0.0106020273768772,-0.00451125097775083,0.0370486963396078,0.124932911077441
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,-0.00431091802566614,0.00282153858642814,-0.0098411336550653,0.00121929760373302,0.126566782490308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0132541683121274,0.00868414654915333,-0.00376675892421316,0.0302750955484679,0.126972035846825
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0178709239374933,0.01171006918655,-0.00508081166814456,0.0408226595431312,0.127005140105879
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PODXL2,Podocalyxin-like protein 2,40411,-0.00405472304313079,0.002657368740009,-0.00926316577354843,0.00115371968728685,0.127069202316818
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00758032784368036,0.00497966244325472,-0.0173404662324596,0.00217981054509889,0.127968705901661
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.00475656549883349,0.0031274449081145,-0.0108863575187379,0.00137322652107093,0.128302442680061
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN15,Tetraspanin-15,37562,-0.00757898191403302,0.00499929294709547,-0.0173775960903401,0.0022196322622741,0.129540740831448
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00734229502624575,0.00485089738122839,-0.0021654638409619,0.0168500538934534,0.130152643590486
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STEAP4,Metalloreductase STEAP4,37541,-0.011108023742269,0.00738344818217188,-0.0255795821793259,0.00336353469478788,0.13248983653259
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.00922862542152665,0.00616306810164781,-0.00285098805770305,0.0213082389007563,0.134311289467868
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTKN2,Rhotekin-2,37562,-0.00765210595215035,0.00515899574821834,-0.0177637376186583,0.00245952571435759,0.138030726676128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00807981626129847,0.00545335606858048,-0.00260876163311928,0.0187683941557162,0.138461025978518
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTF,Ciliary neurotrophic factor,37541,-0.00491235490989054,0.00331961497655593,-0.0114188002639402,0.00159409044415908,0.13895160706909
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOE,Apolipoprotein E,38013,0.0108172084570623,0.00731459430555622,-0.00351939638182789,0.0251538132959525,0.139202880443348
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00610901577600063,0.00413736464535555,-0.0142182504808975,0.00200021892889624,0.139820951075473
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REN,Renin,40359,0.010235886072263,0.00694870915769494,-0.00338358387681905,0.0238553560213451,0.140753846402641
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00722174591060536,0.00491742438944726,-0.00241640589271128,0.016859897713922,0.14196552817862
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFHD1,EF-hand domain-containing protein D1,37959,0.00497773188298866,0.00339276017895668,-0.00167207806776643,0.0116275418337438,0.142355027730593
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FZD10,Frizzled-10,37572,0.00874097843099278,0.0059634623873925,-0.00294740784829652,0.0204293647102821,0.142738843570345
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM2,Intercellular adhesion molecule 2,40536,0.00440952126707378,0.00303607757726113,-0.00154119078435803,0.0103602333185056,0.146417044803887
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.0113145168797927,0.00781454304702016,-0.00400198749236676,0.0266310212519523,0.147670855782421
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PYDC1,Pyrin domain-containing protein 1,37628,-0.00604394732520261,0.004180119539153,-0.0142369816219425,0.00214908697153727,0.148234909869547
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCUN1D1,DCN1-like protein 1,37541,-0.0105819885413606,0.00732909675765246,-0.0249470181863594,0.00378304110363826,0.148810014268926
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00584107933337676,0.00404584025069968,-0.00208876755799461,0.0137709262247481,0.148835919177181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABO,Histo-blood group ABO system transferase,37987,-0.0202774440112886,0.0140804969622503,-0.0478752180572992,0.00732033003472204,0.149859820562342
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSTN,Osteocrin,37572,-0.00606169161524356,0.0042131114884241,-0.0143193901325548,0.00219600690206767,0.150240010799219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS53,Serine protease 53,37942,0.00514216821171682,0.00358879370921636,-0.00189186745834725,0.0121762038817809,0.151926657787587
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOX2,Transcription factor SOX-2,37937,0.00326717518307413,0.00228111830024835,-0.00120381668541263,0.00773816705156089,0.152090010491239
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00243493076828978,0.00170272356657385,-0.000902407422194954,0.00577226895877452,0.152730580050289
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00942373496197908,0.00659917248341893,-0.00351064310552203,0.0223581130294802,0.153306906525412
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP112,Centrosomal protein of 112 kDa,37562,0.0065605153746004,0.00462170233552061,-0.00249802120302,0.0156190519522208,0.155776511444821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00525485254756544,0.00370518299038859,-0.0125170112087271,0.00200730611359619,0.156143387863282
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.02388119035772,0.0169529292706941,-0.0571089317282805,0.00934655101284051,0.158954011873939
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC4A1,Band 3 anion transport protein,37998,-0.00635587177622853,0.00451268878741719,-0.0152007417995662,0.00248899824710915,0.159022436270804
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD86,T-lymphocyte activation antigen CD86,37901,0.00401768417983688,0.0028561551875003,-0.00158037998766371,0.00961574834733746,0.159546672346045
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VNN2,Vascular non-inflammatory molecule 2,40305,0.00612276725317412,0.00437155218162741,-0.00244547502281559,0.0146910095291638,0.161355259732142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.0101249318869174,0.0072373664667556,-0.00406030638792355,0.0243101701617584,0.161838470885833
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00614798326376142,0.00442383716813002,-0.00252273758577341,0.0148187041132963,0.164630862755387
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEPD,Xaa-Pro dipeptidase,37987,0.00349911253430237,0.00251894620138297,-0.00143802202040825,0.008436247089013,0.164819842181033
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00604113063871805,0.00437170091826275,-0.014609664438513,0.00252740316107693,0.167034728497453
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00688492117169686,0.0049963844094997,-0.0166778346143163,0.00290799227092256,0.168232772589147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHH,Sonic hedgehog protein,37598,-0.00585684008886395,0.00425292105176997,-0.0141925653503331,0.0024788851726052,0.168494422650004
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTOA,Otoancorin,37541,-0.00737163951965426,0.00537169984957193,-0.0179001712248152,0.00315689218550672,0.169990348032185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTF3,Neurotrophin-3,40341,0.0046505663515201,0.00340581907647572,-0.00202483903837231,0.0113259717414125,0.172122623959324
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRG3,Proteoglycan 3,37998,-0.00667862088192358,0.00489322454645823,-0.0162693409929817,0.00291209922913455,0.172316228997029
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM171A2,Protein FAM171A2,37959,0.0214597092242763,0.0157310409099334,-0.00937313095919315,0.0522925494077458,0.172538894572559
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.00844095976845144,0.00619492168682387,-0.00370108673772334,0.0205830062746262,0.17304053455884
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN1,Calsyntenin-1,39961,0.00698089721019433,0.00512379005951448,-0.00306173130645406,0.0170235257268427,0.173076347706344
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLB1,"Phospholipase B1, membrane-associated",37942,-0.00807629308099226,0.005930333769424,-0.0196997472690633,0.00354716110707878,0.173264348136964
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPE4,NXPE family member 4,37562,-0.00484204383360752,0.00356155199507234,-0.0118226857439493,0.00213859807673427,0.174001458361049
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00432663642737641,0.00318889248693767,-0.00192359284702142,0.0105768657017742,0.174873438357835
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAC1,Cartilage acidic protein 1,40536,-0.00386498364730159,0.0028527534301674,-0.0094563803704297,0.00172641307582651,0.175492127113153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.00925614477950245,0.00683557343748897,-0.00414157915797592,0.0226538687169808,0.175719077188688
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.00372496332148951,0.00275153916874842,-0.0016680534492574,0.00911798009223642,0.175827593228223
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISM2,Isthmin-2,37998,-0.00589089823259254,0.00435643726157935,-0.0144295152652881,0.00264771880010298,0.176324832051793
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL4,Early placenta insulin-like peptide,37900,-0.00714895149690841,0.00529339432085346,-0.0175240043657812,0.00322610137196438,0.176864907684963
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPON1,Spondin-1,40379,0.00432519661690202,0.00320466390849871,-0.00195594464375545,0.0106063378775595,0.17714525981845
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBH,Dopamine beta-hydroxylase,37967,-0.0138818870037892,0.0103036166661458,-0.0340769756694349,0.00631320166185652,0.177911709964645
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GKN1,Gastrokine-1,39602,0.00364539603838814,0.00272320377518402,-0.00169208336097254,0.00898287543774883,0.180707202830823
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL3A1,Collagen alpha-1(III) chain,37998,0.00300936447326746,0.00225749874397534,-0.00141533306492421,0.00743406201145913,0.18253697571457
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNGR1,Interferon gamma receptor 1,40422,0.00265538691933298,0.00199496433200447,-0.00125474317139579,0.00656551701006175,0.183193268704801
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTNAP4,Contactin-associated protein-like 4,37572,0.0131096789870991,0.00993969734616926,-0.00637212781139265,0.0325914857855908,0.187218429124049
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00467092793318536,0.0035437014501364,-0.0116165827754527,0.00227472690908198,0.187495560388358
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.00446175097195489,0.00339504963879869,-0.00219254632009053,0.0111160482640003,0.188800253608524
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.0101486527136148,0.00776778420723722,-0.0253735097597997,0.00507620433257019,0.1914036149804
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHPK,Sedoheptulokinase,37714,-0.00546081315113588,0.00419742074895146,-0.0136877578190807,0.00276613151680898,0.193283605599611
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.010823838970227,0.00833669535494751,-0.0271637618659241,0.00551608392547014,0.19419386595234
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM3,Paralemmin-3,37562,0.0092049102746871,0.00709913206451743,-0.00470938857176707,0.0231192091211413,0.19478315682123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,-0.00325020894137287,0.00251242223757446,-0.00817455652701882,0.00167413864427308,0.195807220899414
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00510034810114852,0.00394464150846692,-0.00263114925544665,0.0128318454577437,0.196040088671562
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00459011648062222,0.00355159621089977,-0.00237101209274132,0.0115512450539858,0.196238104433732
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD55,Complement decay-accelerating factor,39802,0.0032998897348911,0.00256136170859746,-0.00172037921395992,0.00832015868374212,0.197649092430959
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESPL1,Separin,37482,-0.00718585051583476,0.00561391480957731,-0.0181891235426063,0.00381742251093677,0.200565445559231
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB118,Beta-defensin 118,37541,0.007303112145794,0.00571137572079573,-0.00389118426696564,0.0184974085585536,0.2010268704756
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXDC1,Plexin domain-containing protein 1,39980,0.00422694497260518,0.00331038587387215,-0.00226141134018423,0.0107153012853946,0.201665900866949
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,40403,-0.00340583477479484,0.0026801012573442,-0.00865883323918946,0.00184716368959979,0.203823374125228
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00483007947983109,0.00381309980008206,-0.0123037550879919,0.00264359612832975,0.205282648172787
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPT2,Angiopoietin-2,40489,0.0047500632521533,0.00377135541930629,-0.00264179336968702,0.0121419198739936,0.207864186454238
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00562922955870761,0.0044912266049633,-0.0144320337044357,0.00317357458702046,0.210088445007726
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KDM3A,Lysine-specific demethylase 3A,37598,-0.0113176967840722,0.00906551737685722,-0.0290861108427123,0.00645071727456799,0.211894532141035
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00475979135277874,0.00382390632939956,-0.0027350650528444,0.0122546477584019,0.213247454394645
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SULT1A1,Sulfotransferase 1A1,40471,-0.0155438780512322,0.012524438610993,-0.0400917777287784,0.00900402162631411,0.214592961974917
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHGB,Secretogranin-1,40406,-0.00487325794451721,0.0039274717326285,-0.0125711025404691,0.00282458665143466,0.214693086738331
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR2,Toll-like receptor 2,37714,0.00278895213887915,0.00225086654068133,-0.00162274628085626,0.00720065055861456,0.215346285610191
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM25,Transmembrane protein 25,37959,-0.00530318614699367,0.00428419825744826,-0.0137002147315923,0.00309384243760491,0.215793951010984
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPNMB,Transmembrane glycoprotein NMB,39957,0.00340405972577957,0.00275298359395781,-0.00199178811837774,0.00879990756993688,0.216292100941513
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASPN,Asporin,37990,-0.00328976713912353,0.00266288916512071,-0.00850902990276011,0.00192949562451305,0.216698380228751
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0166126046463276,0.0134574368742281,-0.0429891809198147,0.00976397162715955,0.217054697176511
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP29,Dual specificity phosphatase 29,37572,-0.00805502321429103,0.00652535898007663,-0.0208447268152412,0.00473468038665917,0.217069143662323
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.00326875940558786,0.00267445345949006,-0.00197316937501265,0.00851068818618838,0.221644201990594
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOX9,Transcription factor SOX-9,37572,0.00323045177889897,0.00265663941823728,-0.0019765614808461,0.00843746503864404,0.224009918869763
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANPEP,Aminopeptidase N,40370,-0.00334677578504486,0.00275462821224007,-0.0087458470810354,0.00205229551094568,0.224397611545679
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.0095762695887158,0.00790028892691788,-0.00590829670804325,0.0250608358854749,0.225476612185301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.00837430275861949,0.00691113577724356,-0.0219201288820169,0.00517152336477789,0.225644671061951
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNL2,Interferon lambda-2,37541,0.0076617210557685,0.00634710636074806,-0.0047786074112977,0.0201020495228347,0.227407624547142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GJA8,Gap junction alpha-8 protein,37482,0.00734677123785814,0.00609983290984542,-0.00460890126543888,0.0193024437411552,0.22844849841645
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WNT9A,Protein Wnt-9a,40044,0.00336024508739287,0.00279855783535559,-0.00212492826990408,0.00884541844468982,0.229883519886492
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS1,"Nitric oxide synthase, brain",39961,0.00582858106202657,0.00486086746945642,-0.00369871917810802,0.0153558813021612,0.230514192306808
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD82,CD82 antigen,37714,-0.00490719935381748,0.00410113164667912,-0.0129454173813085,0.00313101867367358,0.23150431308078
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.00991709074151796,0.00830383861066795,-0.00635843293539122,0.0261926144184271,0.232387117051507
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00425686603130084,0.00356564847913781,-0.0112455370504109,0.00273180498780928,0.232556562416255
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2RB,Cytokine receptor common subunit beta,37598,-0.00511926969970425,0.00433360405834963,-0.0136131336540695,0.00337459425466101,0.237506474489789
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEO1,Neogenin,37959,0.00245914581621182,0.0020854704013446,-0.00162837617042359,0.00654666780284724,0.238347120236791
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,37942,0.00323442642121568,0.00276299444331021,-0.00218104268767233,0.00864989553010369,0.241770797215449
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00803039623457968,0.00686275784186077,-0.0214814016046268,0.00542060913546743,0.241965374141087
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA11,Serpin A11,40536,-0.00457868015977923,0.00391333125030671,-0.0122488094103804,0.00309144909082192,0.242009811728469
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37942,-0.00354570681329896,0.00303210132295848,-0.00948862540629758,0.00239721177969965,0.24226748433693
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLHL41,Kelch-like protein 41,37959,0.00542186152640035,0.00464443662981846,-0.00368123426804383,0.0145249573208445,0.243074154125463
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF20,Fibroblast growth factor 20,37598,-0.00509439458224449,0.00437593277368132,-0.0136712228186599,0.00348243365417088,0.244370241170508
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00384282921200041,0.00330863556312646,-0.00264209649172746,0.0103277549157283,0.245477696151795
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIP1,Huntingtin-interacting protein 1,37562,0.00386942649336972,0.00333321870033837,-0.00266368215929349,0.0104025351460329,0.245716774084393
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00435654277992385,0.0037540521862742,-0.00300139950517358,0.0117144850650213,0.24587002131277
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,-0.00334440792812551,0.00288577397203366,-0.00900052491331148,0.00231170905706046,0.246505445565172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DENND2B,DENN domain-containing protein 2B,37562,-0.00593546252783136,0.0051395733410513,-0.0160090262762919,0.00413810122062919,0.248170814438361
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOM,Apolipoprotein M,40372,-0.00300046436851935,0.00260279421616306,-0.00810194103219894,0.00210101229516024,0.249015598231949
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY6D,Lymphocyte antigen 6D,40268,0.00417063378301696,0.00364045883573116,-0.00296466553501611,0.01130593310105,0.251963915452155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL24,Interleukin-24,40044,0.00551165764269619,0.00481591115579285,-0.0039275282226578,0.0149508435080502,0.252447046337136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.00382718014688123,0.00338109926614124,-0.0104541347085181,0.0027997744147556,0.257683146666065
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.00703494822858268,0.00623144386582772,-0.00517868174843965,0.019248578205605,0.258938637854138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10,Interleukin-10,40044,0.00936887422212991,0.00839654324485211,-0.00708835053778023,0.02582609898204,0.264524375094792
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STC2,Stanniocalcin-2,40309,0.00294548855592505,0.00264475056576295,-0.00223822255297033,0.00812919966482042,0.265419946773701
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.00400095612941947,0.00360916106772522,-0.00307299956332197,0.0110749118221609,0.267642125313275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUCL3,Mucin-like protein 3,37482,-0.004887441612364,0.0044142877632445,-0.0135394456283232,0.00376456240359522,0.2682335661128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00787858925541256,0.00711948567299876,-0.00607560266366501,0.0218327811744901,0.268477086703991
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00382788862812879,0.00346152561728833,-0.00295670158175634,0.0106124788380139,0.268816663068161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLGAP5,Disks large-associated protein 5,37959,-0.00580500786292668,0.00525704838545608,-0.0161088226984206,0.00449880697256725,0.269511620727498
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.01289731444724,0.0117013408107576,-0.0100373135418449,0.0358319424363248,0.270391377250568
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNNI3,"Troponin I, cardiac muscle",40042,0.00908703577553697,0.00826047024935098,-0.00710348591319095,0.0252775574642649,0.271321759895078
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.00611003282155052,0.00555927192990013,-0.00478614016105374,0.0170062058041548,0.271753852713214
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00415384776738776,0.00378598238496252,-0.0115743732419143,0.00326667770713877,0.272588738079508
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.00527159711032532,0.0048181629300927,-0.014715196453307,0.00417200223265637,0.273927123996643
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YY1,Transcriptional repressor protein YY1,37598,0.00300523458631989,0.00274837040310418,-0.0023815714037643,0.00839204057640409,0.274211681108752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00266826695932857,0.00244050941146041,-0.00745166540579098,0.00211513148713384,0.274271110601658
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.00618277889714363,0.00565872644652336,-0.0172738827323294,0.00490832493804215,0.274585350708763
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAP1,Antigen peptide transporter 1,37714,-0.00659721127684978,0.00603874345423233,-0.0184331484471452,0.0052387258934456,0.274641670243476
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00504460028185452,0.00462242683481244,-0.00401535631437786,0.0141045568780869,0.275146442412888
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCIN,Adseverin,37541,0.00783363090259195,0.00719700812565217,-0.00627250502368631,0.0219397668288702,0.276413632393482
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,-0.00393608346000573,0.00363919877592495,-0.0110689130608186,0.00319674614080717,0.279456431966277
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37562,-0.00347036456882782,0.00321213731871151,-0.00976615371350238,0.00282542457584674,0.279987932093019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBN2,Fibrillin-2,37572,0.00642795252278229,0.0059649454660816,-0.00526334059073765,0.0181192456363022,0.281222587919308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTLA,B- and T-lymphocyte attenuator,37482,0.0093637219356467,0.00870117059842538,-0.00769057243726705,0.0264180163085605,0.281882301521578
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHGA,Chromogranin-A,37998,-0.00943624275408845,0.00881801875165287,-0.0267195595073281,0.00784707399915118,0.284589237549577
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADA2,Adenosine deaminase 2,40258,0.0043608163018838,0.00408063005067777,-0.00363721859744462,0.0123588512012122,0.285238096229098
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELL,L-selectin,38013,-0.00241603690442508,0.00226111618484479,-0.00684782462672086,0.0020157508178707,0.285307218807253
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00466781447784009,0.00440337979177936,-0.00396280991404746,0.0132984388697276,0.289139946398779
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.00280443392745162,0.00264628757812598,-0.00238228972567529,0.00799115758057854,0.289269114436717
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTX1,Neuronal pentraxin-1,40332,0.00406666795911414,0.00384223699244026,-0.00346411654606878,0.011597452464297,0.289883961363805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAGLN3,Transgelin-3,37482,-0.00632340560068382,0.00597453272816832,-0.0180334897478937,0.00538667854652609,0.289895778355359
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTNAP2,Contactin-associated protein-like 2,40341,-0.00411116392765414,0.00391238720454059,-0.0117794428485537,0.00355711499324541,0.293363213685577
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDAN1,Codanin-1,37942,0.00238419415976023,0.00227024202537103,-0.00206548020996699,0.00683386852948744,0.293647820224379
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00409439453270055,0.00389934332620361,-0.00354831838665852,0.0117371074520596,0.293727013839822
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMP,Cartilage oligomeric matrix protein,40198,0.0034583708964196,0.00329502249313904,-0.00299987319013293,0.00991661498297212,0.293929990930938
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFRC,Transferrin receptor protein 1,40391,-0.00402308220464734,0.00385164139577022,-0.011572299340357,0.00352613493106228,0.296264825335384
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLL1,Delta-like protein 1,40411,0.00296639897532785,0.00285091376436482,-0.0026213920028272,0.00855418995348289,0.298119647565805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00590182350076675,0.00567265399507778,-0.00521657832958569,0.0170202253311192,0.298173873791307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPHS2,Podocin,37598,-0.0106719734010451,0.0102678851803765,-0.0307970283545829,0.00945308155249278,0.298658978976892
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTA4H,Leukotriene A-4 hydrolase,40489,0.00586038032041763,0.00564232677902827,-0.00519858016647777,0.016919340807313,0.298985048262277
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC44A4,Choline transporter-like protein 4,37572,-0.00712362012661281,0.00685973202500831,-0.0205686948956291,0.00632145464240349,0.299070825437959
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUOX2,Dual oxidase 2,40042,0.00733915241955956,0.00707271915503891,-0.00652337712431672,0.0212016819634358,0.299439551051419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC1A,C-type lectin domain family 1 member A,40042,-0.00334189340923075,0.00322254899676542,-0.00965808944289098,0.00297430262442948,0.299736019149321
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PITHD1,PITH domain-containing protein 1,37457,-0.00832992689259384,0.00804157196349256,-0.0240914079410393,0.00743155415585158,0.300287640445853
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00465842887946972,0.00449941908053651,-0.0134772902773213,0.00416043251838185,0.300529248946229
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBR1,T-box brain protein 1,37572,0.00492810852604412,0.00477620243085701,-0.00443324823843562,0.0142894652905239,0.302182596247039
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA6C,Semaphorin-6C,37598,0.00268358842672005,0.00260461597266537,-0.00242145887970408,0.00778863573314418,0.302878679173293
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00645788543498558,0.00628443319258034,-0.0187753744924431,0.00585960362247189,0.30415695808797
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_DRA,,40288,-0.00359469427715513,0.00351438193823789,-0.0104828828761014,0.00329349432179114,0.306393225566006
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00387909626015346,0.00379819828942601,-0.0113235649074284,0.00356537238712152,0.307131612980819
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.00707638144958906,0.00696047238531459,-0.0207189073248057,0.00656614442562754,0.309337574920762
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLN1,Cerebellin-1,37541,-0.00976327199887626,0.00962030316784348,-0.0286190662078495,0.00909252221009697,0.310190775341614
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.00455876435453022,0.00449367881828292,-0.0042488461293043,0.0133663748383647,0.310367278779301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEX33,Testis-expressed protein 33,37714,-0.00390768085695441,0.00386711678548581,-0.0114872297565066,0.00367186804259778,0.312279269123246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53BP1,TP53-binding protein 1,37598,0.0087288399345029,0.00870060672491899,-0.00832434924633831,0.0257820291153441,0.315761145880024
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RSPO1,R-spondin-1,40228,0.00345632359664012,0.0034478687764574,-0.00330149920521638,0.0102141463984966,0.316140623009997
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNC5D,Netrin receptor UNC5D,37598,-0.00261103967115287,0.00261631598968832,-0.00773901901094198,0.00251693966863624,0.31830582450723
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00500209753594265,0.00503337885049798,-0.0148675200829187,0.00486332501103339,0.320345930153906
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR158,Probable G-protein coupled receptor 158,37959,0.00358080468508145,0.0036075022572723,-0.00348989973917225,0.0106515091093351,0.320922983640743
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,40341,0.00350596902947626,0.00353705766641543,-0.00342666399669798,0.0104386020556505,0.321597852918501
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNMA2,Paraneoplastic antigen Ma2,37541,0.00421691338696271,0.00425806556575248,-0.00412889512191215,0.0125627218958376,0.322028478986049
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.0114677509771289,0.0116035536646028,-0.0112752142054925,0.0342107161597503,0.323022537880149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00388391610058932,0.0039472760647877,-0.0116205771875732,0.00385274498639456,0.325159025980001
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF12,Fibroblast growth factor 12,37598,0.00460487813089099,0.00471844407174394,-0.00464327224972713,0.0138530285115091,0.329116376129524
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NENF,Neudesin,37900,0.0101831183357241,0.0105862844489504,-0.0105659991842186,0.0309322358556669,0.336109003598307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00619565840792813,0.00644703876686209,-0.0188318543909778,0.00644053757512157,0.336565514004572
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSG1,Tryptase gamma,37598,-0.00255421858279616,0.00267154639120812,-0.00779044950956407,0.00268201234397176,0.33904816852372
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR4,Toll-like receptor 4,37598,0.00265310277283317,0.00278139128056787,-0.00279842413707984,0.00810462968274619,0.340163882177575
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCUN1D2,DCN1-like protein 2,37482,0.0075454382958517,0.00792195715577331,-0.00798159772946399,0.0230724743211674,0.340875588426653
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.004358554902841,0.00460119293035513,-0.0133768930463371,0.00465978324065505,0.343520676350892
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4C,C-type lectin domain family 4 member C,40341,0.0042130520370729,0.00444935021037136,-0.00450767437525497,0.0129337784494008,0.343708453259264
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.00390383475253255,0.00417467748268968,-0.0120862026186043,0.00427853311353921,0.349741974520173
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPT,Microtubule-associated protein tau,39961,0.00476564316321251,0.00517973426263632,-0.00538663599155468,0.0149179223179797,0.357558050353458
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL5,Fc receptor-like protein 5,40332,-0.00499448828207257,0.00545095265025366,-0.0156783554765697,0.00568937891242461,0.359544609548673
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARG2,"Arginase-2, mitochondrial",37900,0.00395664222920771,0.00434761487927309,-0.00456468293416756,0.012477967392583,0.362800891828093
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP1,Retinol-binding protein 1,37572,0.0061132428510095,0.00674541636143775,-0.00710777321740849,0.0193342589194275,0.364803769845986
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1A,Interleukin-1 alpha,40044,0.00474389582920147,0.00525911249715635,-0.00556396466522498,0.0150517563236279,0.367052988260489
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEBP1,Heme-binding protein 1,40042,0.00475910238869679,0.00531516820683078,-0.00565862729669154,0.0151768320740851,0.370597100347833
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHP1,Calcineurin B homologous protein 1,37541,0.00637907489358877,0.00715577998437789,-0.00764625387579189,0.0204044036629694,0.372700082006874
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00314967945733955,0.00353445061627052,-0.00377784375055067,0.0100772026652298,0.372871883673337
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",39530,0.00248101070115322,0.00278692145780901,-0.00298135535615243,0.00794337675845887,0.373354751379321
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRND,Prion-like protein doppel,37942,-0.00466471120112959,0.0052487827562463,-0.0149523254033723,0.00562290300111316,0.374168095620807
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00527176329275186,0.00595418530936925,-0.0169419664991156,0.00639843991361188,0.375963725223064
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.00514151621929188,0.00587341428091375,-0.00637037577129907,0.0166534082098828,0.38137887923971
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH17,Protocadherin-17,40359,0.00297037442245635,0.0033959906545049,-0.00368576726037326,0.00962651610528596,0.381766168402041
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL9A1,Collagen alpha-1(IX) chain,40341,-0.00401926947505646,0.00459605128822742,-0.0130275299999822,0.00498899104986927,0.381856558547068
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCNE1,G1/S-specific cyclin-E1,37598,0.00801095433283173,0.00916767525786113,-0.00995768917257609,0.0259795978382396,0.382228901795766
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,40044,0.00507147892781693,0.00580768598612686,-0.00631158560499171,0.0164545434606256,0.382548050020432
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00797946958711501,0.00918002912746186,-0.0100133875027102,0.0259723266769403,0.384742401258088
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASQ2,Calsequestrin-2,37562,-0.00424958367389708,0.00491091799282293,-0.01387498293983,0.00537581559203588,0.386871399799361
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GH2,Growth hormone variant,39980,0.0142442482001363,0.0164639038929241,-0.018025003429995,0.0465134998302676,0.386953105757293
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF6,Fibroblast growth factor 6,37598,-0.00363398530289823,0.00421057551285884,-0.0118867133081016,0.0046187427023051,0.388119440261456
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00531554706185058,0.00617951432702519,-0.00679630101911879,0.01742739514282,0.389700701029148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,-0.00346300942390349,0.00404148842443472,-0.0113843267357955,0.00445830788798857,0.391532431018634
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDNRB,Endothelin receptor type B,37598,0.00394712463959183,0.00463845210967232,-0.00514424149536592,0.0130384907745496,0.394808577562681
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB2,Integrin beta-2,40221,-0.00236960060638586,0.00279643875115064,-0.00785062055864112,0.0031114193458694,0.396805307486929
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00418575996747319,0.00495412784306537,-0.00552433060493494,0.0138958505398813,0.398180231722387
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP15,Matrix metalloproteinase-15,37990,0.00409959418339658,0.00487259605183782,-0.00545069407820554,0.0136498824449987,0.400162668508155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.00661672118344255,0.00793052586180552,-0.0221605518725814,0.00892710950569627,0.404107042517692
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA8,Carbonic anhydrase-related protein,37598,-0.00226823667788763,0.00272260326416394,-0.00760453907564896,0.00306806571987369,0.404796033563163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDS,Iduronate 2-sulfatase,40516,0.000701234274356971,0.000842532416748556,-0.000950129262470199,0.00235259781118414,0.405255657566203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.00275877071871936,0.00332079537311777,-0.00926752965003019,0.00374998821259148,0.406126630385298
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAYN,Layilin,40192,0.00277698495920621,0.00334579209233356,-0.00378076754176756,0.00933473746017998,0.406555169958135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13,Interleukin-13,40044,0.00387417587128351,0.00468335862013113,-0.0053052070241735,0.0130535587667405,0.408124074907061
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRR5,Proline-rich protein 5,37598,0.00386816640763889,0.00472179444506621,-0.00538655070469088,0.0131228835199687,0.41267841934382
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK12,Kallikrein-12,39980,-0.0114226405834692,0.0139663497256003,-0.0387966860456457,0.0159514048787073,0.413444702114672
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.00401534284463867,0.00491375942649194,-0.00561562563128554,0.0136463113205629,0.413847571626999
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM132A,Transmembrane protein 132A,37628,0.00498688943496998,0.0061538198519555,-0.00707459747486281,0.0170483763448028,0.417740468641211
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.00760670673928493,0.00946402916547612,-0.0261562039036181,0.0109427904250483,0.421556353308541
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCARE,Photoreceptor cilium actin regulator,37541,0.00668025151961389,0.00844382887651647,-0.0098696530783584,0.0232301561175862,0.428876583397471
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG1A,Lithostathine-1-alpha,40274,0.00373539712483931,0.00475370187331995,-0.00558185854686779,0.0130526527965464,0.432004052182688
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAX,Integrin alpha-X,37714,0.00424688063708393,0.00541002206671911,-0.00635676261368552,0.0148505238878534,0.432466148123141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL12,Stromal cell-derived factor 1,40044,-0.00308823694552909,0.00396358396876739,-0.0108568615243132,0.00468038763325499,0.435901624932422
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR1,TGF-beta receptor type-1,37598,0.00164177159660566,0.00210768209168299,-0.00248928530309299,0.00577282849630432,0.436025249410529
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00254618651133487,0.00329089646847678,-0.00899634358954936,0.00390397056687961,0.439116372492471
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGM2,Phosphoglucomutase-2,37572,0.00453143978655016,0.00587308216134665,-0.00697980124968927,0.0160426808227896,0.440388513428167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,H2AP,Huntingtin-interacting protein M,37482,-0.00392769271318938,0.00510365809122739,-0.0139308625719951,0.0060754771456163,0.441560753674909
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00964608860987831,0.0125872327968319,-0.0150248876719122,0.0343170648916688,0.443488011269865
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAGE2A,G antigen 2A,37482,0.00467432681822782,0.00609969321521569,-0.00728107188359493,0.0166297255200506,0.443498836472754
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRNN,Cornulin,39857,0.00494888517558282,0.00647270817032678,-0.00773762283825766,0.0176353931894233,0.444535053598194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCN15,Lipocalin-15,37959,-0.00472891708709586,0.00623967876360483,-0.0169586874637613,0.00750085328956961,0.448537068686123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00140482070812887,0.0018548646835131,-0.00223071407155681,0.00504035548781456,0.44884078826475
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00417815264081059,0.00552901870004577,-0.00665872401127911,0.0150150292929003,0.449856496430582
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00426390398815088,0.00567933517743577,-0.015395400935925,0.00686759295962322,0.452801433584623
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00499551266375217,0.0066567664207888,-0.00805174952099388,0.0180427748484982,0.45300225882497
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RLN1,Prorelaxin H1,37959,-0.00605136921948691,0.00807149377854664,-0.0218714970254383,0.0097687585864645,0.453435752511698
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMCN2,Hemicentin-2,37648,0.0041836200386724,0.00558662425893101,-0.00676616350883238,0.0151334035861772,0.453952716910919
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HCG22,Protein PBMUCL2,37562,-0.00391414913065251,0.005230940001808,-0.0141667915341962,0.00633849327289118,0.454311470283256
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NME3,Nucleoside diphosphate kinase 3,40379,-0.00173904811015751,0.00233392042901875,-0.00631353215103427,0.00283543593071924,0.45621086853388
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00233171010513027,0.00321216091980199,-0.00396412529768164,0.00862754550794218,0.46791217798675
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.0020676723984933,0.00285310977562641,-0.00352442276173448,0.00765976755872107,0.468641863225458
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00288567954679876,0.00398331618052215,-0.0106929792606222,0.00492162016702464,0.468807593143844
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOS,Proto-oncogene c-Fos,37457,0.00243766569171765,0.00343974271345082,-0.00430423002664595,0.00917956141008126,0.478537797732806
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMIGO1,Amphoterin-induced protein 1,37572,0.00346017413710309,0.00489026851536802,-0.00612475215301822,0.0130451004272244,0.479229108157463
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHODH,Dihydroorotate dehydrogenase,37562,0.00334276900490816,0.00473418593162414,-0.00593623542107516,0.0126217734308915,0.480143711059768
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.0029400407056514,0.00419913968689936,-0.00529027308067133,0.0111703544919741,0.48384410659076
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMCH,Pro-MCH,37562,-0.00580317939928557,0.0083210948197699,-0.0221125252460346,0.0105061664474634,0.485561269338288
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDAC8,Histone deacetylase 8,37598,0.00426950390900775,0.00612255565863596,-0.00773070518191873,0.0162697129999342,0.485602276204642
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,40042,0.00338661675535794,0.00485737746377663,-0.00613384307364427,0.0129070765843601,0.485681183785883
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMMR,Hyaluronan mediated motility receptor,37460,-0.00332123506584725,0.00477077235851369,-0.0126719488885341,0.00602947875683959,0.486339211610821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSC2,Desmocollin-2,40177,-0.00225913797339157,0.00328309564823598,-0.00869400544393409,0.00417572949715094,0.491392316104612
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00256934043572306,0.00373690811334482,-0.00475499946643279,0.0098936803378789,0.491743432701174
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL31,Interleukin-31,37598,-0.00390694210215902,0.00569712886420343,-0.0150733146759977,0.0072594304716797,0.492867810192672
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.00844658122949632,0.012343691844429,-0.0157470547855846,0.0326402172445772,0.493806551485505
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00575340602855196,0.00842997660650062,-0.0222761601772932,0.0107693481201892,0.494938949949853
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB6B,Ras-related protein Rab-6B,39961,0.00324008802410752,0.0047555288904526,-0.00608074860117958,0.0125609246493946,0.49567240881474
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRMD7,FERM domain-containing protein 7,37572,0.00221712277195902,0.00325826375123523,-0.00416907418046202,0.00860331972438006,0.4962243509526
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00571054008999666,0.0084827718527546,-0.0109156927414024,0.0223367729213957,0.500836562063807
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00236765384678547,0.00352976610988489,-0.00455068772858893,0.00928599542215986,0.502380198896524
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALLD,Palladin,37598,-0.00270329421009254,0.00406370942354068,-0.0106681646802323,0.00526157626004719,0.505916199972109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00262289141315061,0.00394802200147044,-0.00511523170973146,0.0103610145360327,0.506472165369857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00323608305626963,0.00488340872382549,-0.00633539804242833,0.0128075641549676,0.507554304506086
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00319213281848196,0.00484987977315361,-0.012697897173863,0.00631363153689911,0.510428943183675
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,37959,0.00504803509613081,0.00767106469640812,-0.0099872517088291,0.0200833219010907,0.510509598064585
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPA33,Cell surface A33 antigen,40305,0.00867601608113928,0.0132626169780609,-0.01731871319586,0.0346707453581386,0.513011294067337
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00466639313278615,0.00715816966817189,-0.00936361941683075,0.018696405682403,0.514478724298858
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,-0.00191413743276824,0.00293911036891716,-0.00767479375584588,0.00384651889030939,0.514887372089579
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACAN,Aggrecan core protein,40224,-0.00179994518301404,0.00276463221310387,-0.00721862432069763,0.00361873395466954,0.515016369293481
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC123,Cell division cycle protein 123 homolog,37482,0.00405257458903561,0.0062788244395313,-0.00825392131244573,0.016359070490517,0.518656534442714
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAP1A,Ras-related protein Rap-1A,37598,0.00438678829345717,0.006823309257217,-0.00898689785068815,0.0177604744376025,0.520292330628687
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA2,Protein disulfide-isomerase A2,37482,-0.00261713246855973,0.00407297758159458,-0.0106001685284851,0.00536590359136565,0.520520951663826
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC2L,C-type lectin domain family 2 member L,37572,0.00311090534561872,0.00485892995909057,-0.0064125973741988,0.0126344080654362,0.522024547614162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00217532639570922,0.0034124452639409,-0.00451306632161494,0.00886371911303338,0.523830498520047
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC2,Mucin-2,37998,0.0056062477548136,0.00885844014965633,-0.0117562949385128,0.02296879044814,0.526828726444202
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSV,Cathepsin L2,40444,-0.00260699184458111,0.00413347080802966,-0.0107085946283192,0.00549461093915702,0.52824384399632
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN2,Contactin-2,40489,0.00274919551817068,0.00436708278494959,-0.00581028674033051,0.0113086777766719,0.529013216804912
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00479181114493285,0.00764416721875986,-0.0101907566038365,0.0197743788937022,0.530762904358032
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL21R,Interleukin-21 receptor,37598,0.00340656043481874,0.00548230061062242,-0.00733874876200121,0.0141518696316387,0.534364184173762
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRN1,Neuritin,37959,-0.00221704925753802,0.00358284110620991,-0.00923941782570945,0.00480531931063341,0.536060914945466
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,40341,-0.00205328635719228,0.0033184110840723,-0.00855737208197399,0.00445079936758944,0.536086064375919
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.0029497631475747,0.00477503150972068,-0.00640929861147785,0.0123088249066272,0.536752931044008
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.0072414135793624,0.0118162731196799,-0.0159184817352102,0.030401308893935,0.53999510108226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF174,Zinc finger protein 174,37598,-0.00232570205363183,0.00379991312165622,-0.00977353177207801,0.00512212766481436,0.540521316343825
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,-0.00323522247278286,0.0052957063613856,-0.0136148069410986,0.00714436199553292,0.541266942621625
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY2B,Alpha-amylase 2B,39311,-0.0028614862662863,0.0047140401404215,-0.0121010049415124,0.00637803240893983,0.54385119106632
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NELL2,Protein kinase C-binding protein NELL2,40422,0.0016589005857588,0.0027517582218243,-0.00373454552901683,0.00705234670053444,0.54661628171242
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00333334642359529,0.00555765852235144,-0.00755966428021352,0.0142263571274041,0.548666365143308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00246802662431299,0.0041158907028456,-0.00559911915326438,0.0105351724018904,0.548760521584782
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD2,Bromodomain-containing protein 2,37541,-0.00202290533379596,0.00338582851615495,-0.00865912922545967,0.00461331855786775,0.550209018621402
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,-0.00192316225532169,0.00322183575906284,-0.00823796034308485,0.00439163583244147,0.550574080258979
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFAP,Glial fibrillary acidic protein,39959,0.00272309291848608,0.00456787235473731,-0.00622993689679904,0.0116761227337712,0.551090187333352
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAND5,DAN domain family member 5,37598,-0.00317163399916628,0.00532925336865372,-0.0136169706017276,0.007273702603395,0.551762375545101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC25A,M-phase inducer phosphatase 1,37482,-0.00237422646196325,0.00401184208737009,-0.0102374369532086,0.00548898402928213,0.553991733371823
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNPO1,Transportin-1,37714,-0.00205604916705291,0.00347496377355809,-0.00886697816322678,0.00475487982912095,0.554078330386778
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR3,Folate receptor gamma,40355,-0.0104649909887067,0.0179528032708683,-0.0456524853996086,0.0247225034221952,0.559957562459499
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00266388402015729,0.00464735442314439,-0.00644493064920572,0.0117726986895203,0.5665161345897
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.00197863579076891,0.00345442368452143,-0.00874930621243091,0.0047920346308931,0.566799537724574
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIRREL1,Kin of IRRE-like protein 1,37541,-0.003465319777098,0.00605132887704177,-0.0153259243760999,0.00839528482190386,0.566888591476551
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.0038700691956117,0.00680202514784373,-0.00946190009416202,0.0172020384853854,0.569394021273675
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGR,Progesterone receptor,37598,-0.00568856346202764,0.0101353686396796,-0.0255538859957997,0.0141767590717444,0.574630783161897
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF9,Fibroblast growth factor 9,37457,0.00221811362820756,0.00397686449680259,-0.00557654078552551,0.0100127680419406,0.577021712503483
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC39A14,Zinc transporter ZIP14,39961,-0.00181567012289253,0.00325598861286609,-0.00819740780411006,0.004566067558325,0.577098152199171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00405368504925444,0.00731527203800554,-0.0102842481452364,0.0183916182437453,0.579492361448811
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDAC9,Histone deacetylase 9,37541,-0.0034309314711406,0.00621631796209627,-0.0156149146768493,0.00875305173456809,0.581010244501396
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVI2B,Protein EVI2B,37482,0.00224973577201709,0.00412694257024042,-0.00583907166565414,0.0103385432096883,0.585670846975348
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00295397853836485,0.00546660049868459,-0.00776055843905695,0.0136685155157867,0.588952184522583
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00144060675928269,0.00267390000869484,-0.00380023725775919,0.00668145077632457,0.590055693471483
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPN3,Calpain-3,37900,0.0019443739686928,0.0036310160675636,-0.00517241752373185,0.00906116546111745,0.592319702184998
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPLX2,Complexin-2,37482,-0.0016167930779514,0.00303510166449888,-0.0075655923403692,0.0043320061844664,0.594251622750264
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRR1B,Cornifin-B,37714,0.0044054770054282,0.00834710823018209,-0.0119548551257287,0.0207658091365851,0.597657524938628
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.00213316709420523,0.00404537262587806,-0.0100620974409262,0.00579576325251576,0.597986963165258
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMP,Olfactory marker protein,37541,0.00259977888723555,0.00496480954669087,-0.00713124782427855,0.0123308055987497,0.600536977133316
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB5,Integrin beta-5,40411,-0.00185468190308243,0.00360734737097237,-0.00892508275018828,0.00521571894402342,0.607161168925539
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,-0.00236527166745139,0.0046212384066515,-0.0114228989444883,0.00669235560958555,0.608780902363249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGN,Cingulin,37572,0.00208943866197021,0.00410941831160392,-0.00596502122877348,0.0101438985527139,0.611145504792086
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM25,RNA-binding protein 25,37482,-0.00230426104060562,0.00453782334940675,-0.0111983948054428,0.0065898727242316,0.611609261592752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXK,Tyrosine-protein kinase TXK,37714,0.00376541070631366,0.00743179794850064,-0.0108009132727476,0.0183317346853749,0.612400317552546
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK15,Kallikrein-15,37880,0.00251262564461744,0.00500918501694375,-0.00730537698859231,0.0123306282778272,0.61595455289735
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP4,Caspase-4,37714,0.0083554806077213,0.0167309476758364,-0.0244371768369181,0.0411481380523607,0.617503994958246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL4,Myosin light chain 4,37628,0.00253867406768999,0.0051499234183771,-0.00755517583232913,0.0126325239677091,0.622053481161955
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00291242930413996,0.00591400250156973,-0.00867901559893672,0.0145038742072166,0.622400106316164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR1,Toll-like receptor 1,37598,0.00124291233019274,0.0025614420951396,-0.00377751417628087,0.00626333883666635,0.627514704365024
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.00264428398633845,0.00545829680114775,-0.00805397774391113,0.013342545716588,0.628072981630656
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPEP,Glutamyl aminopeptidase,37562,-0.00219926626622418,0.00454201584827407,-0.0111016173288414,0.006703084796393,0.628248558091632
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00248206370443742,0.00514116986365042,-0.0125587566371922,0.00759462922831741,0.629258595291483
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRAS,GTPase Hras,37697,-0.00464815813693363,0.00964107460766353,-0.0235446643679542,0.0142483480940869,0.629728430290488
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN3B,Sodium channel subunit beta-3,37541,0.0021678368990872,0.00449976337723085,-0.00665169932028527,0.0109873731184597,0.629979624498961
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00315161074715809,0.00657437656699717,-0.00973416732415635,0.0160373888184725,0.631677811987374
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RUVBL1,RuvB-like 1,39980,0.00495911296548164,0.0104793390684605,-0.0155803916087009,0.0254986175396642,0.63605742771217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,0.00337619984396932,0.00723645427139319,-0.0108072505279613,0.0175596502159,0.640826457056244
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPO,Lactoperoxidase,39831,-0.00267816665172244,0.0057681886919414,-0.0139838164879276,0.0086274831844827,0.642439813293553
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC51B,Organic solute transporter subunit beta,37562,0.00360381403827089,0.0077929986425051,-0.0116704633010391,0.0188780913775809,0.643771678100798
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEB,Nebulin,37562,0.00164705396542811,0.00356624522569009,-0.00534278667692446,0.00863689460778069,0.64419985184322
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL3,Interleukin-3,37482,-0.00266075189283031,0.00589656302805076,-0.0142180154278098,0.00889651164214918,0.651825707035069
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCP11,T-complex protein 11 homolog,37714,-0.00265996625988296,0.00595311242817766,-0.0143280666191112,0.00900813409934524,0.655012742498258
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00173587278913147,0.00400302670816371,-0.00958180513713234,0.00611005955886939,0.664556884332249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALMS1,Alstrom syndrome protein 1,37714,0.00191117461253062,0.00441385663713147,-0.00673998439624706,0.0105623336213083,0.6650259773694
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCND2,G1/S-specific cyclin-D2,37714,0.00152760006614408,0.00359268668719965,-0.00551406584076724,0.0085692659730554,0.670699875420651
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPESP1,Sperm equatorial segment protein 1,37990,0.00112534634209607,0.00269505908422379,-0.00415696946298257,0.0064076621471747,0.67627615549313
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20,Interleukin-20,40044,0.00205820698114783,0.00498077210173955,-0.00770410633826169,0.0118205203005574,0.67944342156253
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.0031337290939249,0.00760755469356225,-0.0180445362933069,0.0117770781054571,0.680402201767904
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTR,Methionine synthase,37562,0.00263614657539636,0.00640879199330203,-0.00992508573147563,0.0151973788822683,0.680835220294692
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00138303139071475,0.0033773265876345,-0.00523652872104887,0.00800259150247839,0.682175979689376
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TET2,Methylcytosine dioxygenase TET2,37697,0.00403315946992568,0.00986427345410252,-0.0153008165001153,0.0233671354399666,0.682645100214316
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MB,Myoglobin,40536,0.00194902069552709,0.00478655656666015,-0.00743263017512681,0.011330671566181,0.683876514558316
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00148003110522285,0.00366345674712783,-0.0057003441191477,0.0086604063295934,0.686219348041963
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL5,Interleukin-5,40044,-0.00575157307522185,0.0142418830508129,-0.0336656638548152,0.0221625177043715,0.686329152949742
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB6A,Ras-related protein Rab-6A,40341,0.00187609966911997,0.00465342534614566,-0.00724461400932552,0.0109968133475655,0.686832042832994
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC11A,C-type lectin domain family 11 member A,40296,0.00187770269846881,0.00466987736294883,-0.00727525693291091,0.0110306623298485,0.687624522348958
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,37541,-0.00248534534338244,0.00623936419377458,-0.0147144991631806,0.00974380847641574,0.690391154378903
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSCA,Prostate stem cell antigen,37901,0.0100849624795443,0.0254163529532697,-0.0397310893088643,0.0599010142679529,0.691528395371388
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00257644902332496,0.00653080537312658,-0.0102239295080031,0.0153768275546531,0.693213121293509
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY2A,Pancreatic alpha-amylase,39695,-0.0017995330170874,0.00460318617305656,-0.0108217779162783,0.00722271188210345,0.695852924985977
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,0.00249444844551291,0.00646074252857085,-0.010168606910486,0.0151575038015118,0.699433946780125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPHA2,Glycoprotein hormone alpha-2,37901,0.00184048949239906,0.00478937866030203,-0.00754669268179291,0.011227671666591,0.700772818155027
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,40128,-0.00654387294585308,0.0170355276144608,-0.0399335070701962,0.02684576117849,0.700886623366296
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSP90B1,Endoplasmin,39878,-0.00253997589685549,0.00684456800391825,-0.0159553291845353,0.0108753773908243,0.710572857640366
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,0.00108951270378027,0.00294467481401986,-0.00468204993169866,0.0068610753392592,0.711392612284615
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00169773434409439,0.00461987969190278,-0.00735722985203506,0.0107526985402238,0.713262479577379
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERCC1,DNA excision repair protein ERCC-1,37482,0.0012011073637067,0.00328987930445977,-0.00524705607303446,0.00764927080044786,0.715048941923573
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFAP2A,Transcription factor AP-2-alpha,37541,-0.00208998601764813,0.00594496233993644,-0.0137421122039236,0.00956214016862729,0.725177073709281
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00218641811926825,0.00631527944200534,-0.0101915295870622,0.0145643658255987,0.729189770587566
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THY1,Thy-1 membrane glycoprotein,40471,0.000928615304503801,0.00272840100571618,-0.00441905066669991,0.00627628127570751,0.733596320441031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL4,Interleukin-4,40044,0.00297088872349462,0.00877154022076813,-0.0142213301092109,0.0201631075562002,0.73484304563419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROK1,Prokineticin-1,40341,-0.002261095667562,0.00671274830799238,-0.0154180823512271,0.0108958910161031,0.736244939404616
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPT1,Translationally-controlled tumor protein,40044,0.00217631890818299,0.00649369913364642,-0.010551331393764,0.01490396921013,0.737521598214531
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD4,Sushi domain-containing protein 4,37900,-0.00146138549767831,0.00436182931304225,-0.0100105709512411,0.0070877999558845,0.737600448732153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCNA,Proliferating cell nuclear antigen,37482,0.00198161767613245,0.00612392055376945,-0.0100212666092557,0.0139845019615206,0.746256345430611
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00182896536833175,0.00567673354649716,-0.00929743238280268,0.0129553631194662,0.747316762701662
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,-0.000852416375972807,0.00266260993910211,-0.00607113185661294,0.00436629910466732,0.748863979865358
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NLGN1,Neuroligin-1,37572,-0.00215746170096166,0.00682433228352013,-0.0155331529766611,0.0112182295747378,0.751899352703172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD177,CD177 antigen,40316,0.00390958826625087,0.0124474877008621,-0.0204874876274388,0.0283066641599406,0.753459446890451
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_A,,37959,0.00100379549344966,0.00319772316396021,-0.00526374190791235,0.00727133289481166,0.753594666815881
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17F,Interleukin-17F,40044,0.00243618857290716,0.0077666335323443,-0.0127864131504877,0.017658790296302,0.753773083925399
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00154763222139248,0.00493875297481816,-0.0112275880520361,0.00813232360925112,0.754008403886904
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLINT1,Clathrin interactor 1,37482,-0.00140416960462401,0.00449814695537051,-0.0102205376371502,0.00741219842790219,0.754919185556223
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANK2,Ankyrin-2,37562,0.00225397595848179,0.00727130065803056,-0.0119977733312581,0.0165057252482217,0.756579191168579
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANGAP1,Ran GTPase-activating protein 1,39980,-0.00149444909113982,0.00485834703511984,-0.0110168092799747,0.00802791109769507,0.758387471110261
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HK2,Hexokinase-2,40042,-0.000822296545679869,0.00269894420191829,-0.00611222718143972,0.00446763409007998,0.76061896648638
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A3,Protein S100-A3,37900,0.00134143457226501,0.00449159426177058,-0.00746209018080532,0.0101449593253353,0.765208336804757
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,0.00166206644886951,0.00558499030221822,-0.0092845145434782,0.0126086474412172,0.766016830833438
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.0024736708440723,0.0083145894510165,-0.0187702661680646,0.01382292447992,0.766082079024201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,-0.00119899387227132,0.00411789071427781,-0.00927005967225583,0.0068720719277132,0.770928195956901
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.00155704824192012,0.00537479103747827,-0.0120916386753775,0.00897754219153729,0.772054413571237
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGLON5,IgLON family member 5,37482,-0.0026509268401727,0.00922626759290178,-0.0207344113222602,0.0154325576419148,0.773868922123021
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAGEA3,Melanoma-associated antigen 3,37714,0.00235179195212253,0.00828058280772248,-0.0138781503510135,0.0185817342552586,0.776404964219604
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00270317225714793,0.00951795109214761,-0.0159520118834614,0.0213583563977572,0.776408895782045
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,37541,-0.00218736593604608,0.0077019392550063,-0.0172831668758584,0.0129084350037663,0.776413361716008
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.000807787979743992,0.00287392486061011,-0.00482510474705182,0.0064406807065398,0.778656611375243
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTNL10,Butyrophilin-like protein 10,37482,0.0011503032301019,0.0040993814373894,-0.00688448438718132,0.00918509084738512,0.779018527574574
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTXR,Neuronal pentraxin receptor,40359,-0.000914974669613884,0.00330864127366646,-0.00739991156600014,0.00556996222677237,0.782136235260059
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00151960709931956,0.00552892778667314,-0.0093170913625598,0.0123563055611989,0.783438438916576
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00171325725751013,0.00624897254907347,-0.0139612434536941,0.0105347289386739,0.783961147225949
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,-0.00134426378173749,0.00495534382302777,-0.0110567376748719,0.00836821011139695,0.786183315762388
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOC2B,Double C2-like domain-containing protein beta,37572,0.000930171962191751,0.00352653129657403,-0.00598182937909335,0.00784217330347685,0.791965927220065
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00125426120719218,0.00484816082128446,-0.00824813400252535,0.0107566564169097,0.795864102486175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCLN,Nicalin,40044,-0.00134118134533898,0.00521477889646135,-0.0115621479824032,0.00887978529172527,0.797036627803265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAG,Myelin-associated glycoprotein,37572,-0.00117080170226256,0.00456381388772817,-0.0101158769222098,0.00777427351768466,0.797537770306246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,-0.00103451444495406,0.00403375368865205,-0.00894067167471207,0.00687164278480395,0.797596201008398
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,0.00092547503977115,0.00361000057514343,-0.00615012608750997,0.00800107616705227,0.797673505054988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFR,Epidermal growth factor receptor,40536,0.00040799314752149,0.00159432990549446,-0.00271689346724766,0.00353287976229064,0.798029329440976
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHD,SH2 domain-containing adapter protein D,37531,0.0021841111330982,0.0085988147171449,-0.0146695657125058,0.0190377879787022,0.799498455273899
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPBGL,Trophoblast glycoprotein-like,37572,0.00103278050389959,0.00408867958010154,-0.00698103147309943,0.00904659248089861,0.80058505950369
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF830,Zinc finger protein 830,37900,-0.00197253141894937,0.00790080746691428,-0.0174581140541014,0.0135130512162026,0.802852558110321
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL6B,Myosin light chain 6B,37572,0.00223946248949336,0.00905856826970069,-0.01551533131912,0.0199942562981067,0.804741559179139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFL4,Insulin growth factor-like family member 4,37598,0.001902442416467,0.00770471133173145,-0.0131987917937266,0.0170036766266606,0.804974486158606
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00197380758250279,0.00808695991620685,-0.0178242490182682,0.0138766338532626,0.807178177691466
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKIV2L,Helicase SKI2W,37562,-0.000969813196690591,0.00397467086568281,-0.00876016809342889,0.00682054170004771,0.807235903510474
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00334686221048407,0.0138607605649946,-0.0238202284969054,0.0305139529178735,0.809200012154773
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIPK1C,Divergent protein kinase domain 1C,37572,-0.00101218330513303,0.00420226760364852,-0.00924862780828413,0.00722426119801808,0.809662753542761
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,0.00153274794922603,0.00639600025193753,-0.0110034125445715,0.0140689084430236,0.810611252953621
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYTH3,Cytohesin-3,37482,0.00168103629613228,0.00722528389450215,-0.0124805201370919,0.0158425927293565,0.816028898868018
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,37598,0.0010740106762614,0.00478916271717935,-0.00831274824941013,0.0104607696019329,0.822559613939479
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC1A4,Neutral amino acid transporter A,37572,0.0011494105121814,0.00514347366826906,-0.00893179787762596,0.0112306189019888,0.823173442796845
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN7,Tetraspanin-7,37541,-0.00199686174173484,0.0089798977530882,-0.0195974613377877,0.015603737854318,0.824029170421275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,37541,-0.00164459393049098,0.00740719236907674,-0.0161626909738814,0.0128735031128994,0.824296619878666
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.000599231767808441,0.00271266673092905,-0.00591605856042937,0.00471759502481249,0.825172568449717
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KHDC3L,KH domain-containing protein 3,37482,-0.00147428793697421,0.00668137379673284,-0.0145697805785706,0.0116212047046221,0.825363433988568
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00121899654112461,0.00573297687898251,-0.0100176381416811,0.0124556312239303,0.831619728297816
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,40044,-0.000805192220733139,0.00379072738653171,-0.00823501789833528,0.006624633456869,0.831789176142544
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,37541,0.00187924775506764,0.0089253066769116,-0.0156143533316791,0.0193728488418144,0.833239572844713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37562,0.000831986747046442,0.00403232611629198,-0.00707137244088585,0.00873534593497873,0.836536950662098
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORN4,MORN repeat-containing protein 4,37482,0.00155350323606532,0.00772726590869718,-0.0135919379449812,0.0166989444171118,0.840669048941039
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.000806743019695271,0.00401643914949316,-0.00867896375270186,0.00706547771331132,0.8408109481431
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,-0.000549251608032203,0.00275763629148843,-0.00595421873934953,0.00485571552328513,0.842129105346733
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00113668993749619,0.00593796677200834,-0.0127751048106325,0.0105017249356402,0.848193685194102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPH3,Neurexophilin-3,37598,-0.000563426502145255,0.00296408589728942,-0.00637303486083253,0.00524618185654202,0.849245925756737
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.000834547224310143,0.00482005990795029,-0.0102818646438927,0.00861277019527243,0.86254325178742
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF3,Fibroblast growth factor 3,37598,0.000497508906004087,0.00298263094659296,-0.00534844774931811,0.00634346556132629,0.867528384314965
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH4,Cadherin-4,37541,-0.000809605036591017,0.00485461683295351,-0.0103246540291799,0.00870544395599786,0.867553505497149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL3,Insulin-like 3,37942,-0.000947419611955232,0.00583510962615641,-0.0123842344792218,0.0104893952553113,0.871020587912786
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37598,-0.000737480462263395,0.00494134027855679,-0.0104225074082347,0.00894754648370791,0.881360984138047
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IKZF2,Zinc finger protein Helios,39980,0.00135608537555963,0.00913831834918894,-0.0165550185888507,0.01926718933997,0.882032573390327
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNIP4,Kv channel-interacting protein 4,39961,0.000721921799097836,0.00500464963215314,-0.00908719147992232,0.010531035078118,0.885304761841218
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.00367488889692139,0.0257199887967173,-0.0540860669384873,0.0467362891446445,0.886386620098689
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,37572,0.000493316299817269,0.00360706511041586,-0.00657653131659782,0.00756316391623236,0.891219515840838
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,-0.000427655494858627,0.00318118241927754,-0.0066627730366426,0.00580746204692535,0.893062351621662
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2,Interleukin-2,40044,-0.000410585788074821,0.00305882933882508,-0.00640589129217197,0.00558471971602233,0.893222662426776
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMOD2,Leiomodin-2,37541,0.000826178351576812,0.00637272183265165,-0.0116643564404204,0.013316713143574,0.896850926074591
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN3,Neuronal-specific septin-3,37959,-0.000933677207475062,0.00720992112404855,-0.0150651226106102,0.0131977681956601,0.896964784832491
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.000693479313516277,0.00549891225750993,-0.0114713473382357,0.0100843887112032,0.899645143773611
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBZ,Hemoglobin subunit zeta,37990,0.00128547407646392,0.010253895513655,-0.0188121611302999,0.0213831092832278,0.900236884186987
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,37482,-0.000772510703377863,0.00621885686899759,-0.0129614701666131,0.0114164487598574,0.901142455453619
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EXOSC10,Exosome component 10,37562,0.000757591917570068,0.00615249306567071,-0.0113012944911445,0.0128164783262847,0.902001480883064
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17C,Interleukin-17C,40044,-0.000813445693493409,0.00684946048695754,-0.0142383882479302,0.0126114968609434,0.905466594009963
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MLLT1,Protein ENL,37482,0.000831114751779885,0.00701692151859027,-0.012922051424657,0.0145842809282168,0.905717407728837
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37990,0.000699929870084875,0.00618278646185146,-0.011418331595144,0.0128181913353137,0.909868744930832
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,37628,0.000540716300554613,0.00478312971470875,-0.00883421794027454,0.00991565054138376,0.909995374355113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.000911631241335223,0.00807560814328056,-0.0167398232021651,0.0149165607194947,0.910121845185307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.000834280061254244,0.0074864674980793,-0.0155077563574897,0.0138391962349812,0.911270140442557
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP350,Centrosome-associated protein 350,37482,-0.000404591754384717,0.00367082506302443,-0.0075994088779126,0.00679022536914317,0.912238021063752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.000706443194612468,0.00658275093550481,-0.0136086350282019,0.012195748638977,0.914538867137104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP2BP,LRP2-binding protein,37572,0.000908211622876892,0.00850544945502927,-0.0157624693089805,0.0175788925547343,0.914965172212495
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSD1,Tryptase delta,37959,-0.000398545059031704,0.00373677540359804,-0.00772262485008385,0.00692553473202044,0.9150644208491
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEX101,Testis-expressed protein 101,37572,0.000409388309081015,0.00384606259518236,-0.00712889437747641,0.00794767099563844,0.915232119784851
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.000554747147333267,0.00586197822525249,-0.0109347301741616,0.0120442244688282,0.924606104284108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.000448012967524139,0.00476296328602506,-0.00888739507308498,0.00978342100813326,0.92506149116716
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.000499249464111736,0.00532746109261216,-0.0109410732056316,0.0099425742774081,0.92533899088175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB5,Serpin B5,40042,-0.000434398250159207,0.00476084993108021,-0.00976566411507642,0.008896867614758,0.927300009731442
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB7,Integrin beta-7,40489,0.000394532204643125,0.00443354168906714,-0.00829520950592847,0.00908427391521472,0.929092522812871
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA6,Corticosteroid-binding globulin,38013,0.000154380549948108,0.00174388748129008,-0.00326363891338045,0.00357240001327666,0.92945939591007
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.000253113291296014,0.0028829098232081,-0.00590361654478389,0.00539738996219187,0.930038643241898
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,-0.000575571167241835,0.00658052321499245,-0.013473396668627,0.0123222543341434,0.930302551597927
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYBB2,Beta-crystallin B2,37942,-0.000582596534039502,0.00672156802640604,-0.0137568698657953,0.0125916767977163,0.930930588144117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.000407478395412723,0.00495209504105641,-0.00929862788505785,0.0101135846758833,0.934422085948848
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIPK2B,Divergent protein kinase domain 2B,37671,-0.000211816412210796,0.00260964834350447,-0.00532672716547955,0.00490309434105796,0.935310650669942
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRX,Cone-rod homeobox protein,40042,-0.000839165901644809,0.0104839856789096,-0.0213877778323075,0.0197094460290179,0.936204369542829
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNB2,Ephrin-B2,37572,-0.000452077861491352,0.00566927610786038,-0.0115638590328977,0.010659703309915,0.936443888808085
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESR1,Estrogen receptor,37598,0.000437654599056925,0.00569828485690398,-0.0107309837204749,0.0116062929185887,0.938780144739355
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMA1,Proteasome subunit alpha type-1,39980,-0.000335734804914269,0.00454168349013252,-0.009237434445574,0.00856596483574546,0.941072617911749
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA10,Ephrin type-A receptor 10,39961,0.000467877269907312,0.00637155033303544,-0.0120203613828422,0.0129561159226568,0.941463102938883
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP73,Tumor protein p73,37572,-0.000250939882428744,0.0034235762109008,-0.00696114925579431,0.00645926949093682,0.941570427502302
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACHE,Acetylcholinesterase,37671,0.000214166534154443,0.00312037304258413,-0.00590176462931046,0.00633009769761934,0.945281265458521
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,-0.000423684774801737,0.00623789734333626,-0.0126499635677408,0.0118025940181373,0.945849493824298
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS2,"Nitric oxide synthase, inducible",37562,0.000239407677703441,0.00384732837280545,-0.00730135593299524,0.00778017128840212,0.950383015037989
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40536,0.000352562042354459,0.00593805997554243,-0.0112860355097087,0.0119911595944176,0.952655540009613
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,-0.000423224267468996,0.00767810667389694,-0.015472313348307,0.014625864813369,0.956042972789715
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,40465,0.000324768118900332,0.00622037862892397,-0.0118671739937906,0.0125167102315913,0.958361740718158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRRT3,Proline-rich transmembrane protein 3,37628,0.000189252378981996,0.00368065971402404,-0.00702484066050513,0.00740334541846912,0.958993174101763
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRC1,Protein regulator of cytokinesis 1,37900,0.00022636642423559,0.00456303668362217,-0.00871718547566386,0.00916991832413504,0.96043493173867
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAD2,Glutamate decarboxylase 2,37598,-0.000214026318108747,0.00463724164904023,-0.0093030199502276,0.00887496731401011,0.963188367464397
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,37598,-0.000178735288800442,0.00417694045562665,-0.00836553858182868,0.0080080680042278,0.965868820745308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN6,Prefoldin subunit 6,37572,-0.000272330258247577,0.00647500531383166,-0.0129633406733576,0.0124186801568625,0.966452549523628
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PXDNL,Peroxidasin-like protein,37900,0.000237941632072148,0.00572978722378559,-0.0109924413265476,0.0114683245906919,0.966876279548578
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF7,Fibroblast growth factor 7,37482,0.000321367401597886,0.00793707071486591,-0.0152352911995393,0.0158780260027351,0.967703560890513
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,-0.000118381018934983,0.00321007200860276,-0.00641012215579639,0.00617336011792643,0.970582757556337
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPB41L5,Band 4.1-like protein 5,37572,-0.000204347617248707,0.00623610757556344,-0.0124271184653531,0.0120184232308556,0.973859731553348
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGN,Secretagogin,40044,-0.00013156891859288,0.00428294399792759,-0.00852613915453096,0.00826300131734521,0.975493815326689
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTN,Neuroplastin,39980,0.000249549603865512,0.00824142922763924,-0.0159036516823074,0.0164027508900384,0.97584422058798
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.000117794363844865,0.00393860207607705,-0.00783745443295588,0.00760186570526615,0.976141154371181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPK3A,Uroplakin-3a,37541,-0.000127508250712216,0.00490757537188234,-0.0097463559796016,0.00949133947817716,0.979272152165586
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40536,-5.68226549754143e-05,0.0021996551434198,-0.00436814673607822,0.00425450142612739,0.979391236697141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPGN,Epigen,37900,-0.000109109786547543,0.00483909091117947,-0.00959372797245931,0.00937550839936422,0.98201149328505
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,9.84904360148834e-05,0.00494946532803396,-0.00960246160693167,0.00979944247896144,0.984124080908966
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,9.00480509639942e-05,0.00475007882756037,-0.00922010645105433,0.00940020255298232,0.98487556049665
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN4,Nectin-4,40411,5.5504826104078e-05,0.00297636120159196,-0.00577816312901617,0.00588917278122433,0.985121703933246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FH,"Fumarate hydratase, mitochondrial",37541,-0.000152146442157445,0.00838765387216493,-0.0165919480316007,0.0162876551472858,0.98552797681901
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,6.23578445155458e-05,0.00347722472528612,-0.00675300261704526,0.00687771830607635,0.985692355990647
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL9,Interleukin-9,37714,9.32012381074281e-05,0.00563090894439073,-0.0109433802928984,0.0111297827691133,0.986794488712026
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK3,Prostate-specific antigen,37998,-9.08785016856102e-05,0.00558952483244658,-0.0110463471732809,0.0108645901699097,0.987028231796605
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENOPH1,Enolase-phosphatase E1,37900,7.86405820052453e-05,0.00560635613982704,-0.0109098174520557,0.0110670986160662,0.988808616410188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-6.12358515349277e-05,0.00483070407358432,-0.0095294158357602,0.00940694413269035,0.989886175232814
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,6.49391822401667e-05,0.00560136130715818,-0.0109137289797899,0.0110436073442702,0.990750137748143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHC1,SHC-transforming protein 1,37482,-0.000106522025722551,0.011438783954426,-0.0225265385763975,0.0223134945249524,0.992570065062517
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,40422,-1.87809643915782e-05,0.00271083949420172,-0.00533202637302694,0.00529446444424378,0.994472307528236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,-2.50720146689456e-05,0.00413589372731988,-0.00813142372021591,0.00808127969087802,0.995163299169991
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,5.78406296588339e-06,0.00416868699492529,-0.00816484244708768,0.00817641057301944,0.9988929541494
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FZD8,Frizzled-8,37541,-4.57771036264169e-06,0.00440042454614069,-0.0086294098207984,0.00862025440007311,0.999169985994932
